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ABSTRACT 
 
This dissertation investigates the utility of layer-by-layer (LBL) assembled carbon 
nanotube (CNT) composites as a neural interfacing material. The theoretical framework 
behind this research is based on the unique properties of CNTs and the ability of the LBL 
technique to impart multifunctionality into nanostructured thin films. The combination of 
CNTs and LBL assembly provides an opportunity to create materials with precisely 
controlled mechanical, electrochemical, and biological properties suitable for neural 
interfacing. In this dissertation, LBL assembled CNT-polyelectrolyte films were 
demonstrated to be biocompatible with neural cells using high-content screening 
methods. Moreover, these CNT composite films also supported the differentiation and 
electrical stimulation of neural stem cells, which hold promising therapeutic potentials. 
The electrochemical properties of LBL assembled CNT composites were established and 
found to outperform those of existing and emerging electrode materials. The 
incorporation of appropriate biological molecules into the CNT LBL films enabled the 
demonstration of enhanced neural stem cell differentiation and gene delivery that 
programmed multipotent cells into neurons. Finally, we purposed an in vitro 3D neural 
tissue model that can be used to facilitate the testing of electrode coatings designed to 
mitigate electrode-induced gliosis. The goal of this dissertation is to contribute to the 
development of next-generation neural electrode technologies, as well as to the 
fundamental understanding of both cellular response to nanomaterials and manipulation 








The development of nanotechnology has penetrated biology and medicine at a 
remarkable scale.1 Nanotechnology has provided tools to measure and understand 
biosystems,2-4 brought insights to challenges in biotechnology and biomedicine,5-7 and 
offered building components for advanced biomaterials.8-10 However, despite these 
advancements in biology and medicine, nanotechnology’s applications to neuroscience 
are far behind applications to other disciplines of biomedicine.11 The reason is multifold. 
The central nervous system (CNS) is highly complex in its anatomy, functional 
structuring, and information processing. Moreover, the CNS is difficult to access and 
consists of an extremely heterogeneous cellular and molecular environment. But recently 
we are beginning to see emerging progress in the application of nanotechnology in 
neuroscience.12, 13 Armed with one of the most fascinating nanomaterials and an 
exceptionally versatile nanostructuring technique, we believe this research can make 
significant contributions to bridge the distance between nanotechnology and 
neuroscience, as well as provide novel solutions for better neural prosthetic devices. 
 2 
1.1 Motivation 
Diagnostic, therapeutic and treatment strategies for various neurological, sensory, 
and psychiatric conditions are increasingly relying on neural prosthetic devices. Deep 
brain stimulation and pace-makers are the two examples of this rapidly growing field of 
medical practice.14-17 The employment of neural prosthetic devices has significantly 
improved the quality of life for those suffering from neurological disorders and injuries. 
The cochlear implant, as the most successful neural prosthetic device, has been in 
common clinical use for over two decades for restoration of hearing.18 Chronic deep-
brain stimulation with spike electrodes has proven to dramatically alleviate symptoms in 
patients of Alzheimer’s and Parkinson’s diseases.19-23 Other devices have also allowed 
patients of ayomyotrophic lateral sclerosis and paralysis to regain their motor control and 
function.24 Cuff electrodes around peripheral nerves are used for treatment of numerous 
disorders from pain and to incontinence, diabetes, depression, and arrhythmia.25-35 All of 
these neural prosthetic devices are essential for restoring neurological functions, mobility 
of limbs and other parts of the body in case of injury or paralysis.36 
Despite general success and proven medical importance, there are still multiple 
practical and fundamental challenges related to the utilization of neural electrodes. While 
most chronically implanted electrodes appear to be well tolerated initially, long-term 
viability of these electrodes remains a significant problem that is rooted in the lack of 
knowledge about neural interfacing and new materials. Some of the existing challenges 
include stability and charge injection safety of the electrode after prolonged use. Another 
 3 
major issue is inflammatory responses brought about by a combination of factors, such as 
electrode size, mechanical mismatch between tissue and electrode, and poor integration 
of the electrode with surrounding tissue, leading to the formation of an insulating sheath 
encapsulating the electrode. Significant strides toward better and safer electrodes hinge 
on improvements of cellular interface, charge transport, mechanical compliance with the 
tissues, and chemical stability of the electrode materials.14, 15, 17, 36-39 
Nanomaterials present an essential and largely untapped resource for the design of 
neural electrodes. The intrinsic properties of nanomaterials enable the engineering of 
cellular interface and nano/micro organization of the electrode which are essential to the 
physical, chemical and biological properties of the device.40-46 For example, carbon 
nanotubes exhibit unique mechanical,47, electrical,48 and optical 49 properties that can be 
exceptionally useful for this application. Nanocomposites have been predominantly 
designed for a variety of high-end electronic and optical applications,50-53 and the very 
same functions can be taken advantage of in designing neural electrodes.  
This dissertation aims to develop a neural interfacing material based on layer-by-
layer (LBL) assembled carbon nanotube (CNT) composite films that offers a more 
compliant and biocompatible interface, better charge transfer capability, and the ability to 
direct neuronal growth and deliver biological agents. The outcome of this research has 
both practical and scientific values. On the practical side, this research contributes to the 
development of a new generation of neural electrodes for electrical stimulation and 
recording of excitable cells. Scientifically, this research allows us to gain fundamental 
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understanding of both cellular response to nanomaterials and manipulation of cell 
behavior through nanostructured materials. 
This dissertation is the convergence of several fields of study, including 
nanotechnology, materials engineering, biomedical engineering, tissue engineering, 
neuroscience, and stem cell biology. Therefore, this introductory chapter provides a 
review on a wide range of topics that are fundamental to this dissertation. We begin our 
review with the neural interface, which includes discussions on electrode materials, the 
issue of inflammatory reaction, and approaches to mitigate inflammatory reactions. This 
is followed by a discussion of the properties of carbon nanotubes (CNTs) and their 
applications in biomedicine and neural interfacing. Presented next is a review on the 
nanostructuring technique of layer-by-layer (LBL) assembly, with an emphasis on 
biomedical applications and LBL composites fabricated with CNTs. We then look at 
neural stem cells (NSCs), examining the significance of using these cells in this research 
and strategies that can be used to manipulate their behaviors. Lastly, we review the 
inverted colloidal crystal (ICC) scaffold design, which enables us to develop 3D neural 






1.2 Neural Interface 
 Despite the variety of neural prosthetic devices and methods of their use, they all 
share a common purpose, which is to exchange information with the nervous system.54 
Neural interfaces are the connections that allow this exchange of information to take 
place, and thus neural interfaces are critically important to the efficacy of neural 
prosthetic devices. To initiate a response in the nervous system, information can be 
delivered by application of electrical signals to induce action potentials. On the other 
hand, information about the state of the nervous system can be extracted by recording the 
action potentials as electrical signals. The ability of a neural electrode to carry out its 
stimulation or recording function chronically is dependent on an array of factors, such as 
implantation techniques, geometry, mechanical properties, biocompatibility, and 
electrochemical properties. Among these, biocompatibility and electrochemical 
properties are perhaps the most important and of interest to this dissertation.  
 To maintain the exchange of information between a neural prosthetic device and 
the nervous system, the ideal neural interface must be able to integrate intimately with the 
surround neural tissue to ensure effective delivery or recording of electrical signals. 
Therefore, the material selection for the electrode is a critical determinant for this 
process. The ideal neural interfacing material must be biocompatible enough or 
encompass biofunctionalities to prevent or resolve inflammatory reactions and maintain 
stable connections with neurons. Inflammatory reactions caused by electrode 
implantation are often detrimental, resulting in loss of neuronal population and formation 
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of an insulating sheath that destroy the neural interface and render the electrode useless. 
In addition, the ideal neural interfacing material must also possess appropriate 
electrochemical properties necessary to carry out the intended functions. To achieve 
successful stimulation, the material must be able to deliver sufficient electrical charges to 
the interface with neurons without inducing chemical reactions that can damage the 
surrounding tissues. For recording purposes, the material must be able to record electrical 
signals at a high signal-to-noise ratio so that the signals can be successfully processed and 
interpreted. In this section, we will now review some of the conventionally used and 
emerging electrode materials, discuss the process of inflammatory reactions, and present 
strategies that have been used to control inflammatory reactions. 
1.2.1 Neural Electrode Materials 
The major types of neural electrode materials can be categorized as capacitive or 
faradaic, depending on the mechanism in which the electron flow in the electrode is 
transitioned into ion flow in the tissue.55 Capacitive reactions are characterized by 
charging and discharging of the electrode-electrolyte double layer. Two of the mostly 
commonly used capacitive charge-injection materials are titanium nitride and 
tantalum/tantalum oxide.56 In general such electrodes are highly desired as no chemical 
species are created or consumed during the process. Typically, for capacitive charge-
injection materials, high charge-injection capacity is achieved through the employment of 
high dielectric constant coatings or the creation of a highly porous geometry that can 
provide large surface area accessible to ions.  
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 Faradaic reactions result from the reduction and oxidation of surface-confined 
species at the electrode-electrolyte interface. Although faradaic reactions can provide 
large amount of charges for stimulation, these reactions often produce unwanted effects 
such as dissolution of the electrode and oxidization and reduction of water, all of which 
can be harmful to the surrounding tissues. Some of the most prevalent and established 
materials in this category are noble metals, such as Pt and PtIr alloys, and various forms 
of iridium oxide.57, 58 Among these materials, iridium oxide is the material with the 
highest performance. Iridium oxide can be formed by electrochemical activation, or 
repeated oxidation and reduction, of iridium on a metal surface. Alternatively, iridium 
oxide can also e produced by reactive sputtering from iridium in an oxidizing plasma.55 
Although iridium oxide has been widely used in stimulation studies in the central nervous 
system and in clinical settings for acute and short-term studies,59, 60 this material poses its 
own set of problems. Delamination and cracking of the iridium oxide coating have been 
reported under high charge density that resulted in the deposition of foreign materials in 
the surrounding tissues.61, 62 Most importantly, this causes significant reduction of the 
charge injection capabilities over time because a layer of electrolytes sips between the 
conductive coating and the backing, causing multiple problems for effective electrical 
stimulation of the cells.63  
Besides the ability to deliver sufficient charges without complications, the 
greatest hurdle for all conventionally used electrode materials is their capability to 
interface with neural tissues chronically. Mechanically, metal coatings are brittle and can 
only withstand limited number of flexural motions. Most importantly, these materials do 
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not encompass the ability to be surfaced modified for enhanced biocompatibility and 
biofunctionality that would enable long-term implantation in the body. 
Poly(ethylenedioxythiophene) (PEDOT) is a conducting polymer that has recently 
emerged as a promising material for this challenge. The biocompatibility of PEDOT has 
been successfully demonstrated in both cell culture and animal studies.64-66 Remarkably, 
PEDOT has been shown to improve various aspects of the neural interface, including 
electrical properties, mechanical stability, neural attachment, and neurite outgrowth.67 
Most significantly, there is a wide array of ways in which biofunctionalities can be added. 
For example, nerve growth factor can be immobilized in PEDOT coatings and drugs can 
be loaded in PEDOT to allow controlled drug release.68, 69 Despite the versatility and 
outstanding biocompatibility, PEDOT also suffers from cracking and delamination after 
repeated charge injections.70  
Carbon nanotubes (CNTs) are another class of material that has emerged as an 
alternative to conventional electrode materials. They are a logical choice of material due 
to their exceptional mechanical and electrical properties, which are later discussed in this 
chapter. The goal of this dissertation is to establish layer-by-layer (LBL) assembled CNT 
composites as a suitable electrode material for neural interfacing. The combination of 
CNTs with LBL assembly is a promising and exciting platform, unmatched by any 
conventional materials, for creating a neural interface because of level of control in 
material properties that can be achieved, as well as the boundless possibilities of new 
functionalities that can be incorporated.  
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1.2.2 Inflammatory Reactions 
 The primary concern in the development of neural interfacing materials is the 
degradation of electrode performance over time due to inflammatory reactions. While the 
goal of every electrode implantation is to achieve a stable interface, characterized by 
minimal cellular changes in the surrounding tissue and sustained functioning of the 
implanted device, the placement and presence of the implanted electrode represents the 
greatest perturbation to the host tissue.  
 Generally, the implantation of an electrode induces a cascade of biological 
responses that are highly complex due to the dynamic environment in the neural tissue. 
The immediate injury caused by the implantation is the disruption of the blood brain 
barrier and neurovasculature, causing hypoxia and death of glial and neuronal cells at the 
implantation site.71 The extent of trauma can be greatly exacerbated by the technique 
used to insert the electrode, the geometry of the electrode, and large mechanical 
mismatch between the electrode and the neural tissue.72, 73 As a counter measure, the 
body initiates inflammatory and wound healing responses to remove the dead cells and 
repair the damaged tissue. An important part of this process is the activation of microglia, 
astrocytes, and infiltrated peripheral macrophages because these cells release both 
beneficial and harmful factors, including cytokines, chemokines, neurotransmitters, and 
reactive oxygen species, that can affect the severity and length of the inflammatory 
reactions.71 Typically, acute inflammatory reactions lead to the displacement of neuronal 
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bodies due to swelling in the implantation site, resulting in an increase in the impedance 
values.65  
 Chronic inflammatory reactions are destructive and the main reason why 
advanced electrode designs are needed. Chronic inflammatory responses at the 
implantation site are characterized by the activation of astrocytes and the attachment and 
invasion of activated microglia on the neural interface. Activated microglia cells secrete 
lytic enzymes and reactive oxygen species in attempts to degrade and remove the foreign 
object and release cytokines that result in astrocyte activation.74, 75 Once activated, 
astrocytes produce inhibitory molecules that lead to the formation of a dense insulting 
sheath around the implant known as glial scarring.76 The encapsulating sheath not only 
pushes neuronal bodies away from the surface of the electrode but also causes neurons to 
degenerate over time. The consequence can be severe, as more charges must be delivered 
to produce a stimulatory response, if any is still inducible. In addition, the increase in 
impedance can potentially render the recorded signals and noises to be indistinguishable 
from each other, and thus bring about the loss of recording capabilities. 
1.2.3 Approaches to Reducing Inflammatory Reactions  
 Various strategies have been explored to mitigate inflammatory reactions induced 
by the implantation of neural electrodes and to maintain a stable neural interface. 
Generally, these strategies can be categorized into four main approaches. They include 
engineering of the mechanical properties of the interface, tailoring the geometry of the 
electrode, controlling of inflammatory response, and maintaining a healthy neuronal 
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population at the electrode interface.  We have to point out that while acute inflammatory 
responses are primarily the result of mechanical injuries than inadequate 
biocompatibility, they can often develop into chronic problems if the inflammation 
persists.  
Mechanical properties of electrodes are an important parameter since mechanical 
stress can activate reactive astrocytes.73, 77-79 The large mismatch between the hardness of 
neural tissue and conventional electrodes is considered to be the main contributor of 
mechanical stress and micromotions.72, 73 Therefore, fabrication of soft conductive 
materials, such as poly(pyrrole) or PEDOT, that could match the stiffness of the neural 
tissuesmay be a promising solution to attaining a more compliant interface.72, 80-87 The 
geometry or physical dimension of neural electrodes is also an important parameter for 
reducing tissue encapsulation.88 Studies have shown that subcellular-sized features can 
reduce adhesion of macrophages and decrease capsular thickness.89, 90 In addition, 
physical dimensions of surface features were found to affect mechanotrunsduction, 
adhesion, and apoptosis.91-93  
 Another approach to reduce tissue reactions is to manage the inflammatory 
responses. One solution is to deliver anti-inflammatory drugs by local or systemic 
routes.94-97 However, with advancement in surface modification technologies, a simpler 
and more elegant solution is to incorporate special anti-inflammatory coatings to the 
electrode surface.98-102 With this method, it is possible to fabricate an inherently anti-
inflammatory surface by immobilization of biomolecules that can modulate the 
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expression of inflammatory cytokines.98 The last approach to maintaining a stable neural 
interface is to ensure an effective neuronal population is available for delivery or 
recording of electrical signals. This can be achieved by attracting neurons to migrate 
toward the implantation site and encourage the development of neural processes. Many 
studies have successfully demonstrated this concept by incorporation of various 
biomolecules, such as proteins and growth factors.85, 95, 103-107 As adult neurons in the 
central nervous system are fragile and do not proliferate, an alternative solution is to 
generate neurons from neural stem cells or other multipotent cells that are already present 
in the nervous system or introduced externally. This is indeed the approach that we will 
explore in this dissertation. Specifically, we will investigate the feasibility to enhance 
neuronal differentiation of neural stem cells and program multipotent cells into neurons 
by tailoring the biological properties of layer-by-layer (LBL) assembled carbon nanotube 
(CNT) composites. 
 
1.3 Carbon Nanotubes 
Carbon nanotubes (CNT) are a special class of nanomaterials. CNTs are tubular in 
structure with nanometer range diameters and micrometer range lengths. Discovered by 
Iijima in 1991,108 multi-walled carbon nanotubes (MWNTs) were the earliest observed 
CNT structures and can be described as sheets of graphite arranged in concentric 
cylinders. Quickly after the discovery of MWNTs, single-walled carbon nanotubes 
(SWNTs) were synthesized in 1993 using arc-discharge methods with transition metal 
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catalysts.109, 110 The structure of SWNTs sets them apart from any other materials and is 
the source of their amazing features and properties, which have attracted scientists and 
engineers from all disciplines. 
1.3.1 Electrical Properties and Applications 
The structure of a single SWNT can be described as a single, one-atom-thick, 
layer of graphite, known as a graphene sheet (Figure 1.1 a), rolled up into a seamless 
cylinder with a diameter close to 1 nm and length that can be thousand of times larger 
(Figure 1.1 e). The way the graphene sheet is wrapped specifies the lattice of a SWNT to 
be armchair, zigzag, or chiral (Figure 1.1 b, c, d) and give rise to different electronic 
structures and properties.111 The unique electrical properties of SWNTs are contributed 
by the peculiar electronic structure of graphene and the one dimensional structure of 
SWNTs. The symmetry and unique electronic structure of graphene allow electrons move 
freely as in metals in some configurations while behave like semiconductors in others112. 
As a consequence, all SWNTs are semiconducting except those with the armchair 
configuration which are metallic. The one-dimensional (1D) structure of SWNTs 
confines electrons to motion along the tube axis, reducing the phase space for the 
scattering processes that are responsible for the electrical resistance of the metallic 
SWNTs.112, 113 For this reason, metallic CNTs are highly conductive and can carry 
enormous current densities up to 109 A/cm2, which are 2 to 3 orders of magnitude higher 
than the threshold in metals such as aluminum and copper.112, 114 Because of their 1D, 
high aspect ratio nanoscale structure and unique electrical properties, SWNTs have been 
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heavily explore for applications in nanoelectronic devices,115-117 sensors,118-120 field-
emission electron sources,121, 122 displays and lighting elements,123 and scanning probe 
tips.124 For this research, we would like to exploit SWNTs’ excellent electrical 
conductivity for the fabrication of a biocompatible and multifunctional neural interface 




Figure 1.1 (a) Schematic honeycomb structure of a graphene sheet. SWNTs can be 
formed by folding the sheet along lattice vectors. Folding of different vectors lead to 
armchair (b), zigzag (c), and chiral (d) carbon nanotubes.125 (e) A scanning electron 
microscopy image of single-walled carbon nanotubes (SWNTs).126 
 
1.3.2 Mechanical Properties and Applications 
Like the electrical properties, the mechanical properties of SWNTs have their 
origin in the structure of SWNTs. Their remarkable strength is a product of the extremely 
strong covalent sp2 bonds between individual carbon atoms in the graphene sheet. 
Experiments127-129 and calculations130-133 have shown that the Young’s modulus of 
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isolated SWNTs has a value of approximately 1 TPa, while the tensile strength has been 
measured to be between 13 and 50 GPa.129, 134 In addition, SWNTs also demonstrate high 
flexibility, toughness, and capacity for reversible deformation as atomic force microscopy 
(AFM) measurements have indicated that SWNTs can bend into loops without 
breaking.135 It has been proposed that SWNTs accommodate large strains by diatomic 
rotation to unlock the pristine nanotube wall through the formation of a dislocations 
dipole with the pentagon-heptagon cores.136 
The exceptional mechanical properties of SWNTs have led to a new generation of 
CNT-based composite materials with extraordinary strength and lightweight. Most of 
them are fabricated by microscale blending of CNTs with polymers, metals, or ceramics 
through processes such as melt mixing, film casting, spin coating, polymerization, and 
fiber spinning.137-140 For biomedical devices, qualities such as durability, material 
stability, and flexibility are critical to the biocompatibility and longevity of the devices. 
In this research, the design and fabrication of novel neural interfacing materials are based 
on the layer-by-layer (LBL) assembly of CNTs. The method of LBL assembly is an 
emerging and versatile nanostructuring technique for fabricating CNT-based composites 
that are mechanically strong and flexible.141 We believe we can create advanced and 
multifunctional neural interfaces by taking advantage of the excellent mechanical 




1.3.3 Functionalization and Biomedical Applications 
In order to exploit the amazing properties of SWNTs for biomedical applications, 
functionalization of SWNTs is essential and requires the understanding and mastery of 
CNT chemistry.142 Since chemistry normally occurs in solution, dissolution of SWNTs is 
crucial126 and allows further functionalization of SWNTs to be achieved. SWNTs without 
any functionalization are chemically inert. They are also extremely resistant to wetting143 
and typically exist as ropes or bundles 10 to 25 nm in diameter and a few micrometers 
long.126 Functionalizations are made possible through covalent and non-covalent means. 
Covalent chemistry of SWNTs is possible at both the end caps and sidewall of 
SWNTs.126, 144-146 The end caps of SWNTs are more reactive then the sidewall because of 
the strain induced from the curvature of the hemispherical caps. Oxidization147-149 of the 
end caps to carboxylic acid and other weakly acidic functionalities by treatment with 
nitric acid147, 150 allows dissolution of SWNTs in amide-type organic solvents and 
introduces chemical functionalities for subsequent elaborations. The less reactive 
sidewall is also susceptible to reaction because of the strain from π-orbital misalignment. 
It’s important to note that covalent functionalizations at the end caps and sidewall 
typically disrupt the aromatic ring system of SWNTs and result in reduction of tube 
length and loss of electrical and mechanical properties.125, 126 Non-covalent methods 
allow the preservation of SWNTs’ important properties. SWNTs can be dispersed and 
functionalized effectively by polymer wrapping151-154  and adsorption of amines and 
molecules with large π-systems.155, 156 
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Functionalization of SWNTs has lead to an explosion of biomedical applications. 
Utilizing the scheme of π-stacking, Chen et al. have immobilized a wide range of 
biomolecules, such as ferritin, streptavidin, and biotin-PEO-amine, on the sidewalls of 
SWNTs with high efficiency.155 Gheith et al. have created biocompatible CNT-based 
composites using polymer-wrapped SWNTs together with LBL assembly.157 Other 
researchers have also functionalized SWNTs with bioactive groups such as peptides,158, 
159 proteins,160 and DNA161 and utilized them as sensing materials for DNA162, 
glucose,163, 164 peptides,165 and proteins.166-168 The development of a smart SWNT-based 
biomaterial for neural interfacing will rely in part on non-covalent functionalization of 
SWNTs. The other part will rely on appropriate selection of components for LBL 
assembly, which will be discussed below. 
1.3.4 Neural Prosthetic Applications 
Biocompatibility is essential to the development of biomedical applications. It is 
always the first and essential step in establishing the applicability of a new material for 
medical applications. So far, cellular behavior with and on CNTs have been tested with 
various types of cells.169-176 In the case of neural cells, biocompatibility of CNT-based 
materials has been demonstrated by several research groups using adult primary neural 
cells.177, 178 In addition, carbon nanofiber reinforced composites were shown to increase 
neuronal cell functions while providing a mechanically strong and electrically conductive 
substrate.179 Patterned CNTs were utilized to guide neural cell growth, and preferential 
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cell attachment on CNTs was demonstrated.180, 181 Neural signal transmission efficacy 
was reported to increase on CNT-coated substrates.182  
These recent studies show that long-term CNT-based implants are a realistic 
target. However, none of the materials employed in these studies can be practically used 
for such a purpose. CNT-based thin films and coatings produced by drying,179, 183 
spraying and evaporation,177, 178, 182, 184 and chemical vapor deposition on silicon 
substrates180, 181 are either not stable or durable enough for chronic implantation in 
physiological conditions or limited to fabrication on silicon substrates. In addition, films 
and coatings fabricated in such ways cannot be controlled or modified at the molecular 
level. This limitation significantly diminishes the excellent electrical and mechanical 
properties that could be brought about by the nanoscale building blocks through 
nanostructuring techniques such as LBL assembly.  
Up to this date, very few stem cell cultures have been investigated in conjunction 
with nanomaterials. As demonstrated in this research, we see strong possibilities, 
fundamental importance, and practical need to use neural stem cells (NSCs)185, 186 rather 
than adult cells in the studies of SWNT-based materials for neural tissue engineering. 
Adult cells have limited capacities for extracellular matrix remodeling, axonal extension, 
and interfacing with implants.187-189 Successful implantation and long-term performance 
of a neural implant and prosthetic device may require a durable interface as well as potent 
stem cells to revitalize the targeted tissue. 
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1.4 Layer-by-Layer Assembly 
The usefulness of nanomaterials is heavily dependent on the ability to assemble 
them into bulk materials by manipulating them at the molecular level. This is especially 
the case for creating and designing biomaterials. For a long time, Langmuir-Blodgett 
deposition, invented by Langmuir190 and Blodgett,191 and self-assembled monolayers 
(SAMs), developed by Nuzzo,192 Allara,192 and Whiteside,193 remained the primary 
methods for fabricating sold thin films from molecular components. As pointed out by 
Tang et al,194 although numerous applications have been developed for tissue engineering 
and drug delivery using these techniques, Langmuir-Blodgett deposition and SAMs 
suffer from significant drawbacks. Langmuir-Blodgett films are unstable, time 
consuming to produce, limited to components with amphiphilic property, and require 
expensive instrumentations. SAMs are low in loading of biological components due to 
their monolayer nature. They are also limited to a few substrate types because of the 
chemistry involved and are relatively unstable under ambient and physiological 
conditions. 
The layer-by-layer (LBL) assembly technique, introduced by Decher195 in 1992, is 
free of the problems associated with Langmuir-Blodgett deposition and SAMs. The LBL 
assembly technique is based on alternating adsorption of monolayers of individual 
molecular components, such as polyelectrolytes, attracted to each other by a combination 
of interactions: electrostatic,196, 197 hydrophobic,198 hydrogen bonding,199 charge-
transfer,200 biological recognition,201 and others (Figure 1.2). The adsorption process is 
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cyclically repeated on substrates until desirable structures, thicknesses, and loadings of 
interested species are obtained. Since thin films are assembled one monolayer at a time, 
LBL assembly affords nanometer level control of the film thickness and composition.196 
It must be emphasized that the individual layers in the thin film are not discrete and 
segregated. In contract, as shown in Figure 2.1, the structure of the assembled material 
consists of interpenetrating layers that result in high homogeneity of the individual 
components which is important for achieving outstanding material properties. Thin films 
produced in this manner are also considerably stable in physiological conditions due to 
the cooperative effects of multiple interactions among the film components. 
 
 
Figure 1.2 Schematics of layer-by-layer (LBL) assembly. LBL assembly is characterized 
by the sequential deposition of complementary species onto a substrate. Here, the LBL 
assembly of carbon nanotube (CNT) with polymer is depicted. The assembled composite 
material consists of interpenetrating layers of polymer and CNTs.  
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The simple and efficient technique of LBL assembly can be preformed on a 
variety of novel and unique geometries to create multilayer thin films and coatings using 
templating and patterning techniques.202, 203 This capability is a powerful advantage for 
medical devices such as implantable chips, probes, and scaffolds that have small 
dimensions, irregular shapes, lithographically patterned elements, and surface engineered 
components. Furthermore, LBL assembly can be performed with to a wide range of 
inorganic and biologically active materials including as nanoparticles,204 nanotubes,141 
nanoplates,205 organic dyes,206 dendrimers,207 polypeptides,208 DNA,209 and proteins.210, 
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1.4.1 Biomedical Applications 
As discussed above, LBL assembly has demonstrated itself as a simple, fast, and 
versatile technique for fabricating solid thin films. LBL films are physiologically stable 
and can be fabricated on essentially any type and shape of substrates. Its ability to 
incorporate a vast variety of biologically interesting species at high loading has led to 
numerous biomedical applications. 
LBL assembled thin films have been developed into biosensors and drug delivery 
agents. By incorporation of inorganic particles, enzymes, antigens, antibodies, proteins, 
nucleic acids, and DNA, a variety of biosensors have been created to detect oxygen, 
glucose, DNA binding, toxic chemicals, insulin, pH changes, and many other chemicals. 
Detection can be achieved by measuring the electrochemical, gravitational, optical, and 
mechanical properties of the films.194 In the case of drug delivery, LBL assembled films 
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offer the ability to control the dosage and kinetics by varying the thickness and 
composition of assembled multilayers. The release of a component typically depends on 
its permeability and the breakdown of the polymer multilayer matrix, which can be 
stimulated by changes in the pH, temperature, or ionic strength of the solution, 
application of an external electrical field, exposure to UV light, or by the incorporation of 
a hydrolytically-, enzymatically-, or self-degradable macromolecular matrix.194 
LBL films have also been engineered to mediate cellular functions by 
incorporating various growth factors and polymers. Poly(ethyleneimine) (PEI), 
poly(allylamine hydrochloride) (PAH), poly(styrene sulfonate) (PSS), poly(D-lysine) 
(PDL), and poly(L-lysine) (PLL) have been utilized to manipulate cell adhesion, 
proliferation, and differentiation. Higher endothelial cell viability was demonstrated on 
PDL and PAH multilayers.194 Enhanced turmor cell adhesion and secretion of 
chemokines were shown on PAH and PLL ending polyelectrolyte films.212 The 
integration of fibroblast growth factor into multilayer PEI films increased fibroblast 
proliferation and secretion of type 1 collagen and interleukin-6.213 For this research, we 
are interested in species that can enhance the adhesion, proliferation, and differentiation 
of neural cells and neural stem cells.  
Lastly, LBL assembled films have been fabricated to yield anti-biofouling 
properties. Resistance against blood coagulation is critical to implantable materials and 
has been demonstrated by the incorporation of serum albumin, heparin, dextran, and 
chitosan into LBL assembled thin films.194 Anti-inflammatory response is especially 
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important to neural prosthetic devices and has been demonstrated on LBL coatings 
containing anti-inflammatory agents and polypeptides.214, 215 Anti-bacterial properties 
have also been realized by the incorporation of antimicrobial peptides216 and silver 
nanoparticles.217  
1.4.2 Layer-by-Layer Assembled Carbon Nanotube Composites 
LBL assembled SWNT-polyelectrolyte multilayers are a class of novel composite 
materials with extraordinary properties. The versatile architectures of SWNT-
polyelectrolyte thin films can be engineered at the nanoscale level to attain desirable 
mechanical, structural, and electrical properties. The immobilization of macromolecular 
species and strong interdigitation of the nanometer-thick film result in close-to-perfect 
molecular blending of the components (Figure 1.2, Figure 1.3 a, b), giving rise an 
impressive tensile strength of 220±40 MPa,141 which is more than sufficient for any 
biomedical implants. SWNT-polyelectrolyte thin films are also mechanically flexible due 
to the homogeneous distribution of polymer chains in the nanostructured material. This 
property is very important for neural prosthetic applications since neural electrodes 
should be mechanically compliant and conformal to reduce mechanical injuries and 
micromotions. SWNT composites also have electrical conductivity of at least 4.15×104 
S/cm,218 which exceeds the requirements of successful excitation of neurons. We believe 
the combination of strength, flexibility, stability, fast charge transport, and a variety of 
necessary geometries and patterns,202, 203, 219 including free-standing films (Figure 1.3 c), 
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available for LBL films demonstrates LBL assembled SWNT composites as the choice of 
material for neural tissue engineering applications. 
Besides the bulk properties, LBL assembled SWNT films also have very 
interesting topological features. The manifold of forces involved in the formation of the 
films make them especially appropriate for the interactions with the cellular membranes. 
The topology of the LBL SWNT composite (Figure 1.3 a, b) resembles very closely the 
nanoscale features of collagen fibers in the extracellular matrix,169, 175, 220, 221 which serves 
as growth and differentiation environment for neurons. The cytoskeleton of neural cells 
consists of microtubules, neurofilaments, and actin microfilaments that range from 7 to 
25 nm in diameter.222 We believe these filamentous structures, which are responsible for 
important functions such as the remodeling of processes and the motility of growth cones, 
can associate with SWNTs to form a biologically cohesive interface for promoting stem 
cell proliferation and differentiation.  
 
 
Figure 1.3 (a) An atomic force microscopy (AFM) image of (PVA/SWNT-PSS)1 on 
silicon substrate. (b) A scanning electron microscopy (SEM) image of (PVA/SWNT-
PSS)3 on silicon substrate. (c) Demonstration of the flexibility of a piece of 
(PVA/SWNT-PSS)200 free-standing LBL composite film.218 
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In a previously reported study, using a murine neuroblastoma × glioma hybrid cell 
line, we demonstrated for the first time neuronal cell attachment and differentiation on 
LBL assembled SWNT-polyelectrolyte coatings and freestanding thin films.157 Although 
this very preliminary study indicates that LBL prepared SWNT composites, which 
encompass the versatility of LBL assembly and novelty of SWNTs, may be well qualified 
for neural interfacing applications, there is tremendous work to be carried out to 
transform this concept into a platform technology. The purpose of this research is exactly 
to accomplish this, by demonstrating SWNT LBL film’s utilities, in terms of 
biocompatibility and electrochemical properties, and developing new functionalities that 
will enhance integration of the artificial interface with neural tissues.   
 
1.5 Neural Stem Cells 
One key focus of this dissertation is the interaction of nanostructured carbon 
nanotube (CNT) materials with neural stem cells (NSCs). This is an area that has not yet 
been explored by researchers and therefore deserves to be investigated in this research. 
NSCs are cells that can generate neural tissues or are cells derived from the nervous 
system with some capacity for self-renewal and ability to give rise to cells other than 
themselves through asymmetric cell divisions223 (Figure 1.4). Ever since their 
discovery,185, 186 NSCs have been extensively studied to understand their niche in the 
CNS224 and demonstrate their potential therapeutic values in replacing damaged and lost 
cells in the CNS.225, 226  Neural progenitor or precursor cells (NPCs) are a subset of NSCs 
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but with a more limited self-renewal potential and are sometimes used interchangeably 




Figure 1.4 Schematic of neural cell lineages. A self-renewing population of 
undifferentiated stem cells ultimately give rise to all of the diverse cell types that are 
present within the adult CNS.227 
 
NSCs for in vitro studies are isolated by dissecting out a region of the fetal or 
adult brain that has been demonstrated to contain dividing cells.223 The tissue is then 
dissociated and exposed to a high concentration of mitogen such as fibroblast growth 
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factor-2 (FGF-2)228 or epidermal growth factor (EGF)229 for proliferation. NSCs are 
typically expanded as floating aggregates called neurospheres and differentiated as 
dissociated single cells or whole neurospheres on coated substrates to provide 
adhesion.230 Differentiation of the cells is induced by either withdrawing the mitogens or 
by exposing the cells to factors that induce differentiation into specific lineages. NSCs 
are capable of generating the three principal cell types of the central nervous system – 
neurons, astrocytes, and oligodendrocytes (Figure 1.4). The differentiated cellular 
phenotypes are most commonly analyzed by immunohistochemical and 
immunocytochemical techniques.223 Cell functionality is demonstrated by staining of 
functional synaptic connections231 or by employing electrophysiological techniques to 
obtain current- and voltage-clamp recordings.232 
Recently, a number of researchers have begun to explore the behavior of NSCs on 
engineered materials. Young and his colleagues have done extensive work in this area, 
especially with polymeric and biomimetic substrates.233-235 Silva and Stupp have studied 
the differentiation of NPCs in peptide nanofiber matrices.236 However, very little is 
known regarding the behavior of NSCs on CNT-based materials. Because of NSC’s 
potential in reducing inflammation, providing trophic support, replacing dead neurons, 
and reforming neural circuitry,237 we find it important to establish their biocompatibility 
with LBL assembled SWNT composites in this research. To fully utilize NSC’s 
therapeutic values, equally important is the ability to manipulate their cellular behaviors, 
such as differentiation, neurite outgrowth, and excitation, which are also demonstrated in 
this research. 
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1.5.1 Manipulation of Neural Stem Cells  
The cellular behavior of neural stem cells (NSCs) is mediated by a wide range of 
biomolecules. Jacques et al. found that ECM molecules fibronectin and laminin produced 
a 2-fold increase in mouse neurospheres cell proliferation compared to a non-specific 
adhesive poly-D-lysine substratum, while the soluble peptide P3 
(VSWFSRHRYSPFAVS) stimulated chain migration by over 300%238. Their study also 
demonstrated that cell proliferation and migration are regulated by distinct integrins. 
Consistently, Flanagan and coworkers confirmed the role for integrins in laminin-
dependent migrations239. They found laminin to enhance human NSC migration, 
expansion, differentiation into neurons and astrocytes, and elongation of neurites from 
neurons. Axon guidance molecules have also been identified by genetic and biochemical 
studies. Guidance cues, such as netrins, slits, semaphorins, and epherins, guide axons by 
repelling or attracting the highly motile and sensitive structure of growth cone240. 
The fate of NSCs is in part regulated by environmental signals. In their study of 
NSCs, Takahashi et al. discovered retinoic acid (RA)’s role in promoting acquisition of a 
neuronal fate and neurotrophins (NTs)’ role in enhancing maturation of neuronal 
phenotypes241. The combination of RA and NTs effectively stimulated NSCs to 
differentiate into neurons of a various phenotypes. NSCs can also adopt a glial fate if 
exposed to ciliary neurotrophic factor (CNTF), leukocyte inhibitory factor (LIF), and 
morphogentic protein 4 (BMP4)242. Recently, Davies et al found that transplantation of 
astrocytes pre-differentiated from embryonic NPCs not only promoted growth of axons 
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and induced realignment of injured tissue in rats but also suppressed scarring243. 
Surprisingly, transplantation of undifferentiated NPCs failed to provide any beneficial 
effects. Potentially layer-by-layer (LBL) assembled carbon nanotube (CNT) composites 
can be engineered to allow controlled pre-differentiation of NSCs and potentially create a 
novel strategy for repairing neural injuries.  
Besides actively participating in the repair process, NSCs can also provide 
therapeutic effects by producing essential enzymes and neural transmitters.227 By 
exposing NPCs to basic fibroblast growth factor 2 (FGF2) and glial cell conditioned 
media, Daadi and Weiss were able to derive neurons that produce tyrosine hydroxylase, 
an important rate-limiting enzyme in the synthesis of dopamine which patients of 
Parkinson’s disease lack244. The enzyme tyrosine hydroxylase is found in the cytosol of 
all cells containing the neural transmitter catacholamine. The possibility of differentiating 
neural progenitor cells toward a catecholamine phenotype was demonstrated by treatment 
with FGF2 and neural growth factors227. Some work has also been done to convert NPCs 
into a cholinergic phenotype by treatment with LIF as a way to replenish the level of the 
vital neurotransmitter acetylcholine in the damaged sites227. Acetylcholine is 





1.6 Inverted Colloidal Crystal Hydrogel Scaffolds 
Considerable effort has been made to develop biocompatible scaffolds for tissue 
engineering as they are needed to guide cells to grow, synthesize extracellular matrix, and 
form functional tissues.245, 246 As biology’s demand for quantitative analysis increases, 
scientists are also looking for a three-dimensional (3D) culture system that can 
authentically represent a cell’s environment in a living organism.247, 248 A properly 
designed 3D scaffold can satisfy the needs in tissue engineering and biomedicine to 
provide better solutions for tissue repair and regeneration and to facilitate the study of 
biological systems. 
The first design criterion for a scaffold is biocompatibility. Cells must be able to 
attach and survive on the scaffold in order to form a functional structure. Secondly, the 
scaffold should have high porosity and proper pore size. This will ensure an adequate 
geometry for cell penetration, a high surface area for cell attachment, and interconnected 
space for intercellular interactions. Thirdly, the scaffold should be mechanically strong 
enough to support the tissue structure. Lastly and very importantly, the scaffold should 
positively interact with cells to enhance adhesion, proliferation, migration, 
differentiation, and functionality.246 249 
Scaffolds prepared from colloidal crystal templates can meet all of the listed 
criteria.250-252 To fabricate these scaffolds, colloidal particles are assembled into 3D 
crystals with hexagonally packed structure (Figure 1.4 a-c) and subsequently infiltrated 
with sol-gel or hydrogel solutions. After solidification or polymerization, the colloidal 
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crystal templates are dissolved to yield scaffolds with high porosity and inverted colloidal 
crystal (ICC) geometry (Figure 1.4 d-f). The ICC geometry can be described as highly 
organized spherical pores with interconnecting channels. This arrangement gives a 
maximum theoretic porosity of 74%, providing large void volume for cell growth while 
preserving structural integrity of the scaffolds. Desirable pore size and channel size can 
be tightly controlled by adjusting the size of colloidal particles used to fabricate the 
templates and by changing the assembly conditions. For this reason, the geometry of ICC 
scaffolds is well-ordered, easily characterized, and highly reproducible. This translates 
into good control over tissue structure, making ICC scaffolds an excellent system for 
tissue engineering and research in cell biology.  
The biocompatibility of ICC Na2SiO3 gel251, 252 and poly(acryalamide) hydrogel250 
ICC scaffolds have been demonstrated for liver cell,253 bone cell,254 thymic stromal 
cell,255 and hematopoietic stem cell cultures.256 Diffusion257 and cell distribution258 in 
ICC scaffolds have also been studied experimentally and computationally. Combined 
with LBL assembly, ICC scaffolds are well suited for investigations of cell-cell and cell-
matrix interactions, cell migration and differentiation, and tissue formation. We have 
shown that LBL modification of scaffolds with collagen, fibronectin, and clay can 





Figure 1.4 SEM images of colloidal crystals (a-c) and their inverted replicas (d-f) 
fabricated from 10-µm (a, d), 75-µm (b, e), and 160-µm (c, f) spheres.252 
 
We devote part of this research to the development of an in vitro 3D neural tissue 
model to study neural electrode induced cellular responses. It has been reported recently 
that a 3D spheroid liver tissue spheroid model can be created from ICC hydrogel 
scaffolds for in vitro assay applications.260 The study, which explored the toxicity of 
nanoparticles, showed dramatic differences between 2D and 3D spheroid cultures that 
resulted from morphologic and phenotypic changes. Similarly, by developing a 3D neural 
tissue model, we aim to improve the predictive power of in vitro assays for neural 




The theoretical framework of this dissertation lies in the unique properties of 
CNTs and versatility of the nanostructuring technique of LBL assembly. The 
combination of excellent mechanical stability and high conductivity required for the ideal 
neural electrode design makes CNTs the perfect candidate for interfacing with the neural 
system. As discussed above, CNTs have an exceptional current carrying capacity, tensile 
strength, and Young’s modulus, as well as a wealth of available chemical modification 
techniques to impart them specific functionalities. The technique of LBL assembly, 
which enables complementary molecular species, such as polyelectrolytes, nanoparticles, 
and biomolecules, to be constructed into a composite film one monolayer at a time, 
allows precise control over the film structure and composition, and therefore fine-tuning 
of the film properties. By combining CNTs with LBL assembly, we envision the ability 
to fabricate neural interfaces of specifically designed mechanical, electrochemical, and 
biological properties that can evolve into a platform technology for next-generation 
neural electrodes and help us gain better understanding of the nano-bio interface.  
 This dissertation is a collection of work that aims to realize this vision and can be 
divided into four parts. The first part consists of studies designed to establish the 
biocompatibility of LBL assembled CNT films. Chapter 2 examines the cytotoxicity of 
CNT LBL films, dispersed CNTs, and other nanoparticles using the technology of high-
content screening. Chapter 3 demonstrates the biocompatibility of CNT LBL films with 
neural stem cells (NSCs). The incorporation of NSCs represents a very important venue 
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for establishing an effective tissue-electrode interface as they can potentially reduce 
inflammatory response and develop into mature functional neurons. The second part of 
this dissertation is contained in Chapter 4, which aims to establish the electrochemical 
properties of electrodes made from LBL assembled CNT composites. Measurements such 
as impedance, charge storage capacity, voltage excursion, and electrochemical stability 
are reported here, and a side-by-side comparison with well-established and emerging 
electrode materials is presented. The third part of this dissertation consists of two studies 
exploring methods for controlling cell differentiation on LBL assembled CNT films. 
Chapter 5 demonstrates that LBL films fabricated from the assembly of CNTs with 
laminin can enhance the differentiation of NSCs and can be used to electrically stimulate 
differentiated NSCs. In Chapter 6, we describe the delivery of genes through CNT LBL 
composite films and demonstrate that multipotent cells can be programmed into neuronal 
cells. The last part of the dissertation, which is encompassed in Chapter 7, describes the 
development of an in vitro three-dimensional neural tissue model for the purpose of 
investigating cellular response induced by electrodes. Such a system can be utilized for 
rapid and inexpensive screening of the numerous electrode interfaces that can be 
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Cytotoxicity Profiling of Nanomaterials Using High Content Screening Assays 
 
2.1 Abstract 
Recent advances and progress in nanobiotechnology have demonstrated many 
nanomaterials as potential and novel drug delivery vehicles, therapeutic agents, and 
contrast agents and luminescent biological labels for bioimaging. The emergence of new 
biomedical applications based on nanomaterials signifies the need to understand, 
compare, and manage their cytotoxicity. In this study, we demonstrated the use of high 
content screening assay (HCA) as a universal tool to probe the cytotoxicity of NPs and 
specifically cadmium telluride quantum dots (CdTe QDs) and gold NPs (Au NPs) in 
NG108-15 murine neuroblastoma cells and HepG2 human hepatocellular carcinoma 
cells. In addition, we also compared the cytotoxic effects of carbon nanotube (CNT) 
dispersions and thin films in the NG108-15 neural cells. Neural cells represent special 
interest for NP and CNT induced cytotoxicity because of the optical and electrical 
functionalities of materials necessary for neural imaging and interfacing are matched well 
with the properties of these nanomaterials. Moreover, the cellular morphology of neurons 
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is particularly suitable for automated high content screening. HepG2 cells represent a 
good model for high content screening studies since they are commonly used as a 
surrogate for human hepatocytes in pharmaceutical studies. We found the CdTe QDs to 
induce primarily apoptotic response in a time- and dosage-dependent manner and 
produce different toxicological profiles and responses in undifferentiated and 
differentiated neural cells. Au NPs were found to inhibit the proliferation and 
intracellular calcium release of HepG2 cells. Layer-by-layer (LBL) assembled single-
walled carbon nanotube (SWNT) thin films displayed minimal cytotoxicity while the 
cytotoxic effect of dispersed SWNTs increased with concentration. 
 
2.2 Introduction 
Research on nanomaterials has generated numerous biological applications in the 
past decade. With continuing progress of nanoscale synthesis and biological applications 
of nanomaterials, such as nanoparticles (NPs) and carbon nanotubes (CNTs), one needs 
to develop a quick and fairly standard assessment tool to evaluate their cytotoxicity. 
Since many structural and physical properties of nanomaterials have clear similarities 
with those of proteins,1-3 it is not surprising that nanomaterials may exhibit cytotoxicity 
or, in more general terms, biological activity that is specific to NPs and CNTs and affects 
cell signaling mechanism differently from that observed for ionic, polymeric systems and 
small molecules. The detrimental effects of such biological activity can be captured by 
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the term nanotoxicity,4-6 which is probably the most critical from a health safety 
perspective.7  
The purpose of this study is to make the first step toward the development both 
fast and fairly comprehensive method of screening of biological activity and cytotoxicity 
of NPs and CNTs.  We see two important factors that necessitate the development of such 
protocol(s). (1) Since the synthesis of NPs and CNTs is much simpler than the synthesis 
of proteins and other drugs, minor changes in the synthetic protocol are likely to affect 
their interactions with cells.  So, one can expect to see a tremendous surge of potential 
candidates for toxicity/biological activity screening. Taking II-VI semiconductor 
quantum dots (QDs) as an example, beside the release of heavy metal elements from the 
core which can lead to cell poisoning,8 studies have shown that the cytotoxicity of these 
QDs is highly dependent on their processing parameters,9 surface modifications,8-10 as 
well as a number of physicochemical and environmental factors, such as size, charge, 
concentration, and stability.11 Such amounts will be difficult to analyze using 
conventional approaches. (2)  Considering the diversity of NPs and CNTs being 
synthesized, one needs a unified approach for screening nanomaterials. Such a systematic 
approach is not only fundamental to the construction of a unified database for biological 
and cytotoxic effects of nanomaterials but will also enable scientists to synthesize safer 
and more efficacious nanostructures at an ever-more efficient rate. We can expect the 
engineering of biologically functional nanostructures to follow the path of synthetic 
pharmaceuticals in drug discovery.  In the near future, panels of nanomaterials with 
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slightly varying properties and structures will be synthesized and evaluated for 
cytotoxicity before qualified candidates are designated subsequent developments.  
In this study, we are motivated to explore the possibility of building a high-content, high-
throughput cytotoxicity assay platform based on high-content screening (HCS) 
technology to meet future’s demand for nanotoxicity studies. HCS is a recent advance in 
the integration and automation of quantitative fluorescence microscopy and image 
analysis, and it has already started to generate impact in pharmaceutical and 
biotechnology industries.12, 13 Zhang et al. were the first to employ high-content image 
analysis, in conjunction with high-throughput analysis, to study the cytotoxicity of QDs.14 
They investigated the cellular and molecular effect of high doses of poly(ethylene glycol) 
silanized QDs (PEG-silane-QDs) on human lung and skin epithelial cells, and reported 
PEG-silane-QDs to induce minimal cytotoxicity even at high dosages. While the use of 
HCS analysis in their study is confined to cell counting, quantification of apoptotic and 
necrotic cell population, and generation of cell cycle profiles, our current study extends 
the application of HCS technology to the evaluation of cell function, specifically neurite 
outgrowth, and the development of a multiplexed cytotoxicity assay that may serve as the 
basis of a standardized nanotoxicity assay and facilitate the formation of a unified 
nanotoxicology database.  
Semiconductor QDs are most well known for their potential applications in 
biosensing, ex vivo live cell imaging and in vivo animal targeting,15-18 while Au NPs 
have demonstrated promising capabilities as novel drug delivery vehicles,19 near-infrared 
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agents for thermal therapy,20 and contrast agents for biomedical imaging.21-23  More 
recently in search of new neurotherapeutic, neuroprosthetic, and neuroimaging strategies, 
many researchers have explored the use of NPs to manipulate and create active cellular 
interfaces with nerve cells.24, 25 Vu et al. utilized peptide conjugated QDs to initiate 
neuronal differentiation26 while Dahan et al. used antibody functionalized QDs to track 
the diffusion of glycine receptors in neurons.27 Jackson and colleagues demonstrated that 
QDs can improve identification and visualization of brain tumors.28 At the neural 
interface, Winter et al. investigated the possibility to build a bioelectronic interface by 
both culturing nerve cells on tethered QD thin films29 and attaching QDs directly to nerve 
cells via biological recognition molecules.30 Most recently, Kotov and colleagues 
demonstrated, for the first time, the excitation of neural cells through a sequence of 
photochemical and charge-transfer reactions on layer-by-layer assembled NP-
polyelectrolyte composite films.31 In the case of CNTs, due to their unique physical and 
electrical properties, many studies have investigated their potential as therapeutic agents 
and neural interfacing materials.32 CNTs have been shown to promote neuron 
differentiation from embryonic stem cells.33 Substrates fabricated from CNTs have also 
been demonstrated to support neural differentiation34 and promote neural electrical 
activity.35  
Our study began with a comprehensive investigation of cadmium telluride (CdTe) 
QD induced cytotoxicity in NG108-15 murine neuroblastoma cells using various HCS 
assays. We then extended the application of our multiplexed cytotoxicity assay to study 
the cytotoxic effect of gold NPs (Au NPs) on the HepG2 human hepatocellular carcinoma 
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cells. Finally, using the same multiplexed cytotoxicity assay, a comparison of 




2.3.1 Synthesis of CdTe Quantum Dots 
Millipore water (120 mL) was degassed by bubbling argon for approximately 1 h. 
Cd(ClO4)2·6H2O (3.22 g, 7.68 mmol), TGA stabilizer (1.24 g, 13.46 mmol, 1.75 molar 
equivalents) were added and the pH was adjusted to 11.2–11.3 by the addition of NaOH 
solution (2M). For gelatin-containing samples, gelatin (0.3 g) was dissolved in water (10 
mL) by heating gently and added to the reaction mixture. Gaseous H2Te, generated from 
Al2Te3 (0.56 g, 0.128 mmol) by dropwise addition of H2SO4 solution (0.5m) was bubbled 
through the cadmium/thiol/gelatin solution under a slow argon flow for approximately 10 
min. The resultant nonluminescent solution was then heated to reflux. Fractions were 
precipitated by the addition of isopropanol and were stored at 4°C. 
2.3.2 Synthesis of Gold Nanoparticles 
Gold chloride solution (0.01g HAuCl4 in 100ml water) was first brought to boil, 
followed by addition of 2ml 1% sodium citrate solution (0.02g trisodium citrate in 2ml 
water). The gold nanoparticle solution was stirred for 10min and allowed to cool to room 
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temperature. Stabilizer was introduced by adding 102µL of cysteine solution (0.01g l-
cysteine in 1ml water) to the gold nanoparticle solution with stirring. The final gold 




2.3.3 Preparation of Carbon Nanotube Dispersion and Thin Films 
Single-walled carbon nanotubes (SWNTs) were dispersed at 0.5 mg/ml in 0.1 
wt% poly(sodium 4-styrene-sulfonate) (PSS; MW 1000k) solution by ultra-sonication. 
Thin films of SWNTs were prepared in 96-well tissue culture plates using the technique 
of layer-by-layer (LBL) assembly. Specifically, SWNT thin films were formed by 
alternating deposition of 1 wt% poly(vinyl alcohol) (PVA; MW 70k, pH 2, 6 or 10) with 
the SWNT dispersion. For each deposition, the bottom of each well was covered with the 
corresponding solution for 5 min, followed by rinsing with deionized water and drying 
with an air jet. The resulting thin film of coating was designated as (PVA/SWNT)n where 
n is the number of bilayers. 
2.3.4 Cell Culture 
NG108-15 murine neuroblastoma×glioma hybrid cells and HepG2 Human 
hepatocyte carcinoma cells were obtained from the European Collection of Cell Cultures. 
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NG108-15 cells were grown in high-glucose Dulbecco's modified Eagle's medium, 
supplemented with 10% (v/v) of fetal calf serum, 0.1 mM hypoxanthine, 1 µM 
aminopterin, and 16 µM thymidine. To induce differentiation, the amount of serum was 
lowered to 1% (v/v). HepG2 cells were cultured in Eagel minimum essential medium 
supplemented with 10% (v/v) fetal bovine serum.  
2.3.5 Apoptosis/Necrosis Assay 
Cells were seeded in 96-well tissue culture plate (Nunc) and allowed to adhere 
overnight. At the indicated time point (1.5h, 6h, 24h) following treatment with TGA-QDs 
or Gelatin-QDs, cells were stained with propidium iodide (1 µg/ml) and Hoechst 33342 
(2 µg/ml) for 10 min at room temperature and imaged using the IN Cell Analyzer 1000 
HCS system (GE Healthcare). The HCS system scans through the bottom the plate, 
focuses on individual fields of cells, and acquires images at each selected fluorescence 
channel. Hoechst was visualized in the blue channel and propidium iodide in the red 
channel. The experiment was conducted in 3 independent runs. For each run, 5 
independent fields from each well were imaged using a 20X objective. Cells were 
classified as either healthy, apopotic, or necrotic using the supervised classification 
function of the IN Cell Investigator image analysis software (GE Healthcare).  
2.3.6 Neurite Outgrowth Assay 
Cells were seeded in 96-well tissue culture plate and allowed to adhere overnight. 
After treatment with TGA-QDs or Gelatin-QDs for 6h, cells were gently washed with 
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fresh medium and cultured with reduced serum supplementation to induce neuronal 
differentiation. No supplementary growth factor was added. After 4 days of 
differentiation, cells were fixed in 2% paraformaldehyde, permeabilized in 0.1% Triton 
X-100 in 1% BSA, and stained using mouse anti-β-tubulin III (1:800 in 1% BSA; 
overnight at 4 ºC) followed by Alexa Fluor 488 conjugated goat anti-mouse IgG (1:200; 
1h at 37 ºC). The experiment was carried out in triplicates. For each well, 4 independent 
fields were imaged using a 10X objective and analyzed using the Neurite Outgrowth 
Analysis Module of the IN Cell Investigator software. The analysis module reports 
population-averaged measurements for a range of cell parameters, including neurite 
length and neurite count. 
2.3.7 Multiplexed Cytotoxicity Assay 
Cells were seeded in 96-well plate and allowed to adhere overnight. Following 
treatment with either CdTe QDs, Au NPs, or CNTs, cells were very gently washed with 
pre-warmed fresh medium and simultaneously loaded with 1 µM Hoechst 33342, 20 nM 
TMRM (tetramethyl rhodamine methyl ester perchlorate), and 1 µM Fluo-4 (fluo-4 
acetoxymethyl ester). Cells were loaded in the corresponding culture media for 30min at 
37 °C and then imaged using the IN Cell Analyzer 1000 HCS system. Hoechst was 
visualized in the blue channel while TMRM and Fluo-4 were visualized in the red and 
green channels, respectively. The following data were collected and analyzed using the 
Dual Area Object Analysis Module of the IN Cell Investigator software. The module 
allows simultaneous quantification of sub-cellular inclusions that are marked by different 
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fluorescent probes and measures fluorescence intensity associated with predefined 
nuclear and cytoplasmic compartments. The following data were collected. Cell count 
was generated from the number of Hoechst 33342 stained nuclei. Nuclear size was 
defined as the mean object area of Hoechst 33342. Cellular mitochondrial membrane 
potential was measured by the TMRM fluorescence intensity in punctuate cytosolic 
regions (cellular inclusions) around the nucleus. Intracellular free calcium concentration 
was measured by the fluorescence intensity of Fluo-4 in an intracellular circular region 
(cellular compartment) centered at the nucleus. 
 
2.4 Results and Discussion 
2.4.1 CdTe Quantum Dots 
One question we would like to answer in our exploration of HCS technology and 
assays is how undifferentiated and differentiated cells respond to treatment with NPs. 
This is an important question because target cells at various stages of differentiation and 
maturation respond to therapeutic interventions in different ways. To answer this, we 
investigated the cellular response of the NG108-15 murine neuroblastoma cells to two 
types of CdTe QDs. The first is a thioglycolic acid (TGA)-capped CdTe QD (TGA-QD), 
and the other is a TGA-capped CdTe QD produced in the presence of gelatin (Gelatin-
QD). Both of these QDs have a diameter of 3nm and emits in the green-yellow region of 
the spectrum (~560nm). Some of us recently published the synthesis and characterization 
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of this Gelatin-NP nanocomposite along with a preliminary cytotoxicity study that 
demonstrated reduced cytotoxicity of Gelatin-QDs in THP-1 human monocytic cells.36 It 
has been suggested that gelatin enables the QDs to grow more discretely (blue shifted) 
and serve as a co-capping agent for stabilization of QDs and encapsulation of the toxic 
heavy metal core. While poly(ethylene glycol) (PEG) remains the most promising coating 
material for reducing cytotoxicity to this date, we believe naturally occurring 
biopolymers, such as gelatin, may provide additional biological functionalities in addition 
to their protective property. We chose to work with the NG108-15 murine neuroblastoma 
cells because they possess neuron-like properties and can be differentiated relatively 
easily and quickly.  
The first HCS assay we employed was an apoptosis/necrosis assay for the 
quantification of healthy, apoptotic, and necrotic cells. At the indicated time point (1.5h, 
6h, 24h) following treatment with TGA-QDs or Gelatin-QDs, cells were stained with 
propidium iodide (1 µg/ml) and Hoechst 33342 (2 µg/ml) for 10 min at room temperature 
and imaged using the IN Cell Analyzer 1000 HCS system (GE Healthcare). Cells in each 
category were classified using the supervised classification function of the IN Cell 
Investigator image analysis software (GE Healthcare), which analyzed the fluorescence 
quantitatively on a cell-by-cell basis. Figure 2.1 illustrates representative images of 
healthy, apoptotic, and necrotic cells. The plasma membranes of necrotic cells are 
permeable to propidium iodide, so necrotic cells were identified by their intense red 
fluorescence. Apoptotic cells were identified as being impermeable to propidium iodide 
but showing condensed and fragmented nuclei from the Hoechst 33342 stain. Healthy 
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cells were stained by Hoechst 33342 only and displayed intact and homogeneously 
stained nuclei. The experiment was carried out in triplicates in 96-well plates, which 
helps to increase throughput and reduce consumption of cell culture and assay reagents 
and ensures reproducibility at the large cell population scale.  
 
 
Figure 2.1 Representative fluorescence and bright field images of a healthy (green 
outline), an apoptotic (red outline), and a necrotic (yellow outline) cell. Outline and 
classification of cells were generated by the IN Cell Investigator image analysis software 
using the supervised classification capability.  
 
Figure 2.2 shows the average result from 3 independent runs. For each run, 5 
independent fields from each well were imaged using a 20X objective. The entire 
experiment, including all concentrations and time points, is an assessment of as many as 
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25,000 individually analyzed cells and demonstrates the robustness of HCS assays. For 
both undifferentiated and differentiated cells, treatment with QDs induced predominantly 
an increase in apoptotic cell population, as the number of necrotic cells remained 
relatively constant regardless of QD dosage or treatment time. This finding is 
corroborated by published results from Chan et al., who demonstrated that CdSe-core 
QDs induce apoptotic biochemical changes in human neuroblastoma cells via 
mitochondrial-dependent pathways and inhibition of survival signals.37 In addition, our 
study also found undifferentiated and differentiated cells to respond differently to 
treatment with QDs. This is an important finding because the human is composed of cells 
and tissue at different levels of maturity and differentiation. For undifferentiated NG108-
15 cells, the number of apoptotic cells remained constant between 1.5h and 6h of 
incubation with QDs and increased sharply after 24h. We suspect the delayed cytotoxic 
response is a buffering effect owing to the proliferating potential of undifferentiated cells. 
For differentiated cells, an incremental increase in apoptotic population was observed 
between the three time points, indicating differentiated cells to be more sensitive and 




Figure 2.2 Effect of QD treatment on NG108-15 cells. Undifferentiated and 
differentiated NG108-15 cells were incubated with various concentrations of TGA-QDs 
and Gelatin-QDs for 1.5 h (blue), 6 h (green), and 24 h (orange). Percentages of apoptosis 
and necrosis were determined by staining the cells with propidium iodide and Hoechst 
33342, followed by image acquisition and analysis using a HCS system.  
 
It should be emphasized that although TGA-QDs and Gelatin-QDs produced 
similar cellular response in NG108-15 cells, in HCS assays even a 5-15% difference 
represents a consistent and significant response at the cell population level and is likely to 
include moderate and below average response typical of the in vivo physiological 
situations. The most obvious difference between the two QDs is seen in the apoptotic 
population of the undifferentiated cells. While the apoptotic population of TGA-QD 
treated cells increased with QD concentration at 1.5h and 6h, the apoptotic population of 
Gelatin-QD treated cells remained unchanged.  In addition, TGA-QD treated cells also 
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displayed a more drastic increase in apoptotic population after 24h compared to Gelatin-
QD treated cells, indicating somewhat lower cytotoxicity in the Gelatin-QDs.  
Generalizing the results, it is important to make three points here.  (1) HCS  allows one to 
reliably identify these differences in cellular response to NPs and use it for comparison of 
their (bio)medical prospects, which provides a substantial advantage over less systematic 
techniques used now. (2)  We used here a version of analysis with fairly wide 
concentration step and finer profiles could be obtained to highlight even smaller effects 
for more advanced fingerprinting.  (3) Greater number of labels in the panel will further 
improve differentiation of the effect of one NPs versus the other or one cell type versus 
the other, which will be demonstrated below. 
To further investigate the difference between TGA-QDs and Gelatin-QDs, we 
conducted a neurite outgrowth assay to investigate the effect of QD treatment on 
neuronal differentiation. One day following cell seeding, NG108-15 cells were incubated 
with either type of QDs for 6 hours, after which the cells were washed with fresh medium 
and cultured in medium with reduced amount of serum to induce differentiation. No 
supplementary growth factor was added in order to avoid interference or counteracting 
effect. After 4 days of differentiation, cells were stained and imaged using the IN Cell 
Analyzer 1000 HCS system. Cells were first fixed in 2% paraformaldehyde and 
permeabilized in 0.1% Triton X-100 in 1% BSA. Neurites were stained using mouse anti-
β-tubulin III (1:800 in 1% BSA; overnight at 4 ºC) followed by Alexa Fluor 488 
conjugated goat anti-mouse IgG (1:200; 1h at 37 ºC). The experiment was carried out in 
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triplicates. For each well, 4 independent fields were imaged using a 10X objective and 
analyzed using the IN Cell Investigator software.  
Figure 2.3 shows representative images acquired by the robotic imaging system at 
different treatment conditions. The measurement of neurite outgrowth is traditionally a 
time-consuming and tedious job, but the work is greatly simplified with the aid of a HCS 
system. An analysis of the total neurite length with respect to the untreated control is 
presented in Figure 2.4. A 6h treatment with 25nM of TGA-QDs prior to neuronal 
differentiation reduced the total neurite length by approximately 50%, primarily due to a 
decrease in cell number as illustrated in Figure 2.3. However, treatment with 25nM of 
Gelatin-QDs led to a slight increase in total neurite length. We suspect this contradicting 
effect at low dose could be a hormetic response as hormesis is frequently observed as a 
result of low dose stimulation in toxicological studies.38, 39 The mechanisms involved in 
countering the cytotoxic effect of a short, non-lethal low dose treatment might have 
stimulated the formation of neurites. The difference between the two QDs is most evident 
at the 50nM concentration, where all TGA-QD treated cells were killed while Gelatin-
QD treated cells still exhibited some viability and a moderate level of neurite outgrowth. 





Figure 2.3 Effect of QD treatment on neurite outgrowth of NG108-15 cells. Cell were 
incubated with TGA-QDs and Gelatin-QDs at various concentrations for 6 h and induced 
to differentiate for 4 additional days in low-serum medium. Cells were stained for β-




Figure 2.4 Neurite outgrowth was assessed in terms of total neurite length per field. The 
result is the average of 3 independent experiments (4 independent fields each) and is 
expressed as percentage relative to the total neurite length per field of the untreated 
control (a). A false-colored composite fluorescent image of neurite outgrowth is shown 
here (b). During image analysis, the software’s image processing algorithm allows 





The apoptosis/necrosis assay and neurite outgrowth assay prompted us to further 
investigate the cellular response of neural cells to QD treatments. The apoptosis/necrosis 
assay measures only late-stage toxicity and cellular events associated with a lethal 
apoptotic or necrotic effect. This assay is important but needs to be augmented with other 
assays for detailed toxicology fingerprinting, because it provides little mechanistic 
understanding of toxicological effects. The neurite outgrowth assay clearly revealed the 
toxicological difference between the two QDs and demonstrated the importance of a 
functionality assay in cytotoxicity studies. Since our motivation is to explore the use of 
HCS assays for the study of nanotoxicity, we subsequently employed another kind of 
assay, this time an assay that would detect sublethal cytotoxicity in a multiparameter 
format to give us more information and sensitivity regarding the cytotoxicity of a given 
nanocolloid.  
Although the success and advantages of a sublethal, multiplexed cytotoxicty assay 
has been demonstrated by O’Brien and his colleagues in the study of hepatotoxicity,39, 40 
it has never been utilized in the context of nanotoxicity. Such an assay evaluates specific 
toxicological mechanisms in cells prior to the onset of the late stages of non-specific 
degeneration and apoptotic or necrotic death, providing greater predictive power and 
extrapolatability across models and species.40 The multiparametric nature of the assay 
originates from the multiple fluorescent probes that simultaneously and coherently 
monitor different cellular functions in vitro and is made possible by recent advances in 
fluorescent probe technology.41   
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In this study, undifferentiated and differentiated NG108-15 cells were treated with 
QDs at various concentrations for 24h, after which the medium was removed and the 
cells were incubated with a cocktail of fluorescent probes for 30 min before they were 
imaged using the IN Cell Analyzer 1000 HCS system. The cocktail of fluorescent probes 
was prepared in fresh medium and consisted of 1µM Hoechst 33342, 20nM TMRM, and 
1µM Fluo-4. These fluorescent probes were selected for specific reasons. First of all, 
these fluorescent probes can be used concurrently and are readily internalized by live 
cells without posing substantial harm. Hoechst 33342 allows identification of individual 
cell nuclei, which permits the measurement of cell count and nuclear area and allows 
subsequent analysis on the complementary stains to be conducted. A decrease in cell 
number indicates cell death and/or decreased cell proliferation, while nuclear shrinkage is 
typically a consequence of chromatin condensation and a sign of apoptotic cell death. 
TMRM and Fluo-4 allow the assessment of mitochondrial membrane potential and 
intracellular free calcium concentration, respectively. The mitochondrion is central to the 
functioning and survival of nerve cells.42 It is responsible for ATP generation, Ca2+ 
uptake and storage, and the generation of detoxification of reactive oxygen species.43 A 
drop in the electrochemical gradient across the mitochondrial membrane therefore signals 
weakened cellular respiratory capacity and energetics. Intracellular Ca2+ is a chief 
regulator of a variety of biological processes.44 For this reason, pharmaceutical 
companies have long adopted the measurement of intracellular Ca2+ for high-throughput 
screening.45 Intracellular Ca2+ is especially important in neural cells since it regulates 
neurite outgrowth and synaptogenesis, synaptic transmission and plasticity, and cell 
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survival.46, 47 A dramatic increase in intracellular Ca2+ is an early event in the 
development of cell injury due to cytotoxicity.48 
The concentration response of cells was measured using the IN Cell Investigator 
software and evaluated in terms of cell number, nuclear area, mitochondrial function, and 
intracellular calcium homeostatsis. Cell count was generated from the number of Hoechst 
33342 stained nuclei. Nuclear size was defined as the area of Hoechst 33342 fluorescence 
(Figure 2.5, inner blue circle). Cellular mitochondrial membrane potential was defined as 
the TMRM fluorescence intensity in punctuate cytosolic regions around the nucleus 
(Figure 2.5, yellow inclusions), while intracellular free calcium concentration was 
measured by the fluorescence intensity of Fluo-4 in a large intracellular circular region 
centered at the nucleus (Figure 2.5, outer green circle). Since the HCS platform is based 
on the acquisition, processing, and analysis of fluorescence images, we made sure the 
NG108-15 cells do not uptake significant amount of QDs to interfere with our 
multiplexed cytotoxicity assay (data not included). The level of fluorescence signal from 
QDs was constant regardless of concentration and was well below the basal fluorescence 
level of TMRM and Fluo-4. This was not a problem in the apoptosis/necrosis and neurite 
outgrowth assays because the emission spectrum of the QDs does not coincide with 
Hoechst 33342 and propidium iodide and immunological staining is much more specific 




Figure 2.5 Representative fluorescence images of a healthy (first row), an impaired 
(middle row), and a dying (last row) cells acquired and processed by the IN Cell HCS 
system. The nucleus, stained by Hoechst 3342, is outlined by a blue circle. The cell body 
or the intracellular region is enclosed by a green circle, within which the intensity of 
Fluo-4 fluorescence is measured. The punctuate, TMRM-bound mitochondrial organelles 
in the cytosol are identified by the yellow inclusions. In the merged images, Hoechst 
3342, Fluo-4, and TMRM stains are shown in blue, green, and red, respectively. As the 
health condition of cells deteriorates, the nucleus shrinks and becomes fragmented, the 
Fluo-4 stain intensifies and signal a sharp increase in intracellular free calcium 
concentration, and the TMRM stain diminishes as a result of reduction in mitochondrial 
membrane potential.   
 
Figure 2.6 shows the average result of our multiplexed cytotoxicity fingerprinting. 
Overall, cell count appears to be the most sensitive indicator of cytotoxicity, as 
significant changes in cell count tend to occur at a much lower QD concentration than the 
other parameters. In addition, the largest difference between the toxicity profiles of TGA-
QDs and Gelatin-QDs treated cells is observed in this fluorescence parameter. For 
Gelatin-QD and TGA-QD treated cells, the cell count falls below 70% at 12.5nM and 
1.56nM respectively in undifferentiated cells and at 1.56nM and 0.39nM respectively in 
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differentiated cells. Similar findings are observed in the other parameters, where the onset 
of change in fluorescence parameters (except nuclear area) consistently occurs at a lower 
QD concentration in TGA-QD treated cells and in differentiated cells. These differences 
are summarized in Table 2.1 and have two implications. (1) It is confirmed that the 
Gelatin-QDs are less cytotoxic and more biocompatible than the TGA-QDs. The gelatin-
CdTe nanocomposite reduced the sublethal concentration (>30% cell death) of CdTe 
QDs by at least 4 times in both undifferentiated and differentiated cells (Table 2.1). This 
outcome validates our rationale behind the incorporation of biological molecules in the 
synthesis of NPs as a mean to achieve better stability and biocompatibility. We have to 
keep in mind that the toxic effect of CdTe made in a general synthetic rout described here 
can never be eliminated but modified or reduced and we use these NPs here as a model 
system. We also have to reiterate that although some of the observed differences between 
the two QDs could potentially be interpreted as marginal, the fact is that in systems 
implementing HCS principles a 5-15% difference represents a consistent and significant 
response because of the large cell population being analyzed. The close resemblance 
between the toxicity profiles of TGA-QDs and Gelatin-QDs also indicates that their 
toxicity share a common source, which most likely comes from the leakage of cadmium 
from the core of the NPs. (2) As already indicated by the apoptosis/necrosis assay, is that 
differentiated cells are more sensitive and vulnerable to QD-induced cytotoxicity, which 
is somewhat surprising because they are generally regarded as more sensitive to the 
environment. The large number of fragmented nuclei (Figure 2.5, last row) observed at 
high QD concentrations again confirms apoptosis as the primary cellular response to the 
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QD-induced cytotoxicity. Beside the larger scale of decrease in cell count and 
mitochondrial membrane potential observed in differentiated cells, the hormetic response 
in the nuclear area observed in undifferentiated cells is absent in differentiated cells and 
is replaced by marginal reduction. While the mitochondrial membrane potential of 
undifferentiated cells follows an inverse decay, the same parameter appears to decay 
exponentially in differentiated cells and could possibly explain their vulnerability to QD-
induced apoptosis. We suspect these differences in cellular response arise from changes 
in biological machinery as cells differentiate.49 Changes involving mitochondria, 
membrane structures, and protein modifications may account for the higher sensitivity of 






Figure 2.6 Cytotoxic effects of TGA-QDs (white bars) and Gelatin-QDs (gray bars) in 
NG108-15 cells. Undifferentiated (left half) and differentiated (right half) cells were 
treated with QDs for 24 h and assayed for cell number (Hoechst 33342; top), nuclear area 
(Hoechst 33342; second from top), mitochondrial membrane potential (TMRM; third 
from top), and intracellular ionized Ca (Fluo-4; bottom). At each concentration, 5 






Table 2.1 A summary of the onset of change in each of the 4 fluorescence parameters.  
 
2.4.2 Gold Nanoparticles 
As an extension to the CdTe QD study, we employed the multiplexed cytotoxicity 
assay to study the effect of gold NPs (Au NPs) on HepG2 human hepatocellular 
carcinoma cells. We have recently demonstrated the use of gold NPs for early detection 
of cancerous tumors and inflammatory responses by photoacoustic imaging.22, 51 
Considering the numerous functionalization strategies available for Au NPs, the ability to 
characterize toxicity using a HCS platform will be immensely valuable for the 
development of biomedical applications. We chose the HepG2 cells because they are one 
of the most commonly used cell types for HCS studies and have implications for metal 
poisoning associated with hepatic toxicities. 
Our study with Au NPs differs from those with CdTe QDs in a couple ways. In 
addition to the use of a different cell line, the Au NP study aims to determine the effect of 
exposure duration to the NPs, as well as post-exposure changes in cell physiology, while 
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the previous studies focus on the concentration-dependent effect of NPs.  To investigate 
these effects, we treated HepG2 cells with Au NPs for various lengths of time (0, 1, 2, 4, 
and 6 h). Following the Au NP treatment, cells were washed with PBS and allowed to 
grow in fresh medium for an additional period of time (1, 2, and 4 days). Similar to the 
previous studies on NG108-15 cells, HepG2 cells were analyzed for nuclei count, nuclear 
area, mitochondrial membrane potential, and intracellular free calcium concentration by 
incubating with a cocktail of dye solutions and imaging with the IN Cell Analyzer 1000 
HCS system to achieve complete fingerprinting of cellular response.  
Our data suggests that Au NPs inhibited the proliferation of HepG2 cells. Figure 7 
shows that although cell number appears to be relatively constant across different 
treatment times on day 1 and day 2 following Au NP treatment, it becomes inversely 
proportional to treatment time on day 4. Stronger inhibitory effect was observed with 
increasing exposure time to Au NPs. The inhibition of proliferation by Au NPs has been 
reported in other cells including endothelial cells and multiple myeloma cells.52-54 Au 
NPs have been found to bind to and block the function of proteins that are essential for 
cell proliferation. In addition, Au NPs can also block and disrupt certain cellular 
signaling pathways that required for growth and survival. In our study, this inhibitory 
effect was also accompanied by enlargement in the nuclear area. Cells having the longest 
exposure to Au NPs had an average nuclear area that was 13% larger than the untreated 
cells on day 4 after treatment. The concentration and exposure times of Au NPs 
employed in this study were shown to be only mildly cytotoxic to the HepG2 cells. 
Changes in the cellular mitochondrial membrane potential and intracellular free calcium 
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concentration never deviated more than 10% from the untreated control. Treatment with 
Au NP reduced the mitochondrial membrane potential, which is a typical cellular 
response to cytotoxic material. The reduction was only apparent after 4 days following 
treatment and increased slightly with increasing exposure time. While cytotoxic 
stimulation typically leads to an increase in intracellular free calcium concentration, we 
unexpectedly observed a decrease in intracellular free calcium concentration 1 day 
following the Au NP treatment. The decrease appeared to be proportional to the exposure 
time, reaching approximately 10% for the longest exposed cells (6h). Interestingly, the 
drop in intracellular free calcium concentration recovered by itself to the normal level as 
the culture time increased. The rate of recovery was inversely proportional to the 
exposure time, with the cells having the shortest exposure to Au NPs (1h) making the 
quickest recovery. These findings indicate that the Au NPs inhibited intracellular calcium 
release in the HepG2 cells. Similar findings have also been reported for endothelial 
cells.54 In our study, we also found this inhibitory effect by Au NPs to be reversible once 




Figure 2.7 Cytotoxic effects of gold NPs in HepG2 cells. HepG2 cells were treated with 
gold NPs for 0, 1, 2, 4, and 6h and assayed for cell number (Hoechst 33342; top), nuclear 
area (Hoechst 33342; second from top), mitochondrial membrane potential (TMRM; 
third from top), and intracellular ionized Ca (Fluo-4; bottom) 1, 2, and 4 days after 




2.4.3 Dispersed Carbon Nanotubes and Carbon Nanotube Thin Films 
As a final demonstration, we again employed the multiplexed cytotoxicity assay 
to study the effect of carbon nanotubes (CNTs) on NG108-15 murine neuroblastoma 
cells. We are interested in the cytotoxicity of CNTs in two different modes: free CNTs in 
the dispersed form and immobilized CNTs as thin films. Although there have been 
intensive research efforts exploring biological applications of CNTs,55, 56 studies 
investigating the cytotoxicity of CNTs have generated conflicting results. While 
researchers have found dispersed CNTs to exert a wide range of effects, ranging from 
indirect and minimal to severely cytotoxic,57, 58 studies have found immobilized CNT 
matrixes and substrates to produce little to no cytotoxicity and in some cases even 
enhanced cellular functions.59, 60 As these studies were motivated by vastly different goals 
and employed different experimental methods, the development of a universal assay for 
evaluating the cytotoxic effects of dispersed and immobilized CNTs can provide a more 
objective viewpoint on the cytotoxicity of CNT-based nanostructures and create a model 
platform for future studies of functionalized CNTs and CNT-based substrates.  
In this study, NG108-15 cells were treated with culture medium containing 
various concentrations of single-walled carbon nanotubes (SWNTs) dispersed with 
poly(sodium 4-styrene-sulfonate) (PSS). To eliminate any differences caused by the 
presence of dispersing reagent,61 all treatments, including the control, were prepared with 
the same concentration of PSS. In addition, cells were also cultured on polystyrene 
culture plate coated with SWNT thin films fabricated from the layer-by-layer (LBL) 
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assembly of poly(vinyl alcohol) (PVA) with PSS-dispersed SWNTs (SWNT-PSS). Thin 
films of SWNTs were assembled with PVA solutions at a pH value of 2, 6 or 10 and 
fabricated to a total of 2 or 6 bilayers of PVA/SWNT-PSS. Following 48 hours of 
treatment, cells were washed with PBS, incubated with a cocktail of dye solutions, and 
imaged with the IN Cell Analyzer 1000 HCS system to analyze for nuclei count, nuclear 
area, mitochondrial membrane potential, and intercellular free calcium.  
Our data shows that all of the SWNT LBL films we tested displayed minimal 
degree of cytotoxicity regardless of the number of bilayers and the pH of the PVA 
solution used to assemble the films. As illustrated by Figure 2.8, for cells cultured on the 
SWNT thin films, the four parameters examined by the assay remained relatively 
constant and close to the level exhibited by the untreated control group, indicating that 
the SWNT LBL films are inert and behave like the polystyrene cell culture plate. Figure 
2.8 shows a small drop in the nuclear area for cells cultured on SWNT LBL films with a 
thickness of 6 bilayers. However, this effect is absent for cells on the 2-bilayer films. We 
suspect this is an artifact from the automated HCS imaging system caused by the 
opaqueness of SWNTs in the thicker 6-bilayer films. The slight loss of transparency was 
an issue for measurements relying on the area and intensity of the fluorescence staining, 
but not so much for the measurement of cell count, which tallies the total number of 
stained cell nuclei. We were able to correct the fluorescence intensity measurements of 
TMRM and Fluo-4 using a reference culture plate to reflect the true values. However, 
without a simple and reliable fix, the nuclear area measurements were not adjusted, and 
therefore the data presented here does not account for the reduction in software-
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determined nuclear area as a result of decreased transparency of the culture substrates. 
Nevertheless, with the reduced nuclear area measurements at above 80%, and along with 
the data from the other parameters, the outcome still indicates a very healthy cell culture 
on the SWNT LBL films, demonstrating their potential as a biocompatible material for 
neural cells.  
For cells treated with dispersed SWNTs, cytotoxicity was observed to increase 
with SWNT concentration. Mitochondrial membrane potential, which was probed with 
TMRM, was the most sensitive indicator of cytotoxicity. While, a SWNT concentration 
of just 0.8 µg/ml caused the fluorescence intensity of TMRM to fall below 80%, all other 
parameters were unchanged. Another noticeable difference in the cytotoxicity profiles is 
the change in intracellular free calcium concentration with respect to SWNT 
concentration. While the profiles for cell count, nuclear area, and mitochondrial 
membrane potential followed similar pattern as those obtained in the CdTe QD study, 
here the intracellular free calcium concentration did not increase with raising SWNT 
concentration but instead remained largely unchanged. This could be an indication that a 
different mechanism might be at play in generating cytotoxicity in response to the SWNT 
treatment. In this study, we found that a relatively high concentration of SWNTs (>25 
µg/ml) was required to inhibit cell proliferation or cause significant cell death. At the 
same time, low concentrations of SWNTs were sufficient to disrupt the mitochondrial 
membrane potential considerably, which has been reported previously.62 Judging from 
this result, it’s likely that prolong exposure with SWNTs could elicit more enhanced level 
of cytotoxicity at lower concentrations.  
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Figure 2.8 Cytotoxic effects of dispersed SWNTs and SWNT LBL films in NG108-15 
cells. NG108-15 neuroblastoma cells were seeded on SWNT LBL films or treated with 
dispersed SWNTs for 48h and assayed for cell number (Hoechst 33342; top), nuclear area 
(Hoechst 33342; second from top), mitochondrial membrane potential (TMRM; third 
from top), and intracellular ionized Ca (Fluo-4; bottom). At each treatment, five 





In summary, we have demonstrated the use of various HCS assays to study the 
cytotoxicity of CdTe QDs, Au NPs, CNTs, and LBL films of CNTs in NG108-15 
neuroblastoma cells and HepG2 human hepatocellular carcinoma cells. We found the 
neurite outgrowth assay, which assesses the functionality of differentiated neural cells, to 
be particularly important and the multiplexed cytotoxicity assay as a sensitive and 
informative assessment of toxicological mechanisms. The versatility of the multiplexed 
cytotoxicity assay was demonstrated across the different nanomaterials tested in this 
study. The assays were capable of distinguishing the subtle differences in the cytotoxicity 
generated by TGA-QDs and Gelatin-QDs. The Gelatin-NPs, which were synthesized in 
the presence of gelatin, provided insight for surface modification and bio-
functionalization of NPs. Most importantly, we demonstrated that undifferentiated and 
differentiated NG108-15 neuroblastoma cells respond differently to CdTe QD-induced 
cytotoxicity. Specifically, the differentiated cells are more sensitive and vulnerable to QD 
treatment, which can be understood as the demonstration of adaptability of cells in 
undifferentiated state. This difference should be taken into account in the establishment 
of treatment dosage for any NP-based biological studies or therapies. Using the 
multiplexed cytotoxicity assay, we were able to uncover the inhibitory effect of Au NPs 
on cell growth and release of intracellular free calcium in HepG2 cells. In addition, we 
were also able to examine the cytotoxic effects of dispersed CNTs and CNT LBL films, 
demonstrating that free CNTs induced a drop in mitochondrial membrane potential while 
the CNT LBL films appeared to be biocompatible.     
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The cytotoxicity profiles generated from the multiplexed cytotoxicity assay can be 
regarded as the “fingerprints” of the corresponding nanomaterials. The multiparametric 
nature of these profiles will allow cytotoxicity analyses to be conducted at much higher 
throughput and accuracy in the future. Importantly, we demonstrate here that the 
application of HCS technology in the study of nanomaterials is not limited to the 
cytotoxicity of colloidal NPs, but is also suitable for the assessment of biocompatibility 
of multilayer thin films produced from LBL assembly. We believe HCS technology can 
also be extremely useful for the study of the transport and localization of engineered NPs 
and CNTs in living cells. Such an endeavor could shed light on the development of new 
drugs and drug delivery strategies based on nanomaterials. 
We also consider it essential to mention here that the presented modality of the 
technique also has a significant limitation that needs to be addressed. It is related to the 
two-dimensional nature of cell cultures currently used in HCA most often. Cellular 
response in 2D cell cultures was shown to be different than cells in the natural tissue 
environment. More adequate 3D cell cultures techniques need to be developed. HCA 
does afford analysis of 3D images in a similar way as we presented here; however, the 
3D approach will indeed require development of appropriate 3D matrixes (scaffolds), cell 
culture techniques, and refinement of software algorithms for image analysis. A suitable 
matrix must be transparent, mechanically robust, very biocompatible, and exceptionally 
standardized. Hydrogel matrixes made with geometry of inverted colloidal crystals63, 64 
and potentially some other sharing the properties65, 66 mentioned above can be 
successfully used for this task.  
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Biocompatibility of Layer-by-Layer Assembled Single-Walled Carbon Nanotube 
Composites with Neural Stem Cells 
 
3.1 Abstract 
The same properties that made carbon nanotube (CNT) composites interesting for 
electronics, sensing and ultrastrong structural materials also make them an asset for 
biomedical engineering.  The combination of electron conductivity, corrosion resistance 
and strength are essential for neuroprosthetic devices.  All the studies in this area 
demonstrating cellular adhesion and signal transduction activity on CNT matrixes were 
conducted, so far, with terminally differentiated primary cells and cancerous cell lines.  
Neural stem cells are very plastic neural precursors capable of adapting to environmental 
conditions and recreating signal transduction pathways.  Their intrinsic biological 
functionality not only makes the transition to stem cell cultures a difficult-to-avoid step 
but also implies several fundamentally important challenges.  Here we demonstrate that 
mouse embryonic neural stem cells (NSCs) from the cortex can be successfully 
differentiated to neurons, astrocytes, and oligodendrocytes with clear formation of 
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neurites on layer-by-layer (LBL) assembled single-walled carbon nanotube (SWNT)-
polyelectrolyte multilayer thin films.  Biocompatibility, neurite outgrowth, and 
expression of neural markers were similar to those differentiated on poly-L-ornithine 
(PLO), one of the most widely used growth substratums for neural stem cells. 
 
3.2 Introduction 
The development of nanotechnology is penetrating biology and medicine at a 
remarkable speed.1  Nanotechnology is poised to provide new tools to measure and 
understand biosystems,2, 3 bring insights to challenges in biotechnology and 
biomedicine,4, 5 and offer building components for advanced biomaterials.6, 7  One area 
that will significantly benefit from the development of nanoscale engineering is the 
technology for neural medicine in its many manifestations.8   The reasons are multifold:  
(1) Nanomaterials were originally developed and still have the most widespread 
applicability for electronics and information processing which makes their 
functionalities quite similar to those of neural system.   
(2) The neural tissue is highly complex in its anatomy, functional structuring, and 
information processing, which frustrates the applications of current technologies 
and requires the change of technological paradigm.   
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(3) The central nervous system is difficult to access and has a heterogeneous 
cellular and molecular environment, which, in turn, means that size reduction of 
any devices to interact with neurons is required to create the least possible 
interference with and disruption to the central nervous system’s functionality.   
Indeed, recently we are beginning to see emerging applications of nanotechnology 
in neuroscience using primarily organic and polymeric materials as scaffolds.  In this 
study, we focus on the development of a new platform biomaterial based on single-walled 
carbon nanotubes (SWNTs) that can find applications in the treatment of neurological 
disorders and injuries.  Why carbon nanotubes?  The unique physical, chemical, 
mechanical, and electronic properties of carbon nanotubes9-14 can be, in part, transferred 
into SWNT composites to combine high electrical conductivity, chemical stability, and 
physical strength with structural flexibility.15-19  Such a unique combination of 
characteristics and the possibility for surface functionalization20, 21 make these SWNT 
composites promising candidates for making neural prosthetic devices with capabilities 
for electrical field recording, sensing of neurotransmitters, and electrical stimulation.  For 
example, several neurological disorders and injuries, such as Parkinson’s disease, 
epilepsy, and stroke require an implantable device to generate electrical activity in the 
damaged or diseased tissue.  One common problem of all chronically implanted 
electrodes lies in the tissue-electrode interface.22  Tissue reactions typically lead to 
encapsulation around the electrode, reducing its performance and lifetime.  Current 
neural prosthetic technology is in active search of a biocompatible material that allows 
chronic implantation of miniaturized electrodes.23, 24  SWNT composites can exactly 
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satisfy these demands by providing a durable, electrically conductive, highly modifiable, 
and biocompatible interface for permanent long-term implantations.  Various strategies 
can be similarly applied to SWNT composites to attract growing neurites25, 26 and reduce 
inflammatory response.27  The first results on neuronal excitation through SWNT films 
made by the layer-by-layer (LBL) assembly had already been demonstrated.28 
All the latest studies of interactions of neural cells with carbon nanotubes were 
carried out with terminally differentiated primary cells or cell lines.  The primary focus 
was on establishing biocompatibility of the proposed materials.29, 30  In addition, carbon 
nanofiber reinforced composites were shown to increase neuronal cell functions while 
providing a mechanically strong and electrically conductive substrate.31  Patterned carbon 
nanotubes were utilized to guide neural cell growth and demonstrate preferential cell 
attachment on carbon nanotubes.32, 33  Neural signal transmission efficacy was also 
reported to increase on carbon nanotube-coated substrates.34  We see strong possibilities, 
fundamental importance, and practical need to use neural stem cells (NSCs)35 in the 
studies of SWNT materials for neural medicine.  Terminally differentiated cells have 
limited capacities for extracellular matrix remodeling, axonal extension, and interfacing 
with implants.36, 37  Successful implantation and long-term performance of a neural 
prosthetic device may and most likely will require an interface that can recruit NSCs.  On 
the other hand, in many cases NSCs are necessary to regenerate the neural tissue,38, 39 
while the implantable device will be needed to establish and train a particular signal 
transmission path.  Despite the obvious importance of NSCs, the overall body of 
knowledge of their behavior on engineered materials remains very limited.  Young and 
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his colleagues have done work in this area with polymeric and biomimetic substrates.40-42 
Silva and Stupp have demonstrated the differentiation of NSCs in peptide fibrous 
matrices.43 Interactions of quantum dots and nanoparticles have been investigated with 
neurons44-46 and bone marrow stem cells47, 48 but not with NSCs.  Likewise, no 
information is available about the interaction of any possible carbon nanotube materials 
and NSCs.  Considering the potential importance of these composites for neural 
medicine, one has to ask the two fundamental questions that are necessary for further 
development of the field and acquisition of knowledge regarding the interaction of 
nanoscale materials and transformable cells.  First, are SWNT composites biocompatible 
enough to support the differentiation of stem cells, which are well known for their 
sensitivity to the environment?  Second, if this is the case, do SWNT materials affect in 
any way the differentiation of NSCs?  In this study, we demonstrate, for the first time, 
differentiation of mouse cortical NSCs on a SWNT-based composite.  Our results provide 
us definite answers to the questions above regarding LBL assembled SWNT-
polyelectrolyte composite films.  The choice of the particular SWNT composite was 
made on the basis of previous success with culturing NG108-15 murine neuroblastoma × 







3.3.1 Preparation of Substrates 
Poly-L-ornithine (PLO, Sigma-Aldrich), a commonly used substratum for NSC 
studies, was used to produce a monolayer of PLO on 12mm #1 round German glass 
coverslips (Bellco Glass Inc.) as the control substrates.  PLO coated coverslips were 
prepared 24 h before seeding by incubating the coverslips in 15 µg/ml PLO solution for 3 
hours followed by 3 washes with PBS.  Prior to coating, the glass coverslips were cleaned 
and sterilized by sonication in 70% ethanol and irradiation with UV light.  The 
experimental substrates were fabricated by coating glass coverslips with layer-by-layer 
(LBL) assembled single-walled carbon nanotube (SWNT) composite multilayers.  A 
stable dispersion of SWNTs was obtained by first dispersing purchased SWNTs (Carbon 
Nanotechnologies Inc.) in 1-wt% poly(sodium 4-styrene-sulfonate) (PSS, MW 1,000,000, 
Sigma-Aldrich) solution50 with 2 h of mild sonication in a ultrasonic cleaner followed by 
centrifuging the mixture at 5000 rpm and collecting the supernatant.  To assemble 
multilayers of SWNTs, round glass coverslips cleaned by sonication in 70% ethanol were 
immersed in a 0.5 wt-% Poly(ethyleneimine) (PEI, MW 750,000, Sigma-Aldrich) solution 
for 20 min followed by wash with high purity water and drying under a gentle air jet to 
form a stable monolayer of PEI molecules. Each subsequent layer was formed by 
immersing the coverslips in the dispersion of SWNTs or PEI for 20 min followed by the 
same washing and drying steps.  The alternating layering process was repeated until 5 or 
6 number of layers, designated as (PEI/SWNT)5 or (PEI/SWNT)6, were obtained. The 
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coated glass coverslips were sterilized with 70% ethanol and UV irradiation prior to cell 
seeding. 
3.3.2 Culture of Mouse Cortex Embryonic 14-day Neurospheres 
Mouse cortex embryonic 14-day neurospheres, basal medium, and all 
supplements for neural stem cell (NSC) culture were purchased from StemCell 
Technologies.  Proliferation and differentiation media were prepared according to the 
manufacturer’s technical manual.  The proliferation medium contains 20 ng/ml of human 
epidermal growth factor (hEFG).  Neurospheres were cultured in the proliferation 
medium for at least two passages (7 to 9 days each) before being used for differentiation 
experiments.  Between passages, neurospheres at moderate densities were harvested, 
mechanically dissociated into single cells, and seeded at a density of 2 × 106 cells per 40 
mL of medium.  For the differentiation of neurospheres, neurospheres were harvested and 
seeded as whole spheres on coated glass coverslips in 24-well plates at a density of 200 
neurospheres per well and cultured in differentiation medium.  For the differentiation of 
single cells, neurospheres were dissociated into single cells using a chemical dissociation 
kit (StemCell Technologies) and seeded at a density of 2 × 105 cells per well.  Cultures 
were observed for morphological changes at the indicated time point using a Nikon 
Eclipse TS100 inverted microscope equipped with a QImaging MicroPublisher 3.3 digital 
CCD color cameras.  Images were captured using QImaging’s QCapture software. 
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3.3.3 Quantification of Process Growth 
The lengths of neural processes were determined from digital photomicrographs 
taken at the indicated experimental points.  Quantification of process growth was 
evaluated from the end-to-end distances of neural processes in 10 independent fields.  
The lengths of 5 longest processes per field were measured from the edge of the 
neuropshere to the tip of the processes in a linear fashion using the NIH Image J 
software.   
2.3.4 Assessment of Cell Viability 
Viability of differentiated neurospheres was determined using the MTT assay.  
The MTT salt (3-(4,5-Dimethyl-2-thiazolyl)-2,5-diphenyl-2H-tetrazolium bromide, 
Sigma-Aldrich) is reduced to insoluble purple formazan by active mitochondrial 
reductase enzymes in the cell.  At the indicated time points, 50 µL of MTT solution (5 
mg MTT/ml PBS, sterile filtered) was added to each well and incubated for 4 h at 37°C.  
After incubation, the MTT formazan solution was collected, precipitated by 
centrifugation, and dissolved in 500 µL of DMSO.  The optical density of the formazan 
solution was measured at 570 nm (reference at 650 nm) using a Maxline microplate 
reader (Molecular Devices).  Viability of differentiated single cells was determined using 
the WST-8 assay.  Unlike the MTT salt, the WST-8 salt (2-(2-methoxy-4-nitrophenyl)-3-
(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium, monosodium) produces a water-
soluble formazan dye upon reduction.  At the indicated time point, 50 µL of WST-8 
solution (Dojindo Molecular Technologies Inc.) was added to each well and incubated for 
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5 h at 37°C.  The absorbance of the solution was measured at 450 nm (reference at 650 
nm).  
3.3.5 Scanning Electron Microscopy 
For SEM analysis, samples were first washed briefly with PBS, fixed with 2.5% 
glutaraldehyde for 1 h, and then washed again with PBS three times for 5 min each.  The 
samples were then dehydrated through a gradient series of ethanol (25%, 50%, 70%, 
85%, 95%, and three times 100%) for 5 min each time and left overnight in the final 
100% ethanol solution.  Completely dried samples were mounted on aluminum stubs and 
coated sputter-coated with gold.  Imaging was carried out using a Philips XL30FEG 
scanning electron microscope. 
3.3.6 Immunocytochemistry 
For immunocytochemical characterization, cultured cells were fixed in 4% 
paraformaldyde in PBS for 30 min and permeabilized in 0.3% Triton X-100 in PBS for 5 
min.  Cells were first incubated with primary antibody diluted in PBS containing 10% 
goat serum for 2 h at 37°C and then with secondary antibody diluted in PBS containing 
2% goat serum for 30 min at 37°C.  All primary and secondary antibodies were 
purchased from Chemicon. Primary antibodies and their dilutions are as follow: mouse 
anti-nestin (1:200), mouse anti-MAP2 (1:200), mouse anti-GFAP (1:200), chicken anti-
GFAP (1:200), and mouse anti-O4 (1:200). Secondary antibodies and their dilutions are 
as follow: goat anti-mouse IgG-rhodamine conjugated (1:100), donkey anti-chicken Igy - 
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FITC conjugated (1:100). Samples were counter-stained for nuclei and mounted with 
Prolong Gold Anti-Fading Reagent with DAPI (Invitrogen). Immunostained samples 
were visualized using an Olympus FluoView FV500 confocal laser scanning microscope.  
The imaged were acquired using the Olympus Fluoview software version TIEMPO 4.3.  
Quantitative cell phenotype analysis was carried out using the NIH ImageJ software by 
counting immunopositive cells against DAPI-stained cells. 
 
3.4 Results and Discussion 
To investigate the behavior of NSCs on LBL assembled SWNT composite films, 
mouse embryonic 14-day neurospheres (ie. spherical clonal structures of NSCs) from the 
cortex were seeded and induced to differentiate on round glass coverslips (12 mm 
diameter) coated with 6 bilayers of SWNT-polyelectrolyte.  SWNTs were dispersed in a 
1-wt% poly(sodium 4-styrene-sulfonate) (PSS) solution and LBL assembled with the 
polyelectrolyte poly(ethyleneimine) (PEI). The resulted thin film of coating was 
designated as (PEI/SWNT)6. As a control, neurospheres were also seeded and 
differentiated on coverslips coated with poly-L-ornithine (PLO), a standard substratum 
commonly used for NSC cultures and studies.  
NSCs were first expanded in proliferation medium containing epidermal growth 
factor (EGF).  To induce cell attachment and differentiation, they were seeded at a low 
density of 200 neurospheres per coated coverslip in 24-well plates and cultured with EGF 
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depleted differentiation medium.  As suggested by Young et al.,41 a high neurosphere 
seeding density encourages cell migration from neurospheres while a low seeding density 
does not support cell survival away from neurospheres and forces cells to extend long 
processes in search for other neurospheres.  Therefore, a low neurospheres seeding 
density truly tests the interaction between cells and their substrate.  In our study, 
neurospheres attached to both types of substrates and developed neural processes away 
from the edge of the neurospheres as early as 1 day in culture (Figure 3.1a).  The lengths 
of processes from differentiated NSCs increased steadily over the 7-day culture period 
(Figure 3.1b).  Throughout the culture period, neural processes developed on PLO coated 
substrates remained longer than those developed on (PEI/SWNT)6 coated substrates; 
however, the differences were not very significant.  By 5 days in culture, NSCs on both 
types of substrates had extended long and complex processes into the area surrounding 
the neurospheres.  It is highly likely that, if the neurospheres were seeded at higher 
densities, the extending processes from individual neurospheres could reach and form 
networks with their neighboring neurospheres.  
Viability of neurospheres was evaluated using the MTT assay (Figure 3.1c).  
There was no noticeable difference between the viability of neurospheres on 
(PEI/SWNT)6 and PLO coated substrates.  Cell viability was maintained at a steady level 
after day 3.  The initial decline in cell activity between day 1 and day 3 is likely to be a 
consequence of cell damage during the EGF depletion process (repeated centrifugation 
and dispersion) and lost of weakly attached neurospheres during medium change.  In any 
case, our viability assessment indicates that (PEI/SWNT)6 coated substrates are as 
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biocompatible as PLO coated substrates in supporting neurosphere differentiation.  The 
differentiated morphology of neurospheres was confirmed by scanning electron 
microscopy (SEM) (Figure 3.1d first row).  Differentiated neurospheres developed 
abundant and highly branched neural processes on both types of substrates.  SEM also 
revealed migration of individual cells away from the original neurospheres (Figure 3.1d 
second row).  In addition, we observed more pronounced spreading of extracellular 
matrix (ECM) on PLO coated substrates which we believe is a consequence of PLO’s 
adhesive nature.  The SEM images are a straightforward indication, together with Figure 
3.1a-b, that LBL assembled SWNT films can support the differentiation of neurospheres 





Figure 3.1 Mouse embryonic 14-day cortical neurospheres differentiated on and 
(PEI/SWNT)6 and PLO coated coverslips in 24-well plate at a low seeding density of 200 
neurospheres per well. (a) Light microscopy images of differentiated neurospheres. (b) 
Evaluation of the lengths of processes extending from the differentiated neurospheres for 
the 7-day culture period. (c) MTT reduction activity of differentiated neurospheres. (d) 
Color enhanced SEM images highlighting neurite outgrowth of differentiated 
neurospheres on day 7 (first row). SEM images at higher magnification showing 






It has been known since the discovery of NSCs that NSCs differentiate into a 
heterogeneous population of cells consisted primarily of neurons, astrocytes, and 
oligodendrocytes.35  To analyze the differentiated phenotypes, neurospheres cultured for 
7 days were immunostained with anti-nestin, anti-microtubule associated protein 2 (anti-
MAP2), anti-glial fibrillary acidic protein (anti-GFAP), and anti-oligodendrocyte marker 
O4 (anti-O4) and countered stained with DAPI nuclei stain (Figure 3.2a).  Nestin 
expression has been adopted as a marker for neural stem and precursor cells.51  MAP2 is 
a cytoskeletal protein component in mature neurons and dendrites52 while GFAP and O4 
are established markers for intermediate filament proteins in astrocytes53, 54 and surface 
antigens of developing oligodendrocytes55, 56 respectively. 
 Immunostaining results on PLO and (PEI/SWNT)6 coated substrates are 
qualitatively comparable (Figure 3.2a).  Both types of substrates supported differentiation 
of neurospheres into the three primary neural cell types – neurons, astrocytes, and 
oligodendrocytes.  In general, nestin expression is intense and abundant near the center of 
neurospheres.  MAP2-positive cells are faintly stained and located near the center, while 
O4-positive cells are sparsely distributed throughout the neurospheres. GFAP is heavily 
expressed at the periphery of neurospheres, indicating that most migrating cells might be 
astrocytes.  Quantitative assessment of cell phenotypes shows that there were slightly 
more neurons and oligodendrocytes on (PEI/SWNT)6 coated substrates and more 
astrocytes on PLO coated substrates (Figure 3.2b).  In general, the cell phenotype 
analysis is consistent with our observations from Figure 3.1 and 3.2a.  Longer neural 
process formation (Figure 3.1a,b) and increased spreading of ECM (Figure 3.1d second 
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row) on PLO coated substrate seem to correlate with increased astrocyte population 
(Figure 3.2).  Fibrous astrocyes are known to have long and slender processes, and ECM 
formation is characteristic for astrocytes.  Similar results have also been obtained by 
Young and his colleagues41 in which, under serum-free condition, a substrate that 
promotes longer processes generated primarily fibrous astrocytes and fewer neurons.  
  
Figure 3.2 (a) Confocal microscopy images differentiated neurospheres on day 7. 
Neurospheres were stained for markers of NSCs (nestin), neurons (MAP2), astrocytes 
(GFAP), and oligodendrocytes (O4). Neural markers are shown in red, while the cell 
nuclei, counterstained with DAPI, are shown in blue. Images represent scans near the 
center of the neurospheres. Scale bars: 20 µm. (b) Average percentages of differentiated 
cell phenotypes after 7 days in culture. 
 
Having successfully demonstrated the differentiation of mouse neurospheres on 
LBL assembled SWNT composite films, we sought to elucidate the differences between 
the different substrates by increasing cell-substrate contact.  To accomplish this, we 
chemically dissociated neurospheres into single cells and differentiated them on 
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(PEI/SWNT)5, PLO, and (PEI/SWNT)5(PLO) coated glass coverslips.  We added 
(PEI/SWNT)5(PLO) coated substrates to help us determine whether the combination of 
PLO’s adhesiveness and SWNT’s nano-topology (Figure 3.3) would produce any 
additive cell behavior.  However, we observed very little variations across NSCs cultured 
on the three different substrates (Figure 3.4a).  As time progressed, NSCs transformed 
from a spherical morphology to a more elongated and spread-out morphology 
representative of differentiated neural cells.  Differentiated NSCs also developed neural 
processes that intertwine with one another.  The change in cell morphology was 
confirmed by scanning electron microscopy (SEM) images acquired on day 1 and day 5 




Figure 3.3 SEM images of (PEI/SWNT)5, PLO, and (PEI/SWNT)5(PLO) coated glass 
coverslips. Individual and bundles of carbon nanotubes are visible on (PEI/SWNT)5 and 








Figure 3.4 Mouse embryonic 14-day cortical neurospheres differentiated as dissociated 
single cells and small clusters on and (PEI/SWNT)6, PLO, and  (PEI/SWNT)6(PLO) 
coated coverslips in 24-well plate. (a) Light microscopy images of differentiated NSCs. 
(b) SEM images of differentiated NSCs. (c) WST-8 reduction activity of differentiated 
NSCs. 
 
Viability of differentiated single cells was assessed using the WST-8 assay.  We 
switched to using WST-8 because a previous study reported MTT’s tendency to associate 
with carbon nanotubes to give false and cytotoxic results and recommended the use of 
water-soluble tetrazolium salts.57  WST-8 is a tetrazolium salt that produces a highly 
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water soluble formazan upon cellular reduction and has been recently adopted as an 
indicator for use in viability assays.58  Overall, NSCs on the three different substrates 
demonstrated similar viability throughout the 7-day culture period (Figure 3.4c).  Cell 
activity appeared to be constant between day 1 and day 4 but increased significantly day 
4 and day 7.  We suspect this increase in cell activity to be the result of increased 
metabolic activity of the extensively differentiated cell populations.  
The progression of NSC differentiation was monitored by immunostaining for 
nestin, MAP2, and GFAP expressions (Figure 3.5).  Identical trends were observed on all 
three types of substrates, and differentiation was not affected by the SWNT-based 
substrates.  While about 10% of differentiated neurospheres expressed MAP2, we 
observed insignificant amount of MAP2 expression in differentiated single cells 
throughout the culture period.  This is not a surprising result considering no additional 
agent was added to the standard differentiation medium supplied by the manufacturer, 
which may be insufficient for inducing or maintaining neuronal differentiation.  Our 
finding also indicates that the three dimensional structure of neurospheres and the 
junctions betweens individual cells in neurospheres may provide an environment similar 
to the neural stem cell niche, and therefore may be essential for neuronal differentiation.  
Despite the lack of MAP2 expression, NSC differentiation was nevertheless confirmed 
through changes in nestin and GFAP expressions.  The entire cell population was nestin-
positive and GFAP-negative on day 1, indicating an undifferentiated state.  As time 
progressed, NSCs began to lose their nestin-expression and acquire GFAP-expression.  
By day 7, none of the cells stained positive for nestin and approximately 80 to 90% of all 
 115 
cells were GFAP-positive.  This transition is well documented.59  As NSCs proliferate 
and differentiate into neurons and glia, nestin is down-regulated and distinct intermediate 
markers are expressed.   
 
 
Figure 3.5 Confocal microscopy images of differentiated NSCs. Cells were stained for 
markers of NSCs (nestin, shown in red), astrocytes (GFAP, shown in green), and neurons 
(MAP2, not shown due to low level of expression). Cell nuclei were counterstained with 







We have demonstrated for the first time that the differentiation of environment-
sensitive NSCs, both as neurospheres and single cells, on a CNT-based material.  Our 
study has the critical importance for further development of nanomaterials for neural 
interfaces.  The nanostructure of the LBL assembled SWNT-polyelectrolyte composite, 
which gives rise to the composite’s structural flexibility, chemical stability, and physical 
properties, showed no adverse affect on the differentiation of NSCs.  NSCs behaved 
similarly as those cultured on the standard and widely-used PLO substratum in terms of 
cell viability, the development of neural processes, and the appearance and progression of 
neural markers.  We also see indications that SWNT substrates might induce preferential 
differentiation into the neuronal lineage; however, this aspect of the study as well as the 
potential mechanism(s) of the influence requires further investigation. 
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The safety, function, and longevity of implantable neuroprosthetic and 
cardiostimulating electrodes depend heavily on the electrical properties of the electrode-
tissue interface, which in many cases requires substantial improvement.  While different 
variations of carbon nanotube materials have been shown to be suitable for neural 
excitation, it is critical to evaluate them vs. other materials used for bioelectrical  
interfacing.  In this study, we found that composite multi-walled carbon nanotube-
polyelectrolyte (MWNT-PE) multilayers electrodes substantially outperform state-of-the-
art neural interface material available today, namely activated electrochemically 
deposited iridium oxide (IrOx). The MWNT-PE coated electrodes also share similar 
reductions in electrical impedance and augmentations in cathodic charge storage capacity 
(CSC) seen with promising conducting polymer coatings. Our findings suggest that 
MWNT-PE multilayers are excellent interfacing material for neural prosthetic 
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Neural and cardiac electrodes are currently utilized in an increasing number of 
diagnostic, therapeutic, and treatment strategies for various neurological, cardiac, 
sensory, and psychiatric conditions. Deep brain stimulators, artificial pacemakers, and 
cochlear implants are some of the most established and widely deployed electro-active 
prosthetic devices. They have been used to reduce symptoms of Parkinson’s disease,1 
maintain regular heart rhythm,2 and restore auditory function.3, 4 Other neural prosthetic 
devices have been used to treat epilepsy,5 depression6 and chronic pain,7 and to regulate 
breathing8 and bladder and bowel control.9 Regardless of their specific medical 
applications, all neural and cardiac electrodes operate by sensing or delivering electrical 
pulses to nearby tissues. Therefore, the safety, function, and longevity of these devices 
are ultimately dependent on the stability of the tissue-electrode interface, which dictates 
the electrode’s sensitivity to small signals and the ability to transfer electro-ionic charges 
to the tissue. Currently used electrodes are made primarily from biocompatible noble 
metals, such as gold, platinum, and iridium, and other non-reactive materials, such as 
titanium, stainless steel, and silicon. These metallic electrodes often suffer from poor 
contact with tissue and suboptimal long-term stimulation and recording performance due 
in large part to scar formation. 
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To improve the performance of electrodes and to resolve these problems, 
researchers have turned to various surface modification strategies to render the electrodes 
more sensitive to electrical signals and more efficient in charge transfer. Most of these 
approaches focus on the reduction of electrical impedance (Z) and augmentation of 
charge storage capacity (CSC) by applying a thin layer of coating on the electrode to 
increase the effective surface area and improve charge transfer at the electrode-tissue 
interface. Further improvements in long-term device performance could be achieved with 
coatings that also provide enhanced biocompatibility and structural integrity. Iridium 
oxide (IrOx) has been extensively characterized as a coating material for electrodes10-13 
and is currently adopted for several commercially available medical devices. Compared 
to metal electrodes, IrOx permits significantly higher levels of charge injection without 
electrode dissolution or electrolysis of water11 and has been used to coat a variety of 
electrodes including deep brain,14, 15 nerve cuff,16 pacing, and defibrillation electrodes.17 
Conducting polymers, including polyacetylene, polyaniline, polypyrrole, poly(3,4-
ethylenedioxythiophene) (PEDOT), and their derivatives, are another class of material 
that has recently received significant attention as an interfacing material for implantable 
electrodes.18, 19 PEDOT has been shown to be the most promising interfacing material 
among them since its ordered and well defined chemical structure gives rise to improved 
conductivity and thermal stability.20 Recently, researchers have demonstrated the ability 
to dramatically improve the electrical properties of neural21-23 and cochlear24 electrodes 
by surface modification with PEDOT. In additions, various strategies have been explored 
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to improve biocompatibility of and incorporate drug release capabilities into the PEDOT 
coatings.25-27   
Despite IrOx’s initial success and PEDOT’s promising outlook, there is still a 
strong demand for new interfacing materials with better combination of properties. IrOx 
is well known for its poor adhesion to underlying substrate, and low structural and 
chemical stability which worsens as increasingly thick oxide layers form during normal 
electrode activity.28, 29 Unlike IrOx, PEDOT coatings do not grow thicker or degrade 
during normal device function. However, recent studies have revealed structural 
problems, such as cracking and delamination.22  
Given that chemical and mechanical stability are fundamental to medical 
electrodes, a logical choice of material for interfacing electrodes with tissues is carbon 
nanotubes (CNTs), which are known for their extraordinary strength, toughness, chemical 
stability, electrical conductivity, high surface area30 and supercapacitor properties31, 32. 
Indeed, many groups have investigated CNT materials and demonstrated promising 
results in biocompatibility with neuronal cells.33-38 They have been shown to increase 
neuronal cell functions,39 boost neural signal transmission efficacy,40 stimulate and record 
brain circuit activity,41, 42 and improve neural recordings.43 Recently, successful growth 
and differentiation of neuroblastoma cells44 and neural stem cells45 on these films, as well 
as stimulation of cultured neurons were demonstrated.46  
Thus far a substantial amount of data on CNTs interfaced with neural cells has 
been obtained.  Yet, these data do not allow realistically compare CNTs with most 
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commonly used and probably the other state of the art materials used for similar 
purposes.  To elucidate the potential of CNT-polyelectrolyte thin films for interfacing 
with electroactive cells, we investigated their ability to reduce interfacial impedance, 
increase charge storage capacity, deliver charge, and withstand continuous charge 
injection cycles by performing a multi-parameter side-by-side comparison with IrOx and 
PEDOT coatings.  This knowledge is critical for the understanding of CNT’s potential as 
an emerging technology. The obtained data also indicate that such comparison and 





CVD-produced multi-walled carbon nanotubes (MWNTs) were purchased from 
NanoLab, Inc. (Newton, MA), respectively. Poly(vinyl alcohol) (PVA; MW 70k) and 
poly(sodium 4-styrene-sulfonate) (PSS; MW 70k and MW 1000k) were obtained from 
Sigma-Aldrich. 3,4-Ethylenedioxythionphene (EDOT, BAYTRON® M; MW 142.17) 
was received from H.C. Stark Inc. (Newton, MA). Iridium tetrachloride was purchased 
from Alfa Aesar. All other chemicals were obtained from Sigma-Aldrich.  
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4.3.2 Electrodes  
400 µm diameter ball electrodes were fabricated from 75 µm diameter Teflon® 
insulated platinum-iridium (90%-10%) wires obtained from A-M Systems, Inc. 
(Carlsborg, WA). The ball electrodes were made by melting the tip of the wire with a 
micro flame oxygen-methane torch. 6 mm diameter Au electrodes were fabricated in 
house by gold sputter coating a barbell-shaped pattern on polystyrene substrates using a 
mask. 
4.3.3 Surface Modification of Electrodes 
Surface modification of electrodes with MWNTs was carried out using the 
technique of layer-by-layer (LBL) assembly. MWNTs were dispersed at 0.5mg/ml in 0.1 
wt% PSS (MW 1000k) solution by ultrasonication and alternately adsorbed with 1 wt% 
PVA solution. For each deposition, the electrode was immersed in the corresponding 
solution for 1 minute, following by rinsing with deionized water and drying with an air 
jet. The resulting thin film of coating was designated as (PVA/MWNT)n where n is the 
number of bilayers.  
Surface modification with PEDOT was conducted by electrochemical deposition 
of the EDOT monomer. The monomer solution was prepared by dissolving EDOT in 0.2 
wt% PSS (MW 70k). The electrochemical process was performed on each electrode by 
an Autolab PGSTAT 12 (EcoChemie, Utrecht, Netherlands) in glavanostatic mode with a 
conventional four-electrode configuration at room temperature. The reference and 
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counter electrodes were connected to a platinum wire within the monomer solution, and 
the working and sensing electrodes were connected to the electrode site. The thickness of 
the deposited material was controlled by the deposition time. For the ball electrodes, the 
deposition current was 1 µA, corresponding to a current density of 0.2 mA/cm2.  
Surface modification with iridium oxide film was performed as described by 
Marzouk et al.47 Briefly, the deposition solution was prepared by dissolving 75 mg 
iridium tetrachloride in 50 mL water, followed by addition of 0.5 mL aqueous 30% 
hydrogen peroxide and 250 mg oxalic acid dihydrate. The pH of the solution was 
adjusted to 10.5 by addition of anhydrous potassium carbonate, and the resulting solution 
was allowed to stabilize at room temperature for 2 days. Electrochemical deposition of 
iridium oxide was carried out using the same setup as EDOT but with a deposition 
current of 8 µA, corresponding to a current density of 1.6 mA/cm2. 
For measurement of coating thicknesses, coatings were deposited on 6 mm 
diameter Au electrodes using the same LBL and electrochemical deposition processes 
described above above. 
4.3.4 Electrochemical Impedance Spectroscopy (EIS) 
An Autolab PGSTAT 12 and Frequency Response Analyzer software 
(EcoChemie, Utrecht, Netherlands) were used to record impedance spectra of the 
electrodes. A solution of 1 M phosphate buffered saline (PBS, pH = 7) was used as an 
electrolyte in a four-electrode configuration. The working and sensing electrodes were 
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connected to the electrode site. The counter electrode was connected to a platinum foil 
immersed in PBS, and an Ag/AgCl reference electrode was immersed in PBS. An AC 
sinusoidal signal of 5 mV in amplitude was used to record the impedance over a 
frequency range of 1-105 Hz.  
4.3.5 Cyclic Voltammetry (CV) and Biphasic Stimulation 
CV and biphasic stimulation were performed using an Autolab PGSTAT 12 
instrument and General Purpose Electrochemical System software (EcoChemie, Utrecht, 
Netherlands) in a four-electrode configuration as described for EIS. For CV, a scan rate 
of 0.1 V/s was used and the potential on the working electrode was swept between -0.9 V 
and 0.5 V. Three cycles were swept to insure that the film had reached a stable state. For 
biphasic stimulation a 2 mC/cm2 (10 mA, 0.5 ms) biphasic, cathodic first current pulse 
was sourced.  
4.3.6 Scanning Electron Microscopy (SEM)  
SEM was conducted using a Philips XL30 FEG SEM and a FEI Nova Nanolab 






4.4 Results and Discussion 
The functional properties of the neural interface depend not only on the properties 
of individual CNT but also on the technique of their deposition on the electrode surface.  
Typical CNT films are produced by solvent evaporation,33, 34, 37, 40, 42 electrochemical 
deposition,43 and chemical vapor deposition.35, 36, 38, 41 While displaying excellent 
electrical properties, they are quite fragile.  Implantable biomedical devices must 
withstand chronic low-level long-term stresses and harsh physical conditions and as such, 
require exceptional mechanical properties.18 For this reason multilayered composites of 
CNTs with polyelectrolytes fabricated by the so called layer-by-layer (LBL) assembly 
capable of delivering such properties48 appeared to us as an attractive technique for 
building a robust neural interface.  Additionally, their ability to support both electronic 
and ionic current, store anti-inflammatory drugs,49 and produce complex 3D surfaces also 
seem to be essential for a successful neuroprosthetic device.   
The CNT LBL coated electrodes were prepared by assembling multi-walled 
carbon nanotubes (MWNTs) dispersed in a solution of poly(styrene sulfonate) (PSS)50 
with a solution of poly(vinyl alcohol) (PVA) on the ball-shaped tips of platinum-iridium 
(PtIr) model electrodes (Figure 4.1a). These model electrodes were made from 
commercially available Teflon-insulated 75 um diameter PtIr wires, which are widely 
used in the assembly of neural microelectrode arrays and have been adopted as model 
monopolar cochlear electrodes for in vitro and in vivo studies.24 PEDOT and IrOx 
coatings were galvanostatically deposited on the model electrodes using methods that 
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have been described previously.23, 47 For PEDOT deposition, PSS was also used as the 
dopant counter ion. The coating thickness of the MWNT coatings was controlled by the 
number of layers assembled on the surface. For PEDOT and IrOx deposition, thickness 
was varied by altering the deposition charge density. The presence of coatings can be 
easily recognized as the modified electrode changes color (Figure 4.1b-d). The surface 
morphology of the MWNT LBL coating (Figure 4.1e) consisted of intertwined MWNT 
bundles whose nanoscale, high aspect ratio features are essential to increasing surface 
area and improving charge transfer efficiency. Features of nanoscale roughness were also 
observed on the PEDOT coating (Figure 4.1f) while the IrOx coating (Figure 4.1g) 
appeared to have less visible surface roughness at the nanometer level. 
 
 
Figure 4.1 Surface modification of electrodes. Ball-tipped IrOx electrodes (a) made from 
Teflon® insulated 75 µm PtIr wires were surface modified with either LBL assembled 
MWNTs (b) or electrochemically deposited PEDOT (c) or IrOx (d). SEM images 
illustrate the differences in their surface morphology. The MWNT coating (e) consists of 
a nanofibrous network of MWNT bundles. The PEDOT coating (f) shows a moderate 
degree of roughness while the IrOx (g) coating is relatively featureless at the nanoscale 
level. Scale bars for the SEM images are 500 nm. 
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Electrochemical impedance spectroscopy (EIS) and cyclic voltammetry (CV) 
were used to characterize the electrochemical properties of the surface modified PtIr 
electrodes. All measurements were conducted in 1 M PBS. For EIS, an AC sinusoidal 
signal of 5 mV in amplitude was used to record the impedance over a frequency range of 
1 to 105 Hz. For CV, a scan rate of 0.1 V/s was used and the potential on the working 
electrode was swept between -0.9 V and 0.5 V.  The measurements showed that all three 
coatings progressively decreased the impedance (Figure 4.2a-c) and phase angle (Figure 
4.2d-f) with increasing coating thickness, rendering the electrodes less capacitive at 
higher frequencies.  Also as expected, the CV data (Figure 4.2g-i) indicated increasing 
charge storage capacity (CSC) with increasing coating thickness, which is proportional to 
the mass of material available for storing charges. As one may notice, the disparity in the 
magnitude of CSC across the three types of coatings is in fact due to differences in the 
coating thickness. To provide an accurate comparison on the electrochemical properties, 
we measured the thickness of the coatings (Figure 4.3) and translated our measurements 
to a per unit film thickness basis (Figure 4.4). The thickness of MWNT LBL film was 
found to depend linearly on the number of bilayers, averaging approximately 7 nm per 
bilayer. For PEDOT and IrOx, coatings thickness appeared to have a logarithmic-like 




Figure 4.2 Characterization of MWNT, PEDOT, and IrOx coated electrodes. 
Electrochemical impedance spectroscopy revealed decreasing impedance (a-c) and phase 
angle (d-f) with increasing thickness of MWNT, PEDOT, and IrOx coatings on PtIr 
electrodes. The charge storage capacity of the surface modified electrodes also increased 





Figure 4.3 Coating thickness as a function of deposition parameters. MWNT (a), 
PEDOT (b), and IrOx (c) were coated with various numbers of bilayers or deposition 
charge densities on 6 mm diameter gold sputter coated electrodes, and the cross-sectional 
thickness of the coatings were measured under SEM. The insets illustrate the cross-
sections of an 80-bilayer MWNT coating (a), and a PEDOT (b) and IrOx (c) coating 
deposited from a charge density of 90 mC/cm2 and 800 mC/cm2, respectively. Scale bars 
are 2 µm. 
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The thickness, deposition methods, and chemical composition of electrode 
coatings significantly affects the electrical and mechanical properties of the films.  We 
chose to compare coatings at a given thickness that would be appropriate for use on 
clinical devices.  By analyzing the measurements on a per unit film thickness basis, we 
find the MWNT LBL coating to be the most effective material for reducing the interfacial 
impedance value (Figure 4.4a). With only 10 bilayers of coating corresponding to a 
thickness of well below 100 nm, the MWNT LBL coating reduced the impedance of the 
PtIr electrode by two orders of magnitude, from over 17,400 Ω to 277 Ω at the 
physiologically relevant frequency of 1,000 Hz. At a thickness of 700 nm, the impedance 
of the MWNT coated electrodes at 1,000 Hz is approximately 30% and 60% lower those 
coated with PEDOT and IrOx, respectively. These findings suggest that MWNT LBL 
films can provide the greatest reduction in impedance with minimal impact on the 
electrode’s physical profile, which has important consequence on the extent of tissue 
damage during the insertion of the electrode.51  
Total CSC (Figure 4.4b) for the MWNT coated electrodes is higher than those 
coated with PEDOT and IrOx for the coatings of the same thickness. The total CSC of 
11.4 mC/cm2 reported here for a 600 nm thick PEDOT coating produced from a 
deposition charge density of 100 mC/cm2 coincides well with previously published value 
of 11.3 mC/cm2 obtained using the same dopant ion, deposition charge density, and CV 
scanning rate.52 Note that coating thickness, method of measurements (CV sweep 
between -0.9 V and 0.5 V), and method of deposition (galvanostatic) were used as 
normalizing factors to make possible proper comparison of the three different materials. 
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The highest CSC for a sputtered IrOx film was reported to be 157 mC/cm2.53 These data 
were obtained for 3 µm thick films scanned under exclusively anodic bias and with a 
slow scanning rate of 0.05 V/s.  All these factors obviously increase the apparent values 
of CSC of electrodes, while not necessarily being the working parameters of actual 
electrodes implanted in the tissue. The trend displayed in Figure 4.4b gives a systematic 




Figure 4.4 Comparison of electrochemical properties on a per unit film thickness basis. 
Measurements obtained from electrochemical impedance spectroscopy and cyclic 
voltammetry were normalized by the coating thickness. Impedance at 1 kHz (a), total 
CSC (b), anodic CSC (c), cathodic CSC (d), and % cathodic CSC (e) with increasing 
coating thickness are compared. 
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The distribution of anodic and cathodic CSCs for the MWNT coating is 
significantly different from the other two coatings for the potential range investigated. 
While the anodic CSCs (Figure 4.4c) of the MWNT coated electrodes are the lowest of 
all, their cathodic CSCs, i.e. the one determining the efficiency of implanted electrodes 
(Figure 4.4d), are nearly 70% higher than those of the PEDOT and IrOx coated electrodes 
at the same coating thicknesses. In addition, while the ratio of cathodic CSC to total CSC 
for the PEDOT and IrOx coatings dropped from 90% to less than 60% with increasing 
thickness, the MWNT coated electrodes appeared to maintain the ratio above 90% 
(Figure 4.4e). These are significant distinctions since cathodic stimuli, which initiate 
cellular action more efficiently, are typically used to stimulate neural tissues,54 therefore 
making the cathodic CSC the physiologically relevant parameter in comparing interfacing 
materials. 
To better understand the effect of surface modification, we examined the voltage 
response of coated electrodes to a 2 mC/cm2 biphasic, cathodic-first current pulse (Figure 
4.5). Such current pulses are commonly employed in the stimulation of nervous tissues.55 
The biphasic stimulation consisted of a 0.5 ms 10 mA cathodic current followed by an 
anodic current of the same length and magnitude after a 0.2 ms pause, corresponding to a 
frequency of approximately 1,000 Hz. For better comparison, the electrodes were coated 
to obtain a thickness of all the materials of ca. 700 nm. The total voltage excursions for 
the bare, MWNT, PEDOT, and IrOx coated PtIr electrodes were 5.8 V, 3.5 V, 3.8 V, and 
4.1 V, respectively (Figure 4.5). As expected, this results correlates with the impedance 
values of the respective electrodes at 1,000 Hz, with lower impedance producing lower 
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voltage excursion. The MWNT coated electrodes produced the greatest reduction in 
voltage excursion, cutting the voltage differential by more than 40%, compared to 34% 
and 21% for the PEDOT and IrOx coated electrodes, respectively. The results indicate 
that the MWNT coated electrodes can deliver higher charge densities without producing 




Figure 4.5 Biphasic charge injection. A 2 mC/cm2 current waveform (a) was sourced 
through bare and coated electrodes and the resulting voltage responses were recorded (b). 
The bare, MWNT, PEDOT, and IrOx coated PtIr electrodes produced a total voltage 
excursion of 5.8 V, 3.5 V, 3.8 V, and 4.1 V, respectively. The MWNT coated electrode 
was most efficient in delivering charges, reducing the voltage differential by 40%. 
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The electrochemical stability of the MWNT LBL electrodes was also tested by 
subjecting the electrodes to 300 CV scanning cycles at a scan rate of 0.1 V/s. As Figure 
4.6a illustrates, the total CSCs of MWNT and PEDOT coated electrodes decreased with 
increasing number of CV scanning cycles during the initial 100 cycles then gradually 
stabilized to relatively constant values. We found the MWNT electrode to be a stable 
interfacial material, losing just 5% of the original CSC, compared to 15% for the PEDOT 
electrodes. This level of decrease for the PEDOT coated electrodes is supported by 
previously published results for PSS-doped52 and surfactant-templated56 PEDOT 
coatings. The IrOx-coated electrode showed an initial decline of 8% but regained 3% 
before maintaining a stabilized percentage comparable to the MWNT coated electrode. 
Setting aside the possibility of artifacts generated from the sample preparation process, 
the SEM images suggest extensive cracking on the IrOx coated electrode (Figure 4.6d) 
that was not observed on the surface of MWNT- and PEDOT-coated electrodes (Figure 
4.6b-c). This led to us to suspect that the increase in CSC was due to the formation of 
new IrOx surface as the layer cracked and exposed additional contact areas in the cracks. 
In an in vivo situation, the cracked brittle IrOx coating can probably easily delaminate, 






Figure 4.6 Electrochemical stability of MWNT, PEDOT, and IrOx coated PtIr electrodes 
under repeated cyclic voltammetry scanning cycles. The total charge storage capacities 
(CSC) of the coated electrodes were recorded while being subjected to 300 cyclic 
voltammetry scanning cycles (a). The data shows a 5% drop in total CSC for the MWNT 
and IrOx coated electrodes and a 15% decline for PEDOT. SEM images reveal a nearly 
intact surface on the MWNT coated electrode (b) and a slightly and extensively cracked 
surface for the PEDOT (c) and IrOx (d) coated electrodes, respectively. Scale bars are 5 
µm. 
 
The superior structural stability of LBL assembled CNT multilayer film can be 
related to its nanoscale morphology. Its stability in physiological conditions has been 
demonstrated in our previous cell culture studies.44, 45 The multilayer design can be seen 
in many biomaterials evolved to exist at the interfaces of different tissues or tissue and 
environment. Some of the most intriguing biological systems found in nature, such as the 
sponge spicule57 and nacre,58, 59 have a layered architecture that gives rise to their 
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mechanical strength and unique material properties. Such design can help make use of 
CNT’s electrical60 and mechanical48, 60 properties. The inter-digitated nanometer-thick 
multilayer structure yields flexible thin films48 of remarkable stability and mechanical 
strength and creates intimate adhesion to the underlying substrate through molecular 
species acting at the nanometer length scale. 
 
4.5 Conclusions 
In summary, this study carried out a systematic multiparameter comparison of 
CNT LBL assembled composites in respect to PEDOT, and IrOx films as the most 
commonly used commercially available materials for biomedical electrodes.  
Unexpectedly, we found that CNT-PE electrodes substantially outperform most state-of-
the art-electrodes in the ability to reduce impedance, increase cathodic charge capacity, 
and facilitate charge transfer. They successfully compete with promising conducting 
polymer coatings in respect to electrical impedance and cathodic CSC. The reasons for 
such performance of these materials are possibly related to CNT electrodes to function as 
supercapacitors31, 32 as well as to structural characteristics of the prepared composites 
with dual electrical and ionic conductivities. The coatings made by LBL assembly are 
uniform and can carry both ionic and electronic currents and can be characterized as 
highly stable under electrochemical conditions retaining almost the entire CSC and 
showing no sign of failure after 300 CV scanning cycles. The morphology of CNT 
coatings with fibers oriented in parallel to the substrate closely mimics that of 
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extracellular matrix.61  However it should be noted that for each of the three materials 
compared in this study, specifically CNT-PE, PEDOT, and IrOx thin film electrode 
coatings, the method of deposition, chemical composition, thickness, and 
micro/nanoscale morphology and topography has a significant effect on electrical, 
mechanical, and biological interfacing properties.  
Despite these promising results, the MWNT-PE composites still have tremendous 
room for improvement in their electrochemical properties, durability, and 
biocompatibility. They have passed initial tests in biocompatiblity44, 45 and the in-depth 
evaluation is expected to follow. The ultra-strong yet highly flexible characteristic of 
free-standing LBL films can be quite useful to minimizing mechanical stress exerted on 
surrounding tissues. Synergistic effects of combining CNT coatings with 
electrochemically deposited PEDOT and IrOx thin films, in which the functional 
properties of the resulting electrode surpass the sum of the individual coatings, should 
also be expected for the adhesion of the electrodeposited films as well as their mechanical 
and electrical properties. 
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Enhanced Differentiation and Electrical Stimulation of Neural Stem Cells Mediated 
by Carbon Nanotube Composites Containing Extracellular Matrix Protein 
 
5.1 Abstract 
One of the key challenges to engineering neural interfaces is to minimize their 
immune response toward foreign materials.  One potential approach is to manufacture 
materials that bear greater structural resemblance to living tissues and by incorporating 
neural stem cells within the materials.  The unique electrical and mechanical properties of 
carbon nanotubes make them an excellent candidate for neural interfaces, but their 
adoption hinges on finding approaches for “humanizing” nanotube-based materials.  In 
this study, we demonstrated the fabrication of layer-by-layer assembled composites from 
single-walled carbon nanotubes (SWNTs) and laminin, which is an essential part of 
human extracellular matrix, and investigated the ability of the films to mediate the 
differentiation and electrical stimulation of neural stem cells (NSCs). Laminin-SWNT 
thin films were found to be conducive to NSC differentiation and suitable for their 
successful excitation.  We observed extensive outgrowth from neurospheres and 
formation of functional neural network as indicated by the presence of synaptic 
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connections. Calcium imaging of the NSCs revealed generation of action potentials upon 
the application of a lateral current through the SWNT substrate, confirming the 
functionality of the differentiated NSCs and the utility of the conductive substrate. These 
results indicate that the protein-SWNT composite can serve as materials foundation of 
neural electrodes with chemical structure better adapted with long-term integration with 
the neural tissue. 
 
5.2 Introduction 
In recent years, carbon nanotubes have been widely explored for adoption in the 
biological realm in the form of biosensors and as agents of cellular transport and 
delivery.1-4 Single-walled (SWNTs) and multi-walled carbon nanotubes (MWNTs) are 
also attractive candidates for developing interfaces with biological systems due to the 
promise of superior physical, electrical, mechanical and optical properties in comparison 
with traditional materials.5 This research direction is of particular relevance to the field of 
neural prosthetics field as strategies for the diagnosis, therapy and treatment of neural 
disorders are increasingly relying on electrical stimulation techniques. However, these 
current techniques have several inherent problems that are associated with the traditional 
materials used for manufacturing of neural electrodes (NEs).6, 7  
The interactions between various cell lines and carbon nanotubes1, 3, 4, 8, 9 have 
been previously reported, including the adhesion, growth and differentiation of neuronal 
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cells on carbon nanotubes-based substrates.  Most recently, the ability of such substrates 
to electrically stimulate neuronal cells was reported.9-12 The strong interest in interfacing 
neuronal cells and carbon nanotubes is not accidental; the unique set of properties of 
carbon nanotubes make them an excellent candidate to address the acute need for better 
neural electrodes (NEs).  The current problems facing neuroprosthetic devices include the 
following: (1) long-term inflammatory response of the neural tissues, which results in the 
neuron depletion around the electrodes and their replacement with reactive astrocytes 
preventing signal transduction, (2) delamination6 and degradation6, 7 of thin metal 
electrodes off the plastic substrates that drastically decrease the stimulation abilities, (3) 
the need for significant miniaturization of the electrodes which is currently limited not by 
manufacturing abilities but by electrical properties of the cell-electrode interface, and (4) 
the need to achieve mechanical compliance with the neural tissues to attain adequate 
long-term performance, which cannot be addressed by semiconductor devices that can 
partially resolve some of the above-mentioned issues.13-15 
In this work we want to propose three current approaches to resolve these issues:  
(1) Exploitation of on the mechanical and electrical properties of nanostructured 
materials to develop new electrodes.  Such materials, including carbon nanotubes 
composites would be able to trigger a drastic decrease of delamination, while 
meeting the necessary mechanical and miniaturization requirements for NEs.  
(2) Incorporation of neural stem cells (NSCs) with the NE due to their ability to 
differentiate into functional neurons, in damaged areas of the central nervous 
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system.16, 17  This could result in significant reduction of inflammation of the 
neural tissue.  
(3) Achieving better integration of tissues and NEs by “humanizing” the material, 
i.e. making it structurally and chemically more similar to tissues surrounding 
neurons.   
Detailed evaluation of all of these approaches will probably require several years 
and, certainly, cannot be done in one paper.  Nevertheless, what we intend to do here is to 
demonstrate the technical feasibility of manufacturing electrodes that satisfy the 
requirements of these hypotheses so that their evaluation can be carried out. In particular, 
the focus will be placed on feasibility of developing CNT-based electrodes that 
incorporate extracellular matrix proteins, one of the key components of tissues 
surrounding neurons and stem cell compatible materials.  
 
5.3 Methods 
5.3.1 Thin Film Fabrication 
CNT thin films were fabricated by a layer-by-layer (LBL) method, with 
alternating layers of single-walled carbon nanotubes (SWNT) and the protein laminin.  
SWNT made by the Hipco process were obtained from Carbon Nanotechnologies Inc. 
and dispersed by bath sonication in a 1% aqueous solution of polystyrene-4-sulfonate 
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(PSS, MW 1,000, 000).  The laminin was obtained from Sigma-Aldrich and used as a 100 
µg/mL solution in PBS.  Thin films were fabricated on a #1 glass coverslide by dipping 
the substrate in the SWNT suspension and protein solution alternatively, with thorough 
rinsing in DI water at each step.  The dipping time for each step of laminin and SWNT 
adsorption was 30 min.  
5.3.2 Cell Lines 
Neural stem cells (NSC) were purchased from Stemcell Technologies and were 
grown and differentiated according to the company’s protocols. 
5.3.3 Cell Interfacing with Thin Films 
To enable cell seeding onto the SWNT substrates, cloning rings are mounted on 
the substrate with high-vacuum grease serving as the adhesive.  The attached cloning 
rings provide a chamber (with volume capacity of ~400 µL) for holding culture media 
required for cell growth.  After the sterilization process, the SWNT samples are 
passivated with the appropriate cell media for at least 12 hr at 37ºC and in a humidified, 
5% CO2 environment. NSC cell suspensions are then seeded within the designed cell 
chambers in the appropriate differentiation medium.  The cells are allowed to incubate for 




5.4 Results and Discussion 
The development of these CNT-based electrodes for NEs hinges on the ability to 
process SWNTs or MWNTs in thin coatings or bulk composites. It is particularly 
important for the case of NSCs because some components of the composites and/or the 
nano-scale morphology of the interface can alter the differentiation pathway of the stem 
cells.18, 19 While, there is a number of methods that can be used to yield carbon nanotubes 
film processing in substrates for neural growth, including simple solvent evaporation, 
chemical vapor deposition, and electrochemical deposition,20-29 not all of them may be 
suitable for NE purposes. In particular, many of these methods do not yield coatings that 
possess the mechanical stability and actual conductivity that are key for NE as discussed 
above.  On the other hand, the technique of layer-by-layer assembly (LBL) provides a 
high level of control and tailoring with respect to the film composition, including the 
polymeric components used.30 It also makes the coating exceptionally mechanically 
robust.31 The ability of carbon nanotubes thin films made by LBL to support growth, 
proliferation and differentiation and to electrically stimulate adult cancer cells of 
neuroblastoma NG108-159, 10 and their ability to support the growth of NSCs in culture32 
was reported recently.  The LBL fabrication for the previous neuronal cell studies has 
however relied on the use of a synthetic non-biological polymer,9, 10 which is one of the 
potential problems with this method.  Along with other points addressing the hypotheses 
1 and 2, we demonstrate in this study that LBL films consisting of SWNTs and natural 
polymers such as laminin, serve as a biocompatible substrate for promoting adhesion and 
differentiation as well as for mediating electrical stimulation of neuronal cell lines.  
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Overall, the interfacing of the biocompatible, electrically conductive and mechanically 
strong SWNT thin films with NSCs is likely to be of particular relevance for developing 
implantable prostheses.   
The favorable biological properties of carbon nanotubesthat have been previously 
reported 12, 23, 24 provide an excellent foundation for exploitation of these properties in 
implantable medical devices.  However, the critical issue of making tissue-friendly 
material still needs to be addressed for carbon nanotube-based NEs.  One of the most 
logical ways to achieve this is to include molecules most familiar to the cells in the 
interfacial environment; such molecules are from extracellular matrix (ECM). While the 
incorporation of ECM proteins in carbon nanotubes composites made by many 
processing methods mentioned before, such as simple blending and solvent evaporation, 
might be faced with fast elution of the protein, the LBL technique can curtail this 
shortcoming. This technique, which is based on alternating the layers of nanotubes (or 
other nanoscale building blocks) and polymers, is versatile and can be easily adapted for 
the incorporation of biological components such as the ECM proteins. In this study, we 
explore and evaluate the performance of CNT-based NEs made by LBL method and that 
incorporate ECM proteins.  The LBL films consisted from SWNTs (HIPCO, 
Tubes@Rice.com) wrapped with poly(styrene-4-sulfonate) (PSS, MW = 1,000,000, 1% 
in water, Sigma-Aldrich) and the glycoprotein laminin (MW ~ 900 kD, 100 µg/mL in 
PBS at pH 7.4).  The latter is an important protein in the basement membrane that is 
widely used for coating substrate to promote cell adhesion and neurite outgrowth.33 
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Dipping time of 30 min per single step of laminin and SWNT adsorption was used 
throughout the project. 
 
 
Figure 5.1 Fabrication of LBL films of SWNTs and laminin. Atomic force microscopy 
image of (a) one monolayer of laminin on piranha-treated SiO2 substrate and (b) 6 
bilayers of SWNT/laminin on the same substrate.  (c) Successful accumulation of 
laminin-SWNT layers on glass substrate monitored by UV-vis absorption.    
 
Despite its large size, laminin (isoelectric point is pH 7) appeared to interact 
strongly with the negatively charged, piranha-treated substrate upon deposition of the 
first layer.  Atomic force microscopy (AFM) image of a single layer of laminin on a 
silicon oxide substrate indicated a uniform coating of the protein (Figure 5.1a).  AFM 
was also utilized to assess the subsequent interactions between the deposited laminin and 
the SWNT dispersions and confirmed deposition of SWNT onto the laminin layer (Figure 
5.1b).  This observation is consistent with reports of strong electrostatic and nonspecific 
adsorption of proteins to carbon nanotubes.34, 35 The film progress of multilayer 
depositions was monitored by UV-VIS absorption, which indicated linear increase in 
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SWNT concentration on the thin films with increasing number of bilayers (Figure 5.1c) 
as expected for the traditional mode of LBL growth observed before.   
As the first step in examination of suitability of SWNT-laminin composites 
suitability for the use as NEs, LBL films of up to 30 bilayers were made and the ability of 
cells to adhere on the SWNT/laminin substrate was assessed (Table 4.1).  The 
architectures of the LBL films tested, that is number of deposition cycles, their sequence 
and the composition of the final layer, were chosen based on several factors: the fact that 
cells typically adhere better to positively charged surfaces and that heat treatment 
enhances cross-linking among the layers within SWNT LBL films and causes an increase 
in electrical conductivity.36, 37  In particular the influence of the structure of the polymeric 
component(s) of the LBL film and the annealing step were investigated.  We found that 
cell adhesion markedly depended on the composition of the final layer.   The initial 
ability of cells to adhere to the substrate was assessed 24 h following seeding and at 
various time points leading to 7 days post-seeding (Table 4.1). The substrate that was 
most conducive to cell adhesion and attachment was the LBL film that contained SWNT 
as the topmost layer and that was heat treated. Control experiments with laminin coated 
slides (no SWNT) that were either used as made or following heat treatment were also 
carried out in parallel.  Interestingly enough, not all “humanized” protein composites 
revealed sufficient adhesion of the cells. As-made films did not reveal any cell adhesion 
after 7 days (Table 4.1).  This is likely to be related with gel-like behavior of laminin.  
Swelling of its composites in water apparently reduced stiffness of the substrates and 
prevented cell adhesion.  On the contrary, SWNT-laminin films obtained after annealing, 
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i.e. after cross-linking, exhibited sufficient stiffness38 and served as excellent adhesion 
support for cells (Table 4.1).  Note that SWNTs and other inorganic materials 
substantially increase thermal stability of proteins and other macromolecules and 
drastically reduce the decomposition of these materials at high temperature.39, 40 So, while 
altering the structure of the proteins, thermal annealing for a fairly short time used here 
does not certainly destroy laminin structure completely as one might expect from pure 
laminin coatings.    
 






Laminin as final layer Yes No 
PSS-wrapped SWNT as final layer Yes No 
Laminin as final layer, annealed at 300 °C (10 min) No No 




Table 5.1 Summary of various LBL configurations investigated in cell seeding and cell 
adhesion experiments. 
 
The interfacing between neuronal cells and the heat-treated SWNT/laminin LBL 
film was monitored more closely by measuring neuronal outgrowth from the cells.  When 
compared to neuronal behavior on laminin-coated glass slides, longer outgrowths were 
noted at every time point (24 h -120 h) on the heat treated SWNT/laminin substrate.  The 
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biocompatibility of the annealed SWNT/laminin substrate was also verified via a 
commercial cell viability assay that confirmed previous reports on the biocompatibility of 
SWNT substrates (Figure 5.2e).  They indicated that 98% of cells on the surface of 




Figure 5.2 Micrograph assessing NSC cell adhesion and differentiation 72 h after initial 
seeding on (a) laminin-coated glass slides and on 10 bilayers SWNT/laminin thin films 
that were (b) used as is or (c) heated at 300 °C for 10 min. (d) Distance of outgrowth 
from neurospheres after 24h (yellow), 48h (red), 72h (blue) and 120h (green) on laminin-
coated slides and heat-treated SWNT/laminin film on slide. (e) Live-dead viability assay 




The observation of neuronal outgrowths from the adhered cells is a promising 
indication of successful cell differentiation.  However, in the context of this study more 
concrete evidence is required to indicate that neural stem cells are capable of 
transforming into neuronal cells following adhesion to the SWNT substrate.  Neural stem 
cells have been shown to transform into functioning neurons as well as glial cells such as 
astrocytes and oligodendrocytes.17, 41  Following cell seeding on the SWNT substrates, 
the NSCs were immunostained with neuronal markers and observed by confocal 
fluorescence microscopy.  The protein markers studied included MAP-2 (for neurons), 
glial fibrillary acidic protein, GFAP (for astrocytes), and nestin (for NSCs).  The results 
indicate that even though neural stem cells precursors still exist 7 days post-seeding on 
the heat-treated SWNT/laminin substrate, differentiated neurons and glial cells are also 
present in large amounts due to spontaneous differentiation caused probably by the 
physical properties of the SWNT-laminin composites.  Interestingly, most of the adhered 
cells showed some signs of differentiation, which can be advantageous from NE 
perspective. The strong presence of neurons (MAP-2, Figure 5.3a, green staining) 
provides indication that successful neuronal communication could possibly be established 





Figure 5.3 Immunostaining of spontaneously differentiated NSCs on heat-treated 
SWNT/laminin thin films.  The blue color in all images indicates DAPI staining of cell 
nuclei.  In (a) GFAP staining is red and MAP-2 staining is green. In (b) GFAP staining is 
red and nestin staining is green.  In (c) cell were stained red for the presence of synapsin. 
 
It is interesting to verify the presence of synaptic connection between 
differentiated cells, which would also show the possibility of connectivity between the 
cells grown on the SWNT-composite and fairly efficient signal transmission.  Synapses 
or synaptic nodes are crucial elements in the propagation of electrochemical signals from 
cells to cells that ensure communication within a neuronal population.42 The cells seeded 
on the CNT surface were thus immunostained for the presence of synapsin protein with 
the appropriate markers.  Synapsin is present between the differentiated cells, thus further 
confirming that neuronal cell growth and differentiation on the SWNT/laminin thin films 
result in functional neuronal networks (Figure 5.3c). 
Once the biocompatibility and cellular composition on the laminin-SWNT 
substrates is established, it is necessary to demonstrate the possibility to excite the 
neuronal cells residing on the nanotubes-protein films. The conductivity of a 10-bilayer 
 162 
SWNT/laminin thin film was estimated to be 430 and 2,140 S/m before and after heat 
treatment, respectively.  Drastic increase of conductivity after heat treatment is not 
surprising, and is also related to reduced swelling behavior. It is certainly beneficial for 
the design of NEs based on these composites. An electrical signal was applied to the cells 
via application of a lateral current through the nanotube substrate.  The electrical stimulus 
was applied in a similar fashion as in the previous study,10 via electrical leads that induce 
a lateral electric field within the entire SWNT/laminin substrate. The device set up used 
is shown in Figure 5.4a: two cloning rings were mounted on the LBL film to serve as 
chambers for the cell and aqueous media.  The electrical leads were attached directly the 
dry area of the SWNT film by using silver paste and copper tape.  The input stimulation 
was applied with the aid of a function generator (Instek Instruments) that gave flexibility 
in the stimulus signal to be applied.  Constant DC signals as well as pulsed signals were 
utilized in this study and were typically verified by the use of an oscilloscope prior to cell 





Figure 5.4 (a) Experimental set-up for electrical stimulation studies indicating the cell 
chambers and electrical leads.  (b) Change in fluorescence intensity of Fluo-4-AM dye 
(∆F/F) in one cell during electrical stimulation by CNT substrate.  Change in 
fluorescence once stimulation is turned off at time t = 300s is shown in inset.  (c) 
Confocal image of a cell cluster before start of stimulation and (d) confocal image of 
same cluster during stimulation.  Data shown in (b) is from the circled cell in (c) and (d). 
 
Cell response to chemical and electrical stimuli typically results in a change in the 
membrane voltage of the cells, commonly referred to as an action potential.  Detection of 
action potentials can be achieved via the invasive patch clamp method43 used before or 
via non-invasive optical detection techniques.  Transparency of SWNT LBL films 
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previously reported by our group44 affords the utilization of optical methods for 
monitoring that can be a great advantage for fundamental studies. The fluorescence 
detection method was chosen for our studies due to its convenience, clarity, and high 
information content. Ion-sensitive dyes undergo a change in fluorescence intensity as a 
result of change in ion concentrations upon application of an action potential.  A Ca2+ 
dependent dye (Fluo-4-AM, Molecular Probes) was used for our study that is membrane-
permeable, thus allowing facile imaging of a large population of live cells.45  The 
versatile nature of the LBL fabrication allowed for simultaneous detection of 
fluorescence changes in cells pre-incubated with Fluo-4-AM during electrical 
stimulation.  The experimental setup for the cells thus underwent minor adjustments to 
ensure that (1) the cells were kept in their physiological media during experiment, (2) 
electrical leads were  kept isolated from any aqueous media and (3) that a #1 cover-glass 
slide was used as the substrate for the LBL film to allow cell recording with an inverted 
confocal fluorescence microscope.   
The cell response appeared to be independent of the type of stimulus applied.  The 
results reported here were obtained from cells that were excited with a pulsed signal.  The 
latter was generally the preferred stimulus in order to minimize any heating effect in the 
SWNT thin films and to ensure that SWNT electrodes as well as cells are not constantly 
under stress during stimulation.  The typical stimulation signal employed consisted of a 
series (~10-15) of 1 ms pulses spaced in 1-10 s intervals.  The pulses were applied at 
these intervals rather than continuously in order to allow both the electrodes and the cells 
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to discharge.  Cellular stimulations were carried out over areas of the films of about 4 
cm2, and output currents from the film range from the order of 1-10 µA/cm2.   
The cells were seeded on the pre-heated SWNT/laminin substrate for at least 72 h, 
incubated with Fluo-4-AM dye and washed prior to electrical stimulation studies.  The 
cells were observed by confocal microscopy during the application of the stimulus.  A 
representative confocal microscope image of a cell cluster is shown after Fluo-4-AM 
incubation/washing step but prior to stimulation is given in Figure 5.4c.  The 
fluorescence level was adjusted such that minimal background fluorescence from the 
cells was present.  A clear increase in fluorescence was observed in the cell cluster 
following electrical stimulation (Figure 5.4d).  In order to obtain a quantitative 
measurement of the fluorescence fluctuation in the cells, the image processing software 
ImageJ was used to measure the fluorescence intensity in the cells during stimulation.  
The change in fluorescence over stimulation time is plotted as ∆F/F (Figure 5.4b) and is 
shown for one cell from the cluster (circled in Figure 5.4c, d).  In addition to the increase 
in fluorescence observed, the presence of two peaks on the fluorescence curve suggests 
that an individual cell can be stimulated more than once upon application of the pulsed 
stimulus in the form of the sequence of two pulses, which what expected from NEs.  The 
fluorescence level is also monitored after the electrical stimulation is stopped at time ~ 
300s.  Upon turning off of the electrical pulses, a leveling off is noticed in the cell 
fluorescence (Figure 5.4b).  This indicates that the observed cell signal is indeed due to 
the stimulation through the electrode and not due to spontaneous firing.  Recording of the 
cell excitation after the excitation process also indicated that generation of action 
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potential in individual cell is dependent on the status of the surrounding cells.  Once one 
cell is excited, the train of the excitation is spreading from one cell to another in a nearly 
sequential manner, which can be identified by video recording of excitation.  Although 
the main source of stimulation comes from the electrode underneath the cells, excited 
state of the neighboring cells causes the next cell to fire with lower threshold. This is 
another fact that confirms communication between the differentiated NSCs probably as 
early neurons.  
 
5.5 Conclusions 
In conclusion, this study establishes the ability of composite SWNT/laminin thin 
films to mediate the differentiation and electrical stimulation of NSCs.  The protein-
SWNT composite can serve as a foundation of a new type of NEs which (1) incorporate 
SWNTs as superior conductor and strengthening agent; (2) are conducive to NSCs 
growth and proliferation; (3) and are suitable for excitation of NSCs and the products of 
their differentiation.  Additional studies to further understand the effect of electrical 
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Neuronal Programming of Multipotent Cells via Gene Delivery on Functionalized 
Carbon Nanotube Nanocomposites 
 
6.1 Abstract 
Inflammatory reactions, encapsulation of implanted electrodes with scar tissues 
and gradual withdrawal of neurons from them are the key problems for the neural tissue 
interfacing.  These issues must be resolved for treatments of several well-known 
debilitating conditions to be effective. If an implanted electrode acquires ability to control 
cell response via in-situ gene transfection, all these problems can be successfully 
mitigated. Taking advantage of layer-by-layer assembled carbon nanotubes composites, 
purposeful engineering of the electrostimulating implants with these functionalities 
becomes realistic. They are conductive and can incorporate plasmid DNA capable of 
altering the response/functionality of surrounding cells. Successful expression of Lyn-
citrine plasmid DNA was achieved in attached neurons. The transfection efficiency was 
found to be remarkably higher than conventional solution-mediated techniques. Most 
importantly, by using plasmid expression vectors for neural basic helix-loop-helix 
proteins, neurons were generated from multipotent P19 embryonal carcinoma cells 
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adhering to SWNT multilayers.  This illustrates the possibility of recruiting resident stem 
cells in brain by the electrostimulating implant, programming of surrounding cells, and 
substantially improved level of tissue-device integration. 
 
6.2 Introduction 
The acute and long-term inflammatory tissue responses around implanted 
electrodes represent the long-standing problems for neural stimulation necessary for the 
treatment of many diseases. Scarring of the tissue around implants is difficult to avoid 
due to the fundamental limitations on electrical properties of the materials used, 
discrepancy in mechanical properties of hard implants and soft tissues, and physical 
dimensions of the electrodes.1 However, encapsulation with resident immune cells and 
related loss of electrostimulation performance can potentially be avoided by in-situ gene 
therapy. It can be particularly suitable for the activation of resident neural stem cells or 
genetic re-programming of scar-forming astroglial cells into neurons.2  Enhanced neural 
population in the vicinity of electrode will improve signal transduction, decrease 
pathological symptoms, and reduce inflammatory reactions at the implantation site.3, 4  
The same approach can be applied to correction of defective genes at the 
implantation site responsible for various neurological and cardiac diseases. For example, 
gene delivery was demonstrated in animal models to prevent the development of neuritic 
plaques in Alzheimer’s disease,5 reverse motor dysfunction in Parkinson’s disease,6 and 
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decrease seizure activity7 in epilepsy. By delivering appropriate genes, researchers were 
also able to prevent degeneration8 and induce generation9 of cochlear hair cells. For 
cardiac conditions such as a heart block, gene delivery effectively generated ventricular 
biological pacemakers.10 Furthermore, by exploiting the highly migratory stem cells as 
delivery vehicles, gene therapy can be combined with stem cell therapy as a new 
treatment strategy for neurodegenerative diseases.11 
Unfortunately, traditional and state-of-the-art inorganic electrode materials, such 
as gold, iridium oxide, doped silicon, and etc., do not have mechanical compliance with 
soft tissues, which results in the activation of astroglial cells. Also, they present multiple 
problems for realization of gene delivery.12 Although conducting polymers have received 
tremendous attention as a promising class of materials for producing functional neural 
interfaces, most developments have so far focused on biocompatibility and incorporation 
of small-molecule drugs.13, 14  
Conductive organic-inorganic composites fabricated from carbon nanotubes 
(CNTs) represent a promising class of materials for neuroprosthetic electrodes. 
According to the data from many groups, these CNT-based materials are not only 
biocompatible15, 16 but can also boost the efficacy of neural signal transmission,17 
stimulate and record neural circuit activities,18, 19 and improve neural recordings.20 As 
electrical/mechanical properties and accessibility of genes are highly dependent on nano- 
and micro-scale morphology of the electrode material, the choice of processing technique 
for preparing CNT composites is extremely essential. Layer-by-layer (LBL) assembly has 
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several advantages significant in this respect. (1) It allows for simple integration of 
biological species into the resulting material.21 The incorporation of deliverable genes in 
the matrix of implants avoids many tough problems of more traditional methods of gene 
therapy, such as systemic administration and solution-based gene delivery.22, 23 (2) The 
composites made by LBL display remarkable mechanical properties,24, 25 which come 
into play during implantation and long-term performance of the implants. (3) High 
loading of CNTs and control over nanotube-nanotube contacts produce high electrical 
conductivity.25 (4) LBL composites can be used as coatings and free-standing materials 
for electrode manufacturing, providing necessary flexibility for device engineering.26-28  
(5) Importantly, they do not interfere with the differentiation pattern of stem cells.29, 30 
Such a complementary set of properties motivated us to test whether single-
walled carbon nanotube (SWNT) LBL composites can be used for in-situ gene delivery. 
As background for this idea, electroporation has been used in conjunction with 
conductive materials to deliver genes,31, 32 but such methods require a counter electrode 
to initiate the delivery which is unlikely to be implemented with implantable electrodes 
and can cause additional damage to the neural tissue. Electrical potential was 
demonstrated to successfully release genetic material from LBL films built on conductive 
surfaces, but unassisted genetic expression in cells was not demonstrated because manual 
incorporation of a transfection agent was subsequently required to enable delivery into 
cells.33, 34 Functionalized individual SWNTs have been shown to condense and deliver 
DNA into cells in solution similar to little spears.35, 36 However, it is unclear how this 
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6.3.1 SWNT Multilayer Composite Preparation 
Purified single-walled carbon nanotubes (SWNTs) were purchased from Carbon 
Solutions, Inc. (Riverside, CA). Poly(vinyl alcohol) (PVA; MW 70k), poly(sodium 4-
styrene-sulfonate) (PSS; MW 1000k) were obtained from Sigma-Aldrich (St. Louis, 
MO). SWNT-PVA multilayers were prepared on round glass coverslips (Bellco Glass, 
Vineland, NJ) using the technique of layer-by-layer (LBL) assembly. SWNTs were 
dispersed at 0.5 mg/ml in 0.1 wt% PSS solution by sonication, and the SWNT-PSS 
dispersion was alternately adsorbed onto glass coverslips with 0.2 wt% PVA solution. 
For each deposition, the coverslips were immersed in the corresponding solution for 5 
minutes, followed by rinsing with deionized water and drying with an air jet. The process 
was repeated to obtain 3 bilayers of PVA/SWNT-PSS on the surface which we 
designated as (PVA/SWNT-PSS)3.  
6.3.2 PEI-pDNA Complex Preparation 
Plasmid DNA (pDNA), pLyn-citrine, was provided by Professor Ronald W. Holz 
(Department of Pharmacology, University of Michigan, Ann Arbor, MI). This plasmid 
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vector encodes a citrine fluorescent protein, a YFP variant, fused to a sequence from Lyn, 
a member of the Src-family kinases, for plasma membrane localization. The pUS2MT-
MASH1, pUS2MT-ngn2, and pUS2MT plasmids were provided by Professor David L. 
Turner (Neuroscience Program, University of Michigan, Ann Arbor, MI). The pUS2MT-
MASH1 and pUS2MT-ngn2 plasmids are vectors for the neural bHLH proteins MASH1 
and ngn2, respectively.37 The plasmids were amplified in Escherichia coli DH5-alpha 
strain, which was provided to us by Professor Xiaoxia Lin (Department of Chemical 
Engineering, University of Michigan, Ann Arbor, MI), and purified using Promega’s 
PureYield Plasmid Midiprep System (San Luis Obispo, CA) according to the 
manufacturer’s instructions. The concentration of pDNA was estimated 
spectrophotometrically using a quartz cuvette. To prepare PEI-pDNA complexes for 
transfection studies, linear polyethylenimine (PEI; MW 25k; Polysciences, Inc., 
Warrington, PA) and pDNA were diluted separately in 150 mM NaCl. Appropriate 
amount and concentration of PEI solutions were added to pDNA solutions to create 
mixtures of desired nitrogen-to-phosphorous (N/P) ratios. For cotransfection of P19 cells, 
the ratio of neural bHLH vector to pLyn-citrine in the mixture was 3 to 1. The mixtures 
were vortexed, incubated at room temperature for 15 min, and used immediately 
following preparation. 
6.3.3 Cell Cultures  
NG108-15 (murine neuroblastoma/glioma) cells, P19 cells, and hypoxanthine, 
aminopterin, and thymidine (H.A.T.) were obtained from American Type Culture 
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Collection (ATCC, Manassas, VA). NG108-15 cells were maintained in Dulbecco’s 
Modified Eagle’s Medium (DMEM) without sodium pyruvate (Invitrogen, Carlsbad, CA) 
supplemented with 0.1 mM hypoxanthine, 400 nM aminopterin, 0.016 mM thymidine, 
100 IU penicillin and 100 µg/ml streptomycin, and 10% fetal bovine serum (FBS). 
NG108-15 neural cells were seeded and cultured in serum-depleted culture media to 
induce neuronal differentiation. P19 cells were cultured in MEMα medium (Invitrogen, 
Carlsbad, CA) supplemented with 10% FBS. All cells were maintained at 37 °C in a 
humidified 5% CO2 atmosphere. 
6.3.4 Cell Transfection  
NG108-15 transfection studies were performed by two different methods in 
triplets – multilayer mediated delivery and solution mediated delivery. For multilayer 
mediated delivery, an additional layer of PEI-pDNA was deposited on top of the 
PVA/SWNT-PSS multilayers. The (PVA/SWNT)3 coated glass coverslips were 
immersed in PEI-pDNA solutions to produce a film structure of (PVA/SWNT)3(PEI-
pDNA). Prior to cell seeding, the glass substrates were washed with cell culture medium 
twice to remove weakly attached PEI-pDNA complexes. Cells were seeded on the 
substrates in 24-well plates at a concentration of 20,000 cells per well in DMEM with 1% 
FBS to induce neuronal differentiation. For solution mediated delivery,38, 39 cells were 
seeded similarly on (PVA/SWNT-PSS)3 coated coverslips. In 2 h, following cell seeding 
and cell attachment, 30 µl of PEI-pDNA solution containing 1 µg of pDNA was added to 
each well. As an additional control to the untreated group, cells were also seeded on 
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(PVA/SWNT-PSS)3(PEI) multilayers or treated with just PEI alone. Cells were cultured 
for 2 days before being assayed for transfection efficiency and metabolic activity.  
P19 cotransfection was performed using the multilayer mediated delivery method. 
P19 cells were seeded and cultured on top of (PVA/SWNT-PSS)3(PEI-pDNA) 
multilayers, where the PEI-pDNA complexes were prepared from a mixture of linear PEI, 
Lyn-citrine plasmid, and a neural bHLH vector (MASH1 or ngn2) at an N/P ratio of 20. 
This N/P ratio was selected to achieve high transfection efficiency while avoiding the 
cytotoxic effects, as the P19 cells may be more vulnerable than the NG108-15 cells. As a 
control, cells were also co-transfected such that the bHLH vector was replaced with an 
empty vector. Cells were seeded in MEMα with 10% FBS. After 2 days in culture, the 
serum content was lowered to 1% and the media was replaced every 2 days.  
6.3.5 Gene Expression  
Gene expression was examined using confocal microscopy. In brief, at indicated 
time points following cell seeding and treatment, NG108-15 cells were fixed with 4% 
paraformaldehyde, stained with DAPI, mounted on coverslides, and observed using an 
Olympus FluoView 500 laser scanning confocal microscope. For each sample, random 
fields were selected under 20X magnification. For each field, total number of all cells 
(DAPI stained nuclei) and transfected cells (YFP expressed cells) were counted. The 
transfection efficiency for each treatment was calculated as the number of transfected 
cells divided by the number of total cells. For P19 cotransfection, the cells were also 
stained with primary antibodies for β-tubulin III (anti-TuJ1, 1:500 diluation, Sigma-
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Aldrich, St. Louis, MO)  and visualized with Alexa Fluor-conjugated secondary 
antibodies (Invitrogen, Calrsbad, CA). 
6.3.6 Cell Metabolic Activity Assay 
Cell metabolic activity was determined by MTT assay (thiazolyl blue tetrazolium 
bromide, Sigma-Aldrich, St. Louis, MO). In brief, 2 days after cell seeding and treatment, 
cells were added with 1.2 mM of MTT solution. After incubation at 37 °C for 2 h, 
isopropanol containing 10% Triton X-100 and 0.1 N HCl was added to dissolve the 
purple formazan crystals formed by dehydrogenase reduction of MTT. The absorbance of 
the resulting solution was measure at a test wavelength of 570 nm and a reference 
wavelength of 690 nm. Absorbance readings were converted to percentage cell viability 
by referencing the untreated cells as 100%.  
 
6.4 Results and Discussion 
SWNT multilayers were fabricated from poly(vinyl alcohol) (PVA) and 
poly(sodium 4-styrene-sulfonate) (PSS) dispersed SWNTs (SWNT-PSS).  The 
conductivity of such composites was as high as 4.15×104  S/m determined as described in 
27, 30. It is sufficient or exceeds the requirements for different modes of neuronal 
excitation. As the first step, the delivery of the Lyn-citrine plasmid DNA (pDNA) to 
NG108-15 neuroblastoma cells was attempted. The NG108-15 cell line was chosen 
because these neural cells can be easily differentiated into neurons with distinctive 
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neuronal morphology, and they are routinely used as a model system for studying 
neuronal tissue. Lyn-citrine encodes a protein with strong luminescence similar to that of 
yellow fluorescent protein and gives strong membrane labeling that makes possible easy 
detection of successful transfection. To impart the SWNT films with gene delivery 
functionality, the pDNA was complexed with polyethylenimine (PEI) and deposited on 
the SWNT films in LBL fashion. The PEI protects pDNA against degradation, 
prolonging pDNA retention in the cell and the nucleus. Because the SWNT-PSS layer has 
a negative charge, the positively charged PEI-pDNA complexes were able to form a 
stable nanoscale layer with the LBL multilayers of SWNTs after thorough rinsing.21 To 
optimize the transfection efficiency, PEI-pDNA complexes of various nitrogen-to-
phosphorous (N/P) ratios were tested. To evaluate the comparative efficiency of gene 
transfer in the SWNT-pDNA multilayer composites, we also conducted in parallel PEI-
mediated gene delivery using the conventional solution method. 
In general, the transfection efficiency was higher in multilayer-mediated gene 
transfer across all N/P ratios tested (Figure 1a, d, e). The maximum transfection 
efficiency achieved in this study was ca. 50% and 30% for the multilayer and solution 
mediated delivery modes, respectively. The data for solution mediated delivery correlates 
very well with previous studies, which have demonstrated efficiencies ranging from less 
than 10% to 50% with increasing N/P ratio, as well as being highly variable depending on 
the cell line used.40, 41 While both transfected and untransfected NG108-15 cells 
differentiated into mature neurons with long neural processes, many which extended over 
100 µm in length, only those transfected with the Lyn-citrine pDNA developed 
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elaborated neural networks that were fluorescently labeled (Figure 1f). This is a clear 
indication that the delivery of functional genes through LBL films does not interfere with 
cellular developments, such as differentiation and neurite outgrowth unless such action is 
purposefully designed in the transferred gene.   
There are several factors contributing to the higher transfection efficiency 
observed in multilayer mediated gene delivery. LBL deposition distributed the PEI-
pDNA complexes evenly across the coated surface and elevated the concentration of the 
complexes on the surface of cells, increasing the number of cells exposed to the vectors 
and the likelihood of the vectors being transported across the cell membrane. 
Furthermore, immobilization of the PEI-pDNA complexes provided additional 
stabilization to the vectors, preventing unwanted degradation and prolonging their 
bioactivity.  
The efficiency monotonously increased with increasing N/P ratio for the 
multilayer composites, while it dropped solution mediated delivery after N/P = 40 and 
was significantly diminished at an N/P = 80 (Figure 1a) because for these ratios PEI-
plasmid complexes become less stable without immobilization onto a solid substrate.  For 
both delivery modes, the increase in N/P ratio also adversely effects cell viability (Figure 
1b) and cell metabolic activity (Figure 1c) due to the cytotoxicity of PEI.  Importantly, in 




Figure 6.1 Transfection of NG108-15 neural cells. Comparison of transfection efficiency 
(a), cell viability (b), and metabolic activity (c) in NG108-15 neural cells transfected with 
pLyn-citrine by multilayer mediated (black bars) and solution mediated (grey bars) gene 
delivery. Untreated cells (white bars) were cultured on SWNT multilayers without any 
additional coating or treatments. Comparison of citrine fluorescent protein expression 
using multilayer mediated (d) and solution mediated (e) gene delivery. Expression of the 
plasmid gave a very strong plasma membrane labeling. Expression of the plasmid not 
only had no noticeable adverse effect on neuronal differentiation, but also improved the 
definition of the neural processes (f). Scale bars are 100 µm. 
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The possibility to generate neurons from resident stem and astroglial cells by 
delivering appropriate genes from the SWNT films would lead to the opportunity to 
control cellular processes around the neuroprosthetic implants. To demonstrate this, we 
decided to deliver both genes encoding a fluorescent protein and the neural basic helix-
loop-helix (bHLH) proteins to the multipotent P19 embryonal carcinoma cells. The P19 
cells are derived from mouse embryo and have been used extensively as a model system 
for studying in vitro differentiation of neural cells, and skeletal and cardiac muscle 
cells.42, 43 Studies have shown that they appear to differentiate by the same mechanisms 
as normal embryonic stem cells.44-46 Forced expression of bHLH proteins, such as 
NeuroD2, MASH1, and neurogenins (ngn1, ngn2, ngn3), which are essential during 
mammalian neuronal determination and differentiation,47 have led to formation of 
neurons.48, 49 Note the exactly the same set of genes is necessary to re-program astroglial 
cells into neurons.2 Genetic control of neural population never been carried out using a 
surface mediated delivery system, which is the most logical approach for electroactive 
implantable devices. 
Indeed, P19 cells cultured on multilayer composites functionalized with 
fluorescent protein and neural bHLH expression vectors gradually adopted a neuronal 
morphology (Figure 2) while reducing proliferation rate. By 4 days in culture, these cells 
expressed both the fluorescent protein and the neuronal specific β-tubulin III protein 
stained with the antibody TuJ1 (Figure 3). The staining of β-tubulin III protein outlines 
the formation of neural processes, which became much more elaborated and intricate by 
day 6 in culture. In general, the outcomes of either MASH1 or ngn2 expression were very 
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similar. In contrast, P19 cells co-transfected with pLyn-citrine and the empty vector 
remained in their undifferentiated morphology and continued to proliferate, generating 
large islands of cells (Figure 2). As expected, some of these cells expressed the 
fluorescent protein but none of them showed expression for β-tubulin III (Figure 3).  
 
 
Figure 6.2 Morphology of transfected P19 embryonal carcinoma cells.  Light microscope 
(a, b, d, e, g, h) and scanning electron microscope (c, f, i) images of P19 embryonal 
carcinoma cells cultured on functionalized SWNT multilayers on day 2 (a, d, g) and day 
4 (b, c, e, f, h, i) after seeding. The SWNT multilayers were functionalized with PEI-
pDNA complexes containing pLyn-citrine and either a neural bHLH protein expression 
vector (a-f) or an empty vector (g-i). Cells transfected with the MASH1 (a-c) and ngn2 
(d-f) vectors adopted a neuronal morphology while those transfected with the empty 
vector continued to proliferated and remained in their undifferentiated morphology (g-i). 




Figure 6.3 Neuronal differentiation of transfected P19 embryonal carcinoma cells. 
Confocal microscope images of P19 embryonal carcinoma cells cultured on 
functionalized SWNT multilayers on day 4 (a-c, e-g, i-k) and day 6 (d, h, l) after seeding. 
Cells were transfected with PEI-pDNA complexes containing pLyn-citrine, in addition to 
a vector for either MASH1 (a-d), ngn2 (e-h), or an empty vector (i-l). The cells were 
labeled for their nuclei with DAPI and expression for the neuronal specific β-tubulin III 
protein with the antibody TuJ1. While all cells showed citrine fluorescence (b, f, j), only 
those transfected with the neural bHLH protein expression vectors stained positive for β-






In conclusion, it is clear that successful delivery of bHLH vectors was sufficient 
to program into the material the generation of neuron from the surrounding cells.  Also 
essential, the direct delivery of genes using SWNT LBL multilayers incorporating pDNA 
was demonstrated to be more efficient and safer than the conventional solution mediated 
delivery.  The use of SWNT composites makes possible integration of essential 
biological properties and signaling functions into the conductive materials, for which the 
reliable delivery of the genes on the implant during the surgical procedure was either 
difficult or impossible.  This ability is critical to the development of new generation of 
neuroprosthetic devices potentially eliminating inflammatory reactions50 that often lead 
to the demise of implanted electrodes.  It can also be used for stimulation of cell 
regeneration51 promoting much better integration of the electrode in the tissue. 
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Development of an In Vitro 3D Neural Tissue Model for Testing of Electrode- 
Induced Cellular Reactions 
 
7.1 Abstract 
 The emergence of new neural interfacing materials, such as layer-by-layer 
assembled composites of carbon nanotubes, offer novel opportunities for addressing the 
problem of inflammatory reactions that current neural electrode designs suffer from. 
While a wide variation of features can be designed into these new neural interfacing 
materials, validation of their efficacy will require a new biological testing platform that is 
accurate, affordable, and high-throughput. In this study, we report the development of an 
in vitro 3D neural tissue model based on high-density culture of cell lines in hydrogel 
scaffolds with inverted colloidal crystal structure. We showed that P19 embryonal 
carcinoma multipotent cells have the potential to differentiate into a mixture of neural 
cell types that are essential for modeling the neural inflammatory process. We also 
demonstrated that co-culture of Neuro-2A neuronal cells, C8-D1A astrocytic cells, and 
HAPI microglial cells represents a promising neural tissue model as the cells were 
dynamic and responsive to their environment.  
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7.2 Introduction 
Implantable neural electrodes are important and valuable tools in both research 
and clinical medicine. Neuromotor prosthetic devices have allowed researchers to 
investigate the biological basis of planning and control of movement by recording brain 
activity from animals.1, 2 New knowledge and technological advances acquired from 
these studies are now being translated into clinical settings. For example, it was recently 
demonstrated that neuronal activity recorded through a microelectrode array enabled a 
tetraplegic human to control a prosthetic hand, opening up the possibilities for such 
patients to communicate and interact with the outside world.3 
Despite the promise offered by advances in neurotechnologies, implantable neural 
electrodes often fail to function reliably in chronic settings, suffering from inflammatory 
tissue responses that prevent a stable, long-term interface to be maintained for acquisition 
of neural signals.4 The inflammatory tissue responses occur in acute and chronic stages. 
The acute responses consist of activated microglia and astrocytes that are recruited to the 
implant site due to mechanical injuries inflicted by the implantation process.5, 6 The 
persistent presence of the electrode induces chronic responses characterized by the 
formation of a dense, encapsulating tissue sheath consisted of microglia and astorcytes.5, 7 
This process, also known as glial scarring, displaces neuronal bodies at the implant site, 
and ultimately leads to loss of electrode connections.   
The need for better neural interfaces has called for the development of new 
materials that are not only biocompatible but possess properties that can mitigate 
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inflammatory responses. Conducting polymers8, 9 and carbon nanotubes (CNTs)10, 11 are 
emerging neural interfacing materials with potentials unmatched by conventional metallic 
electrodes. For example, layer-by-layer (LBL) assembled CNT composites have 
demonstrated excellent biocompatibility12, 13 and electrochemical properties,14, 15 as well 
as endless possibilities for biofunctionalization afforded by LBL assembly.16, 17  
The realization of new neural interfacing materials, especially those made from 
nanomaterials,18 will necessitate extensive biological testing, which has always involved 
in vivo animal models that are time-consuming and labor-intensive.19-21 In order to test 
the wide range of functionalities promised by new neural interfacing materials in an 
affordable, high-throughput, and accurate fashion, in vitro models that can closely mimic 
the neural tissue must be developed.  
 The goal of this study is to develop an in vitro 3D neural tissue model that can be 
used to investigate cellular responses inflicted by neural electrodes. While several 2D22-25 
and 3D26-28 in vitro models have been reported in the literature, they all employ primary 
cells, which require animals to be sacrificed. In this study, we report on the progress we 
have made in the development of an in vitro 3D neural tissue model based on culturing of 
cell lines in hydrogel scaffolds with inverted colloidal crystal (ICC) geometry.29-31 The 
ICC hydrogel scaffold design is characterized by its highly porous and uniform 
architecture consisted of interconnecting spherical cavities. This highly controlled and 
regular structure is the key to reproducible experimental results. Successful development 
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of such an in vitro 3D neural tissue model will enable faster screening of neural electrode 
designs and will make the study of glial scarring easier to advance.  
 
7.3 Methods 
7.3.1 Fabrication of Inverted Colloidal Crystal (ICC) Hydrogel Scaffolds  
Colloidal crystals were first constructed from glass beads with diameters between 
212 and 230 µm. The glass beads were dispersed in ethylene glycol (EG) and slowly 
added to glass vials through long glass Pasteur pipets. The vials were gently shaken using 
an ultrasonic cleaner to allow self-assembly of the glass mircospheres into a colloidal 
crystal with a hexagonally packed geometry. After evaporation of excess EG at 160°C, 
the colloidal crystal arrays were heated at 700°C for 3 h to anneal the glass particles. To 
obtain hydrogel scaffolds with ICC geometry, the glass colloidal crystal arrays were first 
infiltrated with a monomer solution containing 30 wt.-% acrylamide (AAm), a 
crosslinking agent, and an accelerating agent. The solution was then initiated to 
polymerize with a 1 wt.-% potassium peroxide solution. Following removal of excess 
polyacrylamide (PAAm) hydrogel from the exterior of the colloidal crystal arrays, the 
hydrogel infiltrated crystals were immersed in 5% HF solution to remove the glass 
colloids. The resulting 3D hydrogel scaffolds were washed extensively with deionized 
water and phosphate buffered saline (PBS) and then sterilized with 70% ethanol and UV 
irradiation.  
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7.3.2 Cell Culture 
P19 embryonal carcinoma multipotent cells, Neuro-2a neuroblastoma cell, and 
C8-D1A type I astrocytic cells were purchased from American Type Culture Collection. 
HAPI microglia cells were a generous gift from Professor Marina Mata of the 
Department of Neurology at the University of Michigan. Neuro-2a, C8-D1A, and HAPI 
cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM) supplemented 
with 10% fetal bovine serum (FBS). The serum concentration was lowered as needed to 
reduce proliferation and induce differentiation of the cells. P19 cells were cultured in 
alpha Minimum Essential Medium (αMEM) supplemented with 10% FBS. To induce 
differentiation into neural lineages, P19 cells were cultured in αMEM containing 5% FBS 
and 2.5 µM retinoic acid for 4 days, during which cells formed aggregates. Subsequently, 
the aggregates were dissociated into single cells and cultured in a differentiation medium 
consisted of neural basal medium supplemented with B27 and L-glutamine. 
For culture in 3D ICC hydrogel scaffolds, sterilized scaffolds were immersed in 
100% ethanol and allowed to completely dehydrate with evaporation of the ethanol. Cells 
were then seeded into scaffolds by carefully dispensing 20 µl of concentrated cell 
solution containing 50% Matrigel into each scaffold. A cell seeding density of 2 × 106 
cells per scaffold was used. The addition of cell solution caused the scaffolds to gradually 
expand, rehydrate and uptake the dispersed cells. Once in the scaffolds, the cell solution 
was allowed to gel for 30 min before the scaffolds were transferred into 6-well culture 
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plates containing culture medium. For regular 2D culture, cells were seeded in 24-well 
culture plates.  
To inflict damage on the 3D cell culture model, a piece of copper wire (254 µm in 
diamater) was inserted into each scaffold. Alternatively, two to three holes were punched 
in each cell seeded scaffold, resulting in three-dimensional wounds. For 2D culture, cells 
were inflicted with mechanical injury or foreign body response by creating scrape 
wounds on the cell layer or placing 50 µm diamater stainless steel wires on the cutlure.  
7.3.3 Characterization 
At the end of each time point, the 3D scaffolds were fixed with 4% 
paraformaldehyde, dehydrated, paraffinized, and sectioned into circular slices at the 
Histology Core at the University of Michigan. To prepare samples for 
immunocytochemical characterization, the scaffold sections mounted on glass slides were 
deparaffinized and rehydrated. Fixed samples from 2D and 3D cultures were 
permeabilized and blocked in PBS containing 0.3% Triton X-100 and 10% goat serum. 
The samples were first incubated with primary antibody diluted in PBS containing 10% 
goat serum for 24h at 4°C and then with secondary antibody diluted in PBS containing 
2% goat serum for 3h at room temperature. Primary antibodies were purchased from 
Chemicon, Millipore, and Sigma. Primary antibodies and their dilutions are as follow: 
mouse anti-NeuN (1:100), mouse anti-MAP2 (1:200), mouse anti-GFAP (1:200), mouse 
anti-OX-42. rabbit anti-GFAP (1:200), and rabbit anti-MAP2 (1:100), rabbit anti-β-
tubulin III (anti-Tuj1) (1:100), and rat anti-MAC-1 (1:100). Secondary Alexa Fluor 
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antibodies were purchased from Invitrogen and a 1:100 dilution was used. Samples were 
counter-stained for nuclei and mounted with Prolong Gold Anti-Fading Reagent with 
DAPI (Invitrogen). Immunostained samples were visualized using an Olympus FluoView 
FV500 confocal laser scanning microscope. The imaged were acquired using the 
Olympus Fluoview software version TIEMPO 4.3.  
Histological characterization consisted of H&E staining. Samples were visualized 
using a Nikon Eclipse TS100 inverted microscope equipped with a QImaging 
MicroPublisher 3.3 digital CCD color cameras.  Images were captured using QImaging’s 
QCapture software. For SEM analysis, fixed samples were dehydrated through a gradient 
series of ethanol (25%, 50%, 70%, 85%, 95%, and three times 100%) for 5 min each time 
and left overnight in the final 100% ethanol solution.  Completely dried samples were 
mounted on aluminum stubs and sputter-coated with gold.  Imaging was carried out using 
a Philips XL30FEG scanning electron microscope. 
 
7.4 Results and Discussion 
7.4.1 3D Culture of P19 Embryonal Carcinoma Multipotent Cells   
In order to mimick the cellular reactions inflicted by electrode materials in neural 
tissues, the in vitro model must contain the three major cell types that are involved in the 
inflammatory process - neurons, astrocytes, and microglia. Therefore, our approach was 
to generate a dense 3D structure of cells consisted of these three cell types. The P19 
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embryonal carcinoma multipotent cells appeared to be a logical choice of cell line for 
obtaining a mixed population of neural cells as they have been known to differentiate into 
various neural cell types when treated with retinoic acid.32, 33  
In this study, P19 cells were treated with retinoic acid for 4 days before the cell 
aggregates were dissociated into single cells and seeded into polyacrylamide hydrogel 
ICC scaffolds at a cell density of 2 × 106 cells per scaffold. The cells were allowed to 
differentiate and adjust to the scaffold environment for 5 days, after which a piece of 
copper wire with a diameter of 254 µm was inserted into each scaffold to inflict 
mechanical injury and present a foreign material to the cells in the scaffold. The 
treatment day was denoted as Day 0, and the 3D culture was harvested, sectioned, and 
examined 1, 5, and 10 days after the treatment. 
Hematoxylin and eosin (H&E) staining of the sectioned 3D scaffolds was used to 
examine the overall health and distribution of cells within the scaffolds following the 
insertion of testing electrodes. Figure 7.1 shows H&E staining of sectioned scaffolds at 
the different time points. The images indicate that the overall health of cells declined in 
the scaffolds as time progressed. The number of cell nuclei, which are darkly stained in 
H&E staining, dropped significantly between the time points. By Day 10, there were very 
cells remaining in the scaffolds as illustrated by the few dark spots present in the H&E 
stained section. The loss in cell population is mostly likely the result of a combination of 
factors, including a highly dense and crowded population of cells, insufficient diffusion 
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of nutrients through the scaffolds, and inability of the culture medium in keeping the 
differentiated P19 culture healthy for extended period of time. 
The distribution of cells appeared to be even throughout the scaffolds. The 
locations of the inserted testing electrodes can be easily identified by the circular void 
space in the scaffold sections. The testing electrodes did not seem to impact the 
surrounding cells as cell nuclei were present around the electrode site on Day 1 and Day 
5 (Figure 7.1). We also did not observe clustering of cells around the electrode site that 
would indicate possible migration of glial cells and formation of glial scars. It must be 
pointed out that the distribution and motility of the cells are highly dependent on the 
density and health of the cell population, both of which were observed to deteriorate with 
time in this study. 
 
 
Figure 7.1 H&E staining of sectioned 3D scaffolds on Day 0, Day 1, Day 5, and Day 10 
after insertion of copper wire electrodes. Retinoic acid treated P19 cells were cultured in 
the ICC hydrogel scaffolds for 5 days prior to the placement of the testing electrodes. 
Void space created by the inserted electrodes can be easily identified in the images. 
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 To identify the phenotypes of differentiated P19 cells cultured in the scaffolds, the 
scaffold sections were stained and observed under a confocal microscope for various 
neural markers, including NeuN for mature neuronal nuclei, β-tubulin III for neuronal 
microtubule, GFAP for astrocytes, and MAC-1 for microglia. Figure 7.2 shows that the 
retinoic acid treated P19 cells were capable of differentiating into mature neurons and 
astrocytes when cultured in the 3D hydrogel scaffolds. However, no presence of 
microglial cells was observed. The morphology of differentiated neuronal cells are easily 
distinguished under scanning electron microcopy (SEM) as the cells developed elongated 
cell bodies with extensive network of neurites (Figure 7.3). The retinoic acid treated P19 
cells formed cell aggregates that occupied the interconnected spherical cavities of the 
scaffolds. As cell differentiation progressed, cellular contacts were formed between 
adjacent cavities and many cells developed neurites with long extensions that passed 
through multiple cavities. 
 The two biggest drawbacks of this experiment are the decline in the health of the 
3D culture and the absence of microglial cells. These two factors could limit the 3D 
model’s ability in producing a noticeable cellular response to mechanical injuries and 
foreign materials. The ability to generate and maintain a mixed population of neurons, 
astrocytes, and microglia would be a challenging task for the adoption of the P19 
multipotent cell line. Although many studies have reported the generation of neurons, 
astrocytes, oligodendrocytes from P19 cells,33-35 very few studies have demonstrated the 
differentiation of P19 cells into microglial cells. Researchers were able to generate 
microglia-like cells from P19 cells only at late stages of neural differentiation, requiring a 
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culture period of 18 or more days.36 According to the same study, the initial appearance 
of microglia coincided with the disappearance of neurons.36 Therefore, the ability to 
maintain differentiated P19 cells in culture using 3D scaffolds for extended period of 
time will be essential. This is also important as it takes time for cells to migrate and 
reorganize after the culture is challenged with a testing electrode. Optimization of the 
culture condition and media formulation will be required to keep mature neurons alive in 
the culture. Alternatively, neurons from a second delayed culture could be introduced into 




Figure 7.2 Confocal microscopy images of sectioned scaffolds on Day 0, Day 1, Day 5, 
and Day 10 after insertion of copper wire electrodes. Differentiated P19 cells were 
stained for markers of matured neuronal neuclei (NeuN, shown in green) and neuronal 
microtubule (β-tubulin III, shown in red) (a-d). Cells were also stained for markers of 
astrocytes (GFAP, shown in green) and microglia (MAC-1, shown in red) (e-h). Cell 




Figure 7.3 SEM images of vertical cross-section (a, b) and outer surface (c, d) of a 
scaffold 5 days after cell seeding (a, b). Cells aggregates formed by the seeded P19 cells 
not only occupied the spherical pores, but were also interconnected with those in adjacent 
pores (b).  Highly differentiated neurons formed neurites with long extensions that passed 
through multiple pores and interfaced with multiple cells (c, d). Scale bars: 200 µm (a), 






7.4.2 3D Co-culture of Neuronal, Astrocytic, and Microglial Cell Lines 
 Another approach to obtain neurons, astrocytes, and microglia in the same culture 
is through co-culture of three cell lines, each representing a different neural cell type. To 
achieve this, we decided to culture Neuro-2A neuronal cells, C8-D1A astrocytic cells, 
and HAPI microglial cells together. These three cell lines were selected because they can 
be conveniently cultured together using the same culture medium.  
 One convenient feature of using a co-culture approach is that the percentage of 
each cell type can be easily controlled during cell seeding. However, the growth rates of 
the cell lines must be taken into consideration as they are different across different cell 
lines, and therefore the distribution of cell population can change substantially after 
seeding. The distribution of neural cell types can be varied accordingly to model different 
regions of the brain. For example, the ratio of neuronal to non-neuronal cells is 
approximately 1 for the whole brain, 4 for the cerebral cortex, 0.2 for the cerebellum, and 
11.4 for the rest of the brain.37 In mice, the proportion of microglia ranges from 5% in the 
cortex to 12% in the substantia nigra,38 and microglia can comprise up to 20% of the total 
non-neuronal population.39 In general, the ratio of all non-neuronal cell to neurons across 
different primate species is roughly constant and not much larger than 1.40 With these 
numbers in mind, we decided to use a ratio of 50% neurons, 30% astrocytes, and 20% 
microglia for our culture system.  
 We began this study by looking at the cellular behavior of the co-culture system 
of Neuro-2A, C8-D1A, and HAPI cells in regular 2D culture, as such a combination of 
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cells has never been reported in the literature. The cells were seeded and allowed to 
stabilize for three days under reduced serum condition to limit the extent of cell 
proliferation, after which the culture was challenged two treatments. In one scenario, 
stainless steel wires with a diameter of 50 µm were place on top of the cells, whereas in 
another case, scrapes were made to the cell layer.  
 Figure 7.4 illustrates the response of the co-culture system during the 6 days 
following the two treatments. For the wire placement scenario, we observed a very slight 
compacting and clustering of cells around the wire. However, the effect was not very 
significant, and we did not observe considerable attachment of cells to the wires as 
occurred in experiments using primary cells.23 In the scrape test, we found that the co-
culture to be highly migratory. By day 3 after treatment, many cells had already migrated 
into the area once cleared of cells on the treatment day. Overall, we demonstrated a co-
culture system where three different cell lines were able to co-exist with each other at 
high density. Although we did not observe an overwhelming cellular response, perhaps 
due to the lack of effecting inducing conditions, the culture seemed to be dynamic as cell 




Figure 7.4 Time course of cellular events in response to the wire placement (a-d) or the 
scrape wound (e-k) in 2D co-culture of Neuro-2A neuronal cells, C8-D1A astrocytic 
cells, and HAPI microglial cells. The area scraped free of cells is on the right of the 





 The co-culture of Neuro-2A, C8-D1A, and HAPI cell lines was also demonstrated 
in 3D culture with ICC hydrogel scaffolds. Cells were seeded at a concentration of 2 × 
106 cells per scaffold and allowed to stabilize for 3 days under low serum condition. On 
the day of treatment, two to three holes (Figure 7.5) were punched in the scaffolds to 
inflict injury on the cell culture. On day 0, 1, 3, and 5 following treatment, the scaffolds 
were harvested, sectioned, and analyzed. Figure 7.5 shows the H&E staining of sections 
collected from the various time points. Overall, we did not observe reorganization of the 
cells around the punched holes at any of the time points. Although the number of cell 
nuclei within the scaffolds declined as time progressed, interestingly cell population 
actually increased around the periphery of the scaffolds. The layer of cells on the 
periphery had small cell nuclei that are characterisc of microglial cells. In addition, this 
cell layer appeared to thicken with time, resembling that of a glial scarring and 
encapsulation reaction. A couple of factors could have contributed to this reorganization 
of cells. The poor transport of nutrients near the center of the scaffolds might have caused 
cells to migrate toward the edges for more nutrients. Also the exterior of the scaffolds 
consist of open spherical pore structure that are rough in texture. This microscale 




Figure 7.5 H&E staining of sectioned scaffolds on Day 0, Day 1, Day 5, and Day 10 
after insertion of copper wire electrodes. Neuro-2A neuronal cells, C8-D1A astrocytic 
cells, and HAPI microglial cells were seeded at a ratio of 5:3:2, respectively, and cultured 
in the ICC hydrogel scaffolds for 3 days prior to infliction of wound on the 3D culture. 
On the day of treatment, two to three holes were punched in each scaffold, creating void 
spaces that can be easily identified in the stained sections (outlined with red circles). 
 
There are a few adjustments that could improve the performance of the 3D culture 
system. First, coating of the culture plates and 3D scaffolds with biomolecules such as 
polylysine might be necessary to improve cell adhesion as detachment of small patches of 
cells were observed toward the end of the experiment. Secondly, the transport of nutrients 
in the scaffolds must be improved. A healthy culture is critical to inducing a significant 
cellular response.  Vibration could be introduced using a shaker to facilitate the exchange 
of medium around the scaffolds. Alternatively, a rotary vessel could be used for the 3D 
culture. Lastly, the cells should be allowed to differentiate and mature for a longer period 
of time under low serum or no serum condition prior to treatment. However, serum 
should be introduced into the culture system with the treatment as serum has been found 




 In this study we made very important progress toward the development of an in 
vitro 3D neural tissue model that is free of primary cells. Our overall approach was to 
obtain a 3D cell structure consisted of neurons, astrocytes, and microglia, the three 
essential cell types in neural inflammatory process, by culturing cell lines in 3D hydrogel 
scaffolds. Through this study, we obtained valuable knowledge and established important 
protocols for 3D co-culture of neural cells. Our study shows that generation of the three 
target cell types from P19 multipotent cells would be possible if the right culture 
conditions could be provided. However, control over the proportion of the differentiated 
cell types would be difficult. To resolve this, we developed a co-culture system consisted 
of three different cell lines, each representing a different cell type (Neuro-2A neurons, 
C8-D1A astrocytes, HAPI microglia). We demonstrated that this combination of cell 
lines is promising and concluded that the culture conditions should be further optimized 
to achieve a more robust and responsive neural tissue model. 
 211 
7.6 References  
1. Wessberg, J.; Stambaugh, C. R.; Kralik, J. D.; Beck, P. D.; Laubach, M.; Chapin, 
J. K.; Kim, J.; Biggs, J.; Srinivasan, M. A.; Nicolelis, M. A. L., Real-time prediction of 
hand trajectory by ensembles of cortical neurons in primates. Nature 2000, 408 (6810), 
361-365. 
2. Musallam, S.; Corneil, B. D.; Greger, B.; Scherberger, H.; Andersen, R. A., 
Cognitive Control Signals for Neural Prosthetics. Science 2004, 305 (5681), 258-262. 
3. Hochberg, L. R.; Serruya, M. D.; Friehs, G. M.; Mukand, J. A.; Saleh, M.; 
Caplan, A. H.; Branner, A.; Chen, D.; Penn, R. D.; Donoghue, J. P., Neuronal ensemble 
control of prosthetic devices by a human with tetraplegia. Nature 2006, 442 (7099), 164-
171. 
4. Polikov, V. S.; Tresco, P. A.; Reichert, W. M., Response of brain tissue to 
chronically implanted neural electrodes. Journal of Neuroscience Methods 2005, 148 (1), 
1-18. 
5. Szarowski, D. H.; Andersen, M. D.; Retterer, S.; Spence, A. J.; Isaacson, M.; 
Craighead, H. G.; Turner, J. N.; Shain, W., Brain responses to micro-machined silicon 
devices. Brain Research 2003, 983 (1-2), 23-35. 
6. Fujita, T.; Yoshimine, T.; Maruno, M.; Hayakawa, T., Cellular Dynamics of 
Macrophages and Microglial Cells in Reaction to Stab Wounds in Rat Cerebral Cortex. 
Acta Neurochirurgica 1998, 140 (3), 275-279. 
7. Schultz, R. L.; Willey, T. J., ULTRASTRUCTURE OF SHEATH AROUND 
CHRONICALLY IMPLANTED ELECTRODES IN BRAIN. J. Neurocytol. 1976, 5 (6), 
621-642. 
8. Green, R. A.; Lovell, N. H.; Wallace, G. G.; Poole-Warren, L. A., Conducting 
polymers for neural interfaces: Challenges in developing an effective long-term implant. 
Biomaterials 2008, 29 (24-25), 3393-3399. 
9. Abidian, M. R.; Ludwig, K. A.; Marzullo, T. C.; Martin, D. C.; Kipke, D. R., 
Interfacing Conducting Polymer Nanotubes with the Central Nervous System: Chronic 
Neural Recording using Poly (3,4-ethylenedioxythiophene) Nanotubes. Advanced 
Materials 2009, 21 (37), 3764-3770. 
10. Keefer, E. W.; Botterman, B. R.; Romero, M. I.; Rossi, A. F.; Gross, G. W., 
Carbon nanotube coating improves neuronal recordings. Nat. Nanotechnol. 2008, 3 (7), 
434-439. 
 212 
11. Wang, K.; Fishman, H. A.; Dai, H. J.; Harris, J. S., Neural stimulation with a 
carbon nanotube microelectrode array. Nano Lett. 2006, 6 (9), 2043-2048. 
12. Gheith, M. K.; Sinani, V. A.; Wicksted, J. P.; Matts, R. L.; Kotov, N. A., Single-
walled carbon nanotube polyelectrolyte multilayers and freestanding films as a 
biocompatible platformfor neuroprosthetic implants. Advanced Materials 2005, 17 (22), 
2663-+. 
13. Jan, E.; Kotov, N. A., Successful differentiation of mouse neural stem cells on 
layer-by-layer assembled single-walled carbon nanotube composite. Nano Lett. 2007, 7 
(5), 1123-1128. 
14. Gheith, M. K.; Pappas, T. C.; Liopo, A. V.; Sinani, V. A.; Shim, B. S.; Motamedi, 
M.; Wicksted, J. R.; Kotov, N. A., Stimulation of neural cells by lateral layer-by-layer 
films of single-walled currents in conductive carbon nanotubes. Advanced Materials 
2006, 18 (22), 2975-+. 
15. Jan, E.; Hendricks, J. L.; Husaini, V.; Richardson-Burns, S. M.; Sereno, A.; 
Martin, D. C.; Kotov, N. A., Layered Carbon Nanotube-Polyelectrolyte Electrodes 
Outperform Traditional Neural Interface Materials. Nano Lett. 2009, 9 (12), 4012-4018. 
16. Tang, Z. Y.; Wang, Y.; Podsiadlo, P.; Kotov, N. A., Biomedical applications of 
layer-by-layer assembly: From biomimetics to tissue engineering. Advanced Materials 
2006, 18 (24), 3203-3224. 
17. Kam, N. W. S.; Jan, E.; Kotov, N. A., Electrical Stimulation of Neural Stem Cells 
Mediated by Humanized Carbon Nanotube Composite Made with Extracellular Matrix 
Protein. Nano Lett. 2009, 9 (1), 273-278. 
18. Kotov, N. A.; Winter, J. O.; Clements, I. P.; Jan, E.; Timko, B. P.; Campidelli, S.; 
Pathak, S.; Mazzatenta, A.; Lieber, C. M.; Prato, M.; Bellamkonda, R. V.; Silva, G. A.; 
Kam, N. W. S.; Patolsky, F.; Ballerini, L., Nanomaterials for Neural Interfaces. Advanced 
Materials 2009, 21 (40), 3970-4004. 
19. Purcell, E. K.; Seymour, J. P.; Yandamuri, S.; Kipke, D. R., In vivo evaluation of 
a neural stem cell-seeded prosthesis. Journal of Neural Engineering 2009, 6 (2). 
20. Rohatgi, P.; Langhals, N. B.; Kipke, D. R.; Patil, P. G., In vivo performance of a 
microelectrode neural probe with integrated drug delivery. Neurosurgical Focus 2009, 27 
(1). 
21. Purcell, E. K.; Thompson, D. E.; Ludwig, K. A.; Kipke, D. R., Flavopiridol 
reduces the impedance of neural prostheses in vivo without affecting recording quality. 
Journal of Neuroscience Methods 2009, 183 (2), 149-157. 
 213 
22. Polikov, V. S.; Su, E. C.; Ball, M. A.; Hong, J. S.; Reichert, W. M., Control 
protocol for robust in vitro glial scar formation around microwires: Essential roles of 
bFGF and serum in gliosis. Journal of Neuroscience Methods 2009, 181 (2), 170-177. 
23. Polikov, V. S.; Block, M. L.; Fellous, J. M.; Hong, J. S.; Reichert, W. M., In vitro 
model of glial scarring around neuroelectrodes chronically implanted in the CNS. 
Biomaterials 2006, 27 (31), 5368-5376. 
24. Kimura-Kuroda, J.; Teng, X.; Komuta, Y.; Yoshioka, N.; Sango, K.; Kawamura, 
K.; Raisman, G.; Kawano, H., An in vitro model of the inhibition of axon growth in the 
lesion scar formed after central nervous system injury. Molecular and Cellular 
Neuroscience 43 (2), 177-187. 
25. Wanner, I. B.; Deik, A.; Torres, M.; Rosendahl, A.; Neary, J. T.; Lemmon, V. P.; 
Bixby, J. L., A New In Vitro Model of the Glial Scar Inhibits Axon Growth. Glia 2008, 
56 (15), 1691-1709. 
26. Cullen, D. K.; Stabenfeldt, S. E.; Simon, C. M.; Tate, C. C.; LaPlaca, M. C., In 
vitro neural injury model for optimization of tissue-engineered constructs. Journal of 
Neuroscience Research 2007, 85 (16), 3642-3651. 
27. Irons, H. R.; Cullen, D. K.; Shapiro, N. P.; Lambert, N. A.; Lee, R. H.; LaPlaca, 
M. C., Three-dimensional neural constructs: a novel platform for neurophysiological 
investigation. Journal of Neural Engineering 2008, 5 (3), 333-341. 
28. LaPlaca, M. C.; Cullen, D. K.; McLoughlin, J. J.; Cargill, R. S., High rate shear 
strain of three-dimensional neural cell cultures: a new in vitro traumatic brain injury 
model. Journal of Biomechanics 2005, 38 (5), 1093-1105. 
29. Lee, J.; Shanbhag, S.; Kotov, N. A., Inverted colloidal crystals as three-
dimensional microenvironments for cellular co-cultures. Journal of Materials Chemistry 
2006, 16 (35), 3558-3564. 
30. Nichols, J. E.; Cortiella, J. Q.; Lee, J.; Niles, J. A.; Cuddihy, M.; Wang, S. P.; 
Bielitzki, J.; Cantu, A.; Mlcak, R.; Valdivia, E.; Yancy, R.; McClure, M. L.; Kotov, N. 
A., In vitro analog of human bone marrow from 3D scaffolds with biomimetic inverted 
colloidal crystal geometry. Biomaterials 2009, 30 (6), 1071-1079. 
31. Zhang, Y. J.; Wang, S. P.; Eghtedari, M.; Motamedi, M.; Kotov, N. A., Inverted-
colloidal-crystal hydrogel matrices as three-dimensional cell scaffolds. Advanced 
Functional Materials 2005, 15 (5), 725-731. 
32. Berg, R. W.; McBurney, M. W., Cell density and cell cycle effects on retinoic 
acid-induced embryonal carcinoma cell differentiation. Developmental Biology 1990, 138 
(1), 123-135. 
 214 
33. McBurney, M.; Reuhl, K.; Ally, A.; Nasipuri, S.; Bell, J.; Craig, J., 
Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture. J. 
Neurosci. 1988, 8 (3), 1063-1073. 
34. Staines, W. A.; Craig, J.; Reuhl, K.; McBurney, M. W., Retinoic acid treated P19 
embryonal carcinoma cells differentiate into oligodendrocytes capable of myelination. 
Neuroscience 1996, 71 (3), 845-853. 
35. Matsuda, Y.; Koito, H.; Yamamoto, H., Induction of myelin-associated 
glycoprotein expression through neuron-oligodendrocyte contact. Developmental Brain 
Research 1997, 100 (1), 110-116. 
36. Aizawa, T.; Haga, S.; Yoshikawa, K., Neural differentiation-associated generation 
of microglia-like phagocytes in murine embryonal carcinoma cell line. Developmental 
Brain Research 1991, 59 (1), 89-97. 
37. Azevedo, F. A. C.; Carvalho, L. R. B.; Grinberg, L. T.; Farfel, J. M.; Ferretti, R. 
E. L.; Leite, R. E. P.; Filho, W. J.; Lent, R.; Herculano-Houzel, S., Equal numbers of 
neuronal and nonneuronal cells make the human brain an isometrically scaled-up primate 
brain. The Journal of Comparative Neurology 2009, 513 (5), 532-541. 
38. Lawson, L. J.; Perry, V. H.; Dri, P.; Gordon, S., Heterogeneity in the distribution 
and morphology of microglia in the normal adult mouse brain. Neuroscience 1990, 39 
(1), 151-170. 
39. Santambrogio, L.; Belyanskaya, S. L.; Fischer, F. R.; Cipriani, B.; Brosnan, C. F.; 
Ricciardi-Castagnoli, P.; Stern, L. J.; Strominger, J. L.; Riese, R., Developmental 
plasticity of CNS microglia. Proceedings of the National Academy of Sciences of the 
United States of America 2001, 98 (11), 6295-6300. 
40. Hilgetag, C.; Barbas, H., Are there ten times more glia than neurons in the brain? 








Conclusions and Future Directions 
 
8.1 Conclusions 
In this dissertation, we demonstrated key properties of layer-by-layer (LBL) 
assembled carbon nanotube (CNT) composites that are essential for neural interfacing.  
Specifically, we showed that these nanostructured materials are biocompatible and 
possess excellent electrochemical properties for neural prosthetic applications. Most 
importantly, we were able to design biofunctional interfaces that can modulate cellular 
behaviors by integrating biological molecules into LBL assembled CNT composites. The 
combination of LBL assembly with CNTs is the enabling ingredient of this platform 
technology, allowing the unique properties of CNTs to be exploited and additional 
functionalities to be incorporated with high level of control over the material structure 
and composition. 
 In Chapter 2, we demonstrated the novel usage of high content screening assays 
as a convenient and universal tool for investigating the cytotoxicity of nanomaterials. We 
found that unlike CdTe quantum dots, gold nanoparticles, and freely dispersed CNTs, 
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which produced various cytotoxic effects on cells, LBL assembled CNT composite thin 
films were found to be nearly inert. Specifically, we observed little to no change in the 
cell number, nuclear area, mitochondrial membrane potential, and intracellular free 
calcium concentration of neural cells cultured on the CNT composite films, indicating 
their inertness and biocompatibility as a cellular interfacing material. 
In Chapter 3, we investigated the potential of interfacing LBL assembled CNT 
composites with neural stem cells (NSCs) because their plasticity and ability to 
reestablish neuronal circuits may be an important component in the engineering of an 
stable, biocompatible, and effective neural interface. In this chapter, we demonstrated 
that mouse embryonic NSCs from the cortex can be successfully differentiated to 
neurons, astrocytes, and oligodendrocytes with clear formation of neurites on LBL CNT 
thin films. The results suggest that LBL CNT films are a suitable substrate for NSCs as 
cell viability, metabolic activity, neurite outgrowth, and expression of neural markers 
were found to be similar to those obtained from NSCs differentiated on poly-L-ornithine 
coated surface, a commonly employed growth substratum for NSCs.  
In Chapter 4, the electrochemical properties of electrodes made from LBL 
assembled CNT composites were established and compared with electrodes made from 
iridium oxide and poly(3,4-ethylenedioxythiophene) (PEDOT). A thorough investigation 
was carried out to study properties such as electrochemical impedance, charge storage 
capacity, voltage excursion, and electrochemical stability, showing that the CNT 
electrodes outperformed the other electrodes. The LBL assembled CNT composites were 
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not only more stable electrochemically but also demonstrated more pronounced 
reductions in electrical impedance and augmentations in cathodic charge storage 
capacity. This clearly indicates that they are an excellent electrode material for neural 
prosthetic applications.  
In Chapter 5, LBL composites were prepared from CNTs and laminin to create 
an interface that can mediate the differentiation and electrical stimulation of neural stem 
cells. The laminin-CNT composite films were found to enhance the differentiation of 
NSCs. Cells exhibited extensive neurite outgrowth and formed functional neural network. 
In addition, excitation of cells was demonstrated by applying a lateral current through the 
CNT film, confirming the functionality of the differentiated NSCs, as well as the utility 
of the conductive CNT substrate.  
In Chapter 6, LBL assembled CNT composite films were engineered to 
incorporate plasmid DNAs, allowing that composites to deliver genetic materials to 
surrounding cells and thus altering their biological properties. The transfection efficiency 
of these functionalized CNT composites was found to be remarkably higher than the 
conventional solution-mediated technique. By using plasmid expression vectors for 
neural basic helix-loop-helix proteins, neurons were generated from multipotent cells 
adhering to the CNT multilayers. This chapter illustrates the possibility of a substantially 
improved level of tissue-device integration through recruiting and programming of 
resident stem cells in the nervous system.  
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In Chapter 7, we described our approach in developing an in vitro three-
dimensional neural tissue model for testing electrode coatings designed to mitigate 
electrode-induced gliosis. Our goal is to build a model system solely based on cell lines, 
which will negate the use of primary cells and the sacrifice of animals, making the testing 
of electrode materials much cheaper, faster, and easier.  
 In summary, the studies presented in this dissertation provide a detailed 
characterization of the biocompatibility and electrochemical properties of LBL assembled 
CNTs composites. In addition, these studies also serve as valuable examples regarding 
the design and implementation of biofunctionalities in the CNT composites and provide 
important insights into the interaction between nanomaterials and cellular behaviors. All 
of the work presented in this dissertation clearly and strongly supports our hypothesis that 
LBL assembly of CNT composites is a powerful and versatile platform for creating a 








8.2 Future Directions 
Despite the many exciting results generated from this dissertation, there is still 
much to be explored in realizing the full potential of a neural interface platform based on 
LBL assembled CNT composites. One property that remains to be characterized and 
optimized is the long-term stability of CNT composites in biologically relevant 
conditions. Since neural prosthetic devices need to stay inside the body for many years, 
accelerated stability testing of CNT composites would be necessary and could yield 
valuable information. Such testing may involve incubating the nanostructured CNT 
material in a simulated body fluid at body temperature with stirring of the fluid.1, 2 The 
physical structure, surface morphology, and electrochemical properties of the CNT LBL 
composites should be monitored as material degradation can significantly impact the 
biocompatibility and functionality of an implanted neural interface. Post processing of 
LBL assembled CNT composites, such as chemical crosslinking or heat treatment, may 
be required to achieve optimal stability since the high concentration of ions in simulated 
body fluid could destabilize the native composite films, which are held together by a 
combination of electrostatic and weak forces. Post processing strategies are promising as 
they have been shown to be effective in optimizing the mechanical strength and stiffness 
of CNT LBL composites.3 
Another direction of research that deserves attention is the fabrication of 
conductive CNT LBL films with neural tissue-like stiffness. While LBL assembled CNT 
films with high tensile strength and stiffness have been produced in the development of 
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ultra-strong materials,3, 4 very little work has been devoted to the engineering of soft 
multilayer materials.5 Several studies have demonstrated that matrix stiffness not only 
affects the adhesion of cells, but also controls the differentiation of stem cells.6-9 For 
example, mesenchymal stem cells were shown to commit to the lineage specified by 
matrix elasticity. Specifically, soft matrices that mimicked brain elasticity induced 
differentiation toward neurons while stiffer matrices that mimicked muscles were 
favorable for differentiation into myoblasts.8, 9 Both neurons and myoblasts are 
electroactive cells that can be electrically stimulated using conductive substrates like 
CNT LBL films.10 By engineering CNT LBL films with elasticity resembling that of the 
neural tissue (E~0.1-1 kPa),9 it may be possible to reduce acute inflammatory responses 
caused by mismatch in mechanical properties and increase neuronal differentiation of 
resident stem/progenitor cells. The level of control afforded by LBL assembly, as well as 
the wide selection of molecular species available to this nanostructuring technique, will 
be essential for this task. Since the desired material is most likely going to be a hydrogel 
film, the key challenge will be the ability to achieve sufficient electrical conductivity in 
this hydrated multilayer structure.  
The last direction of research to be discussed here is the fabrication of a thin film 
electrode array based on LBL assembled CNT composites. This challenge could generate 
the most impact and encompasses several aspects that go hand in hand with each other, 
including miniaturization, patterning, and packaging of the conductive CNT LBL films. 
One important function highly desired by neural prosthetic devices is the ability to 
acquire high temporal and spatial frequency signals. This function requires the 
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deployment of multiple number of recording electrodes that are not only small (< 0.5 
mm2) but also positioned close to each other.11 The ability to precisely fabricate such an 
array of electrode pads will require a patterning technology that is compatible with LBL 
assembled composite films. Conventional lithography techniques have been successfully 
utilized to create fine patterns on thin films fabricated from LBL assembly.12-14 This 
interesting combination of top-down and bottom-up techniques can be similarly applied 
to CNT LBL films. Although patterning of LBL films using soft-lithography has been 
demonstrated, the fine balance of forces required at the interface may be a limiting factor 
for certain combinations of materials.15 Another interesting strategy for generating 
patterns on LBL films is the use of laser ablation techniques. Femtosecond laser 
patterning of conducting polymer thin films16 has already been demonstrated and should 
be equally applicable to CNT LBL films. The ability to precisely pattern CNT LBL films 
would allow both a dense array of electrodes and their interconnection wires to be 
constructed solely from LBL assembled CNT composites. However, the interconnection 
wires must be packaged and protected with an insulating material to prevent contact with 
the surrounding tissue and fluids. The insulating layer or packaging material can also be 
fabricated from LBL films, and the electrodes can be selectively exposed using 
lithographic techniques. The large surface area covered by this outer insulating layer 
requires it to be biocompatible but also offers opportunities for additional functions to be 
incorporated, such as selective adhesion, anti-inflammatory, and drug delivery.17 With 
careful engineering and selection of materials, it would be possible to fabricate a thin film 
electrode array built entirely from LBL composite films. With a thickness of only a few 
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micrometers, this thin film electrode array would provide highly conformal coverage over 
the convoluted brain surface, which is critical to the establishment of a stable neural 
interface and the acquisition of quality signals.  We envision that such a device would be 
most suitable and successful as a new generation of subdural, non-penetrating surface 
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